Menu
Back to Journals » Vascular Health and Risk Management
Vascular Health and Risk Management
- View all (1189)
- Volume 16, 2020 (6)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Journal Articles:
- 1,189 records -
Inherited Thrombophilia in a Lebanese Family of Four Generations: A Case Report of Recurrent Miscarriage
Khalife S, Bissar-Tadmouri N
Vascular Health and Risk Management 2020, 16:53-56
Published Date: 21 January 2020
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
Sokos GG, Raina A
Vascular Health and Risk Management 2020, 16:41-51
Published Date: 16 January 2020
Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients
Radchenko GD, Zhyvylo IO, Titov EY, Sirenko YM
Vascular Health and Risk Management 2020, 16:29-39
Published Date: 16 January 2020
B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey [Corrigendum]
Onyemelukwe OU, Oyati AI, Danbauchi SS, Obasohan A
Vascular Health and Risk Management 2020, 16:27-28
Published Date: 15 January 2020
Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care
Alonso R, Perez de Isla L, Muñiz-Grijalvo O, Mata P
Vascular Health and Risk Management 2020, 16:11-25
Published Date: 9 January 2020
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date
Jia X, Koh S, Al Rifai M, Blumenthal RS, Virani SS
Vascular Health and Risk Management 2020, 16:1-10
Published Date: 9 January 2020
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives
Manolis AA, Manolis TA, Melita H, Manolis AS
Vascular Health and Risk Management 2019, 15:571-579
Published Date: 30 December 2019
B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey
Onyemelukwe OU, Oyati AI, Danbauchi SS, Obasohan A
Vascular Health and Risk Management 2019, 15:559-569
Published Date: 20 December 2019
Knowledge and Associated Factors of Blood Pressure Control Among Hypertensive Patients Attending Chronic Illness Follow-Up Clinic at University of Gondar, Comprehensive Specialized Hospital, Northwest, Ethiopia
Mekonnen CK, Mekonnen BY, Mekonnen HS
Vascular Health and Risk Management 2019, 15:551-558
Published Date: 13 December 2019
Effect of Long-Term Allopurinol Therapy on Left Ventricular Mass Index in Patients with Ischemic Heart Disease; A Cross-Sectional Study
Alem MM, Aldosari SR, Alkahmous AA, Obad AS, Fagir NM, Al-Ghamdi BS
Vascular Health and Risk Management 2019, 15:539-550
Published Date: 6 December 2019
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients
Toth PP, Philip S, Hull M, Granowitz C
Vascular Health and Risk Management 2019, 15:533-538
Published Date: 4 December 2019
Periodontitis As A Risk Factor For Stroke: A Systematic Review And Meta-Analysis
Fagundes NCF, Almeida APCPSC, Vilhena KFB, Magno MB, Maia LC, Lima RR
Vascular Health and Risk Management 2019, 15:519-532
Published Date: 6 November 2019
Polysaccharide Peptide (PsP) Ganoderma lucidum: A Potential Inducer For Vascular Repair In Type 2 Diabetes Mellitus Model [Corrigendum]
Heriansyah T, Nurwidyaningtyas W, Sargowo D, Tjahjono CT, Wihastuti TA
Vascular Health and Risk Management 2019, 15:517-518
Published Date: 5 November 2019
Marker Of Sepsis Severity Is Associated With The Variation In Cardio-Ankle Vascular Index (CAVI) During Sepsis Treatment
Nagayama D, Imamura H, Endo K, Saiki A, Sato Y, Yamaguchi T, Watanabe Y, Ohira M, Shirai K, Tatsuno I
Vascular Health and Risk Management 2019, 15:509-516
Published Date: 5 November 2019
Lp-PLA2 Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus
Wihastuti TA, Aini FN, Tjahjono CT, Sulfia YH, Sholichah Z, Heriansyah T
Vascular Health and Risk Management 2019, 15:503-508
Published Date: 1 November 2019
How To Support Smoking Cessation In Primary Care And The Community: A Systematic Review Of Interventions For The Prevention Of Cardiovascular Diseases
Odorico M, Le Goff D, Aerts N, Bastiaens H, Le Reste JY
Vascular Health and Risk Management 2019, 15:485-502
Published Date: 31 October 2019
Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany
Waßmuth S, Rohe K, Noack F, Noutsias M, Treede H, Schlitt A
Vascular Health and Risk Management 2019, 15:477-483
Published Date: 31 October 2019
Association Between Adherence To The French Dietary Guidelines And Lower Resting Heart Rate, Longer Diastole Duration, And Lower Myocardial Oxygen Consumption. The NUTRIVASC Study
Fysekidis M, Kesse-Guyot E, Valensi P, Arnault N, Galan P, Hercberg S, Cosson E
Vascular Health and Risk Management 2019, 15:463-475
Published Date: 30 October 2019
Splanchnic Vein Thrombosis: Current Perspectives
Valeriani E, Riva N, Di Nisio M, Ageno W
Vascular Health and Risk Management 2019, 15:449-461
Published Date: 22 October 2019
Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
Ajmera P, Pothineni R, Chawla KK, Mantravadi SS, Jariwala PV, Vijan V, Vijan V
Vascular Health and Risk Management 2019, 15:439-447
Published Date: 18 October 2019
Clinical Characteristics And Health Care Resources In Patients Treated With Oral Anticoagulants: Evidences From Italian Administrative Databases
Degli Esposti L, Andretta M, Di Pasquale G, Gambera M, Saragoni S, Perrone V, Buda S
Vascular Health and Risk Management 2019, 15:429-437
Published Date: 11 October 2019
Polysaccharide peptide (PsP) Ganoderma lucidum: a potential inducer for vascular repair in type 2 diabetes mellitus model
Heriansyah T, Nurwidyaningtyas W, Sargowo D, Tjahjono CT, Wihastuti TA
Vascular Health and Risk Management 2019, 15:419-427
Published Date: 3 October 2019
Retrospective study of cardiovascular disease risk factors among a cohort of combat veterans with lower limb amputation
Bhatnagar V, Richard E, Melcer T, Walker J, Galarneau M
Vascular Health and Risk Management 2019, 15:409-418
Published Date: 19 September 2019
When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics
Seelig J, Pisters R, Hemels ME, Huisman MV, ten Cate H, Alings M
Vascular Health and Risk Management 2019, 15:399-408
Published Date: 17 September 2019
Evaluation of the calculation formulas of the cardio-ankle vascular index used in the Japanese apparatus
Ato D
Vascular Health and Risk Management 2019, 15:395-398
Published Date: 13 September 2019
Comparison of perioperative costs with fast-track vs standard endovascular aneurysm repair
Krajcer Z, Ramaiah VG, Henao EA, Nelson WK, Moursi MM, Rajasinghe HA, Anderson LH, Miller LE
Vascular Health and Risk Management 2019, 15:385-393
Published Date: 3 September 2019
PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve
Haraldsson I, Gan LM, Svedlund S, Torngren K, Westergren HU, Redfors B, Lagerström-Fermér M, Angerås O, Råmunddal T, Petursson P, Odenstedt J, Albertsson P, Erlinge D, Omerovic E
Vascular Health and Risk Management 2019, 15:375-384
Published Date: 28 August 2019
Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus
Lessey G, Stavropoulos K, Papademetriou V
Vascular Health and Risk Management 2019, 15:365-373
Published Date: 22 August 2019
Screening of peripheral arterial disease in primary health care
Tóth-Vajna Z, Tóth-Vajna G, Gombos Z, Szilágyi B, Járai Z, Berczeli M, Sótonyi P
Vascular Health and Risk Management 2019, 15:355-363
Published Date: 20 August 2019
Visceral bed involvement in thromboangiitis obliterans: a systematic review
Fakour F, Fazeli B
Vascular Health and Risk Management 2019, 15:317-353
Published Date: 15 August 2019
Activation of stem cell up-regulation/mobilization: a cardiovascular risk in both mice and humans with implications for liver disease, psoriasis and SLE
Gemery JM, Forauer AR, Hoffer EK
Vascular Health and Risk Management 2019, 15:309-316
Published Date: 26 August 2019
Patients’ expectations of returning to work, co-morbid disorders and work capacity at discharge from cardiac rehabilitation
Salzwedel A, Reibis R, Hadzic M, Buhlert H, Völler H
Vascular Health and Risk Management 2019, 15:301-308
Published Date: 14 August 2019
The association between sedentary behavior, physical activity and hyperuricemia
Park DY, Kim YS, Ryu SH, Jin YS
Vascular Health and Risk Management 2019, 15:291-299
Published Date: 13 August 2019
The role of precise imaging with intravascular ultrasound in coronary and peripheral interventions
Shammas NW, Radaideh Q, Shammas WJ, Daher GE, Rachwan RJ, Radaideh Y
Vascular Health and Risk Management 2019, 15:283-290
Published Date: 7 August 2019
Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit
Caruso P, Signori R, Moretti R
Vascular Health and Risk Management 2019, 15:259-281
Published Date: 7 August 2019
Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature
Waisayarat J, Plumworasawat S, Vilaiyuk S, Sirachainan N
Vascular Health and Risk Management 2019, 15:253-258
Published Date: 7 August 2019
Prognostic implications of left ventricular strain by speckle-tracking echocardiography in the general population: a meta-analysis
Al Saikhan L, Park C, Hardy R, Hughes A
Vascular Health and Risk Management 2019, 15:229-251
Published Date: 24 July 2019
Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction
Al Aseri ZA, Habib SS, Marzouk A
Vascular Health and Risk Management 2019, 15:221-227
Published Date: 15 July 2019
Cholesterol-embolization syndrome: current perspectives
Ozkok A
Vascular Health and Risk Management 2019, 15:209-220
Published Date: 8 July 2019
The burden of critical limb ischemia: a review of recent literature
Duff S, Mafilios MS, Bhounsule P, Hasegawa JT
Vascular Health and Risk Management 2019, 15:187-208
Published Date: 1 July 2019
Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
Song AB, Rosovsky RP, Connors JM, Al-Samkari H
Vascular Health and Risk Management 2019, 15:175-186
Published Date: 21 June 2019
Electronic cigarettes and cardiovascular health: what do we know so far?
MacDonald A, Middlekauff HR
Vascular Health and Risk Management 2019, 15:159-174
Published Date: 21 June 2019
High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus
Artha IMJR, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, Yuwono J, Bhargah V, Prabawa IPY, Manuaba IBAP, Rina IK
Vascular Health and Risk Management 2019, 15:149-157
Published Date: 5 June 2019
Stability of thromboxane in blood samples
Helgadóttir H, Ólafsson Í, Andersen K, Gizurarson S
Vascular Health and Risk Management 2019, 15:143-147
Published Date: 4 June 2019
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
Giannandrea D, Mengoni A, Carluccio E, Ambrosio G
Vascular Health and Risk Management 2019, 15:139-142
Published Date: 23 May 2019
Validation of two automatic devices, Omron HEM-6232T and HEM-6181, for self-measurement of blood pressure at the wrist according to the ANSI/AAMI/ISO 81060-2:2013 protocol and the European Society of Hypertension International Protocol revision 2010 [Corrigendum]
Saito K, Hishiki Y, Takahashi H
Vascular Health and Risk Management 2019, 15:137-138
Published Date: 17 May 2019
Serum untargeted lipidomic profiling reveals dysfunction of phospholipid metabolism in subclinical coronary artery disease
Djekic D, Pinto R, Repsilber D, Hyotylainen T, Henein M
Vascular Health and Risk Management 2019, 15:123-135
Published Date: 13 May 2019
Iliac vein compression: epidemiology, diagnosis and treatment
Radaideh Q, Patel NM, Shammas NW
Vascular Health and Risk Management 2019, 15:115-122
Published Date: 9 May 2019
Screening for obstructive sleep apnea among patients undergoing coronary catheterization in Jordan
Jarrah MI, Yassin AM, Ibdah RK, Ibnian AM, Eyadeh AA, Khassawneh BY
Vascular Health and Risk Management 2019, 15:109-113
Published Date: 1 May 2019
Carotid intima-media thickness among normoglycemia and normotension first-degree relatives of type 2 diabetes mellitus
Purnamasari D, Abdaly MS, Azizi MS, Wijaya IP, Nugroho P
Vascular Health and Risk Management 2019, 15:101-107
Published Date: 2 May 2019
Obesity paradox in cardiovascular disease: where do we stand?
Carbone S, Canada JM, Billingsley HE, Siddiqui MS, Elagizi A, Lavie CJ
Vascular Health and Risk Management 2019, 15:89-100
Published Date: 1 May 2019
Successful reversal of isolated delayed spinal cord ischemia following endovascular abdominal aneurysm repair
Aljarrah Q, Al-Omari MH, Elheis M, Al-Jarrah M, Jamal A, Alzoubi A
Vascular Health and Risk Management 2019, 15:81-87
Published Date: 23 April 2019
Variation in the choice of elective surgical procedure for abdominal aortic aneurysm in Spain
Quintana MJ, Gich I, Librero J, Bellmunt-Montoya S, Escudero JR, Bonfill X
Vascular Health and Risk Management 2019, 15:69-79
Published Date: 8 April 2019
Characteristics of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA ) from the ARIAM-SEMICYUC registry: development of a score for predicting MINOCA
Ballesteros-Ortega D, Martínez-González O, Blancas Gómez-Casero R, Quintana-Díaz M, de-Miguel-Balsa E, Martín-Parra C, López-Matamala B, Chana-García M, Alonso-Fernández MÁ, Manso-Álvarez M
Vascular Health and Risk Management 2019, 15:57-67
Published Date: 13 March 2019
Validation of two automatic devices, Omron HEM-6232T and HEM-6181, for self-measurement of blood pressure at the wrist according to the ANSI/AAMI/ISO 81060-2:2013 protocol and the European Society of Hypertension International Protocol revision 2010
Saito K, Hishiki Y, Takahashi H
Vascular Health and Risk Management 2019, 15:47-55
Published Date: 6 March 2019
Blood pressure control in treated hypertensive Middle Eastern patients: a post hoc analysis based on JNC8 definitions
Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S
Vascular Health and Risk Management 2019, 15:35-46
Published Date: 6 March 2019
The prevalence, awareness, treatment, and control of hypertension among adults: the first cross-sectional national population-based survey in Laos
Pengpid S, Vonglokham M, Kounnavong S, Sychareun V, Peltzer K
Vascular Health and Risk Management 2019, 15:27-33
Published Date: 27 February 2019
Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study – data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA)
Monelli M, Molteni M, Cassetti G, Bagnara L, De Grazia V, Zingale L, Zilli F, Bussotti M, Totaro P, De Maria B, Dalla Vecchia LA
Vascular Health and Risk Management 2019, 15:19-25
Published Date: 14 February 2019
Long-term effects on survival after a 1-year multifactorial vascular risk factor intervention after stroke or TIA: secondary analysis of a randomized controlled trial, a 7-year follow-up study
Hagberg G, Fure B, Sandset EC, Thommessen B, Ihle-Hansen H, Øksengård AR, Nygård S, Wyller TB, Ihle-Hansen H
Vascular Health and Risk Management 2019, 15:11-18
Published Date: 7 February 2019
Biomarkers in acute myocardial infarction: current perspectives
Aydin S, Ugur K, Aydin S, Sahin İ, Yardim M
Vascular Health and Risk Management 2019, 15:1-10
Published Date: 17 January 2019
Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
Skelley JW, Carter BS, Roberts MZ
Vascular Health and Risk Management 2018, 14:419-428
Published Date: 7 December 2018
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
Hines DM, Rane P, Patel J, Harrison DJ, Wade RL
Vascular Health and Risk Management 2018, 14:409-418
Published Date: 10 December 2018
Prevalence and risk factors of peripheral artery disease in black Africans with HIV infection: a cross-sectional hospital-based study
Kamdem F, Mapoure Y, Hamadou B, Souksouna F, Doualla MS, Jingi AM, Kenmegne C, Kemta Lekpa F, Kweban Fenkeu J, Imandy G, Nda Mefo’o JP, Luma H
Vascular Health and Risk Management 2018, 14:401-408
Published Date: 6 December 2018
Enhanced external counterpulsation in rehabilitation of erectile dysfunction: a narrative literature review
Raeissadat SA, Javadi A, Allameh F
Vascular Health and Risk Management 2018, 14:393-399
Published Date: 3 December 2018
All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study
Degli Esposti L, Perrone V, Veronesi C, Buda S, Rossini R
Vascular Health and Risk Management 2018, 14:383-392
Published Date: 20 November 2018
Noncardiac Lebanese hospitalized adult patients’ awareness of their coronary artery disease risk factors
Ghaddar F, Salameh P, Saleh N, Farhat F, Chahine R, Lahoud N, Hleyhel M, Zeidan RK
Vascular Health and Risk Management 2018, 14:371-382
Published Date: 8 November 2018
Walking activity during ambulant cardiac rehabilitation is related to maximum working capacity, age, and smoking behavior
Al Najem S, Groll A, Schmermund A, Nowak B, Voigtländer T, Kaltenbach U, Dohmann P, Andresen D, Scharhag J
Vascular Health and Risk Management 2018, 14:361-369
Published Date: 9 November 2018
Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
Bussotti M, Sommaruga M
Vascular Health and Risk Management 2018, 14:349-360
Published Date: 8 November 2018
Brachial–ankle pulse wave velocity, cardio-ankle vascular index, and prognosis
Ato D
Vascular Health and Risk Management 2018, 14:321-348
Published Date: 24 October 2018
Use of photoplethysmography to predict mortality in intensive care units
Kock KS, Marques JLB
Vascular Health and Risk Management 2018, 14:311-320
Published Date: 31 October 2018
Assessment of some traditional cardiovascular risk factors in medical doctors in Southern Nigeria
Ambakederemo TE, Chikezie EU
Vascular Health and Risk Management 2018, 14:299-309
Published Date: 24 October 2018
Redefined clinical spectra of diabetic foot syndrome
Shatnawi NJ, Al-Zoubi NA, Hawamdeh H, Khader YS, Omari AEK, Khammash MR
Vascular Health and Risk Management 2018, 14:291-298
Published Date: 18 October 2018
Role of androgens in cardiovascular pathology
Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN
Vascular Health and Risk Management 2018, 14:283-290
Published Date: 15 October 2018
Idiopathic true aneurysm of distal radial artery: case report
Al-Zoubi NA
Vascular Health and Risk Management 2018, 14:279-281
Published Date: 11 October 2018
Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)
Radchenko GD, Mushtenko LO, Sirenko YM
Vascular Health and Risk Management 2018, 14:265-278
Published Date: 11 October 2018
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
Correale M, Ferraretti A, Monaco I, Grazioli D, Di Biase M, Brunetti ND
Vascular Health and Risk Management 2018, 14:253-264
Published Date: 4 October 2018
Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?
Mohareri M, Mirhosseini A, Mehraban S, Fazeli B
Vascular Health and Risk Management 2018, 14:247-251
Published Date: 28 September 2018
Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses
Fernet M, Beckerman B, Abreu P, Lins K, Vincent J, Burgess E
Vascular Health and Risk Management 2018, 14:233-246
Published Date: 20 September 2018
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)
Nomura S, Taniura T, Shouzu A, Omoto S, Suzuki M, Okuda Y, Ito T
Vascular Health and Risk Management 2018, 14:225-232
Published Date: 18 September 2018
Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents
Aflyatumova GN, Nigmatullina R, Sadykova DI, Chibireva MD, Fugetto F, Serra R
Vascular Health and Risk Management 2018, 14:213-223
Published Date: 18 September 2018
Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study
Blaes AH, Mulrooney DA, Vogel RI, Solovey A, Hebbel R, Peterson BA, Neglia JP, Biewen C, Konety SH, Duprez DA
Vascular Health and Risk Management 2018, 14:205-211
Published Date: 10 September 2018
Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana
Antwi-Boasiako C, Campbell AD
Vascular Health and Risk Management 2018, 14:199-204
Published Date: 6 September 2018
Clinical accuracy of the Omron M3 Comfort® and the Omron Evolv® for self-blood pressure measurements in pregnancy and pre-eclampsia – validation according to the Universal Standard Protocol
Topouchian J, Hakobyan Z, Asmar J, Gurgenian S, Zelveian P, Asmar R
Vascular Health and Risk Management 2018, 14:189-197
Published Date: 31 August 2018
Prognosis of patients with pulmonary embolism after rehabilitation
Amoury M, Noack F, Kleeberg K, Stoevesandt D, Lehnigk B, Bethge S, Heinze V, Schlitt A
Vascular Health and Risk Management 2018, 14:183-187
Published Date: 30 August 2018
Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies
Chowdhury MZI, Haque MA, Farhana Z, Anik AM, Chowdhury AH, Haque SM, Marjana LLW, Bristi PD, Mamun BAA, Uddin MJ, Fatema J, Rahman MM, Akter T, Tani TA, Turin TC
Vascular Health and Risk Management 2018, 14:165-181
Published Date: 21 August 2018
Risk factors for deep vein thrombosis of lower extremities in Sudanese women
Ibrahim NA, Hassan FM, Elgari MM, Abdalla SE
Vascular Health and Risk Management 2018, 14:157-164
Published Date: 20 August 2018
Spontaneous internal jugular vein thrombosis as primary presentation of antiphospholipid syndrome: case report
Al-Zoubi NA
Vascular Health and Risk Management 2018, 14:153-155
Published Date: 16 July 2018
Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness
Sabry HH, Sabry JH, Daifalla AEH, Akl EM, Hamed AM, Torky AAA
Vascular Health and Risk Management 2018, 14:145-152
Published Date: 9 July 2018
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance
Shunmoogam N, Naidoo P, Chilton R
Vascular Health and Risk Management 2018, 14:137-143
Published Date: 18 June 2018
Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism
Kim SH, Patel N, Thapar K, Pandurangadu AV, Bahl A
Vascular Health and Risk Management 2018, 14:129-135
Published Date: 12 June 2018
The association between the serum level of vitamin D and ischemic heart disease: a study from Jordan
Jarrah MI, Mhaidat NM, Alzoubi KH, Alrabadi N, Alsatari E, Khader Y, Bataineh MF
Vascular Health and Risk Management 2018, 14:119-127
Published Date: 12 June 2018
Anemia and acute coronary syndrome: current perspectives
Stucchi M, Cantoni S, Piccinelli E, Savonitto S, Morici N
Vascular Health and Risk Management 2018, 14:109-118
Published Date: 30 May 2018
Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
Liu L, Chang B, Wu X, Guo Y, Pan Y, Yang L
Vascular Health and Risk Management 2018, 14:103-108
Published Date: 29 May 2018
Nonadherence to statins: individualized intervention strategies outside the pill box
Lansberg P, Lee A, Lee ZV, Subramaniam K, Setia S
Vascular Health and Risk Management 2018, 14:91-102
Published Date: 24 May 2018
Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada
Senay A, Trottier M, Delisle J, Banica A, Benoit B, Laflamme GY, Malo M, Nguyen H, Ranger P, Fernandes JC
Vascular Health and Risk Management 2018, 14:81-89
Published Date: 8 May 2018
Age–gender distribution of coronary artery calcium score in a black African population in Ghana
Asafu Adjaye Frimpong G, Owusu IK, Anyitey-Kokor IC, Wiafe-Kwakye CSNS, Aboagye E, Coleman NE, Amankwah P, Abaidoo NK
Vascular Health and Risk Management 2018, 14:75-80
Published Date: 4 May 2018
Critical limb ischemia: current challenges and future prospects
Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R
Vascular Health and Risk Management 2018, 14:63-74
Published Date: 26 April 2018
Pitfalls in the ankle-brachial index and brachial-ankle pulse wave velocity
Ato D
Vascular Health and Risk Management 2018, 14:41-62
Published Date: 3 April 2018
Patient knowledge on stroke risk factors, symptoms and treatment options
Faiz KW, Sundseth A, Thommessen B, Rønning OM
Vascular Health and Risk Management 2018, 14:37-40
Published Date: 7 February 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease
Power TP, Ke X, Zhao Z, Bonine NG, Cziraky MJ, Grabner M, Barron JJ, Quimbo R, Vangerow B, Toth PP
Vascular Health and Risk Management 2018, 14:23-36
Published Date: 5 February 2018
Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice
Vimalesvaran K, Dockrill SJ, Gorog DA
Vascular Health and Risk Management 2018, 14:13-21
Published Date: 9 January 2018
Postural tachycardia syndrome: current perspectives
Wells R, Spurrier AJ, Linz D, Gallagher C, Mahajan R, Sanders P, Page A, Lau DH
Vascular Health and Risk Management 2018, 14:1-11
Published Date: 29 December 2017
Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
ten Cate H, Henskens YMC, Lancé MD
Vascular Health and Risk Management 2017, 13:457-467
Published Date: 13 December 2017
Extracorporeal ultrafiltration for acute heart failure: patient selection and perspectives
Milazzo V, Cosentino N, Marenzi G
Vascular Health and Risk Management 2017, 13:449-456
Published Date: 11 December 2017
Pelvic vein incompetence: clinical perspectives
Riding DM, Hansrani V, McCollum C
Vascular Health and Risk Management 2017, 13:439-447
Published Date: 27 November 2017
Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease
Mordi IR, Badar AA, Irving RJ, Weir-McCall JR, Houston JG, Lang CC
Vascular Health and Risk Management 2017, 13:427-437
Published Date: 21 November 2017
Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population
Calderón-Gerstein WS, López-Peña A, Macha-Ramírez R, Bruno-Huamán A, Espejo-Ramos R, Vílchez-Bravo S, Ramírez-Breña M, Damián-Mucha M, Matos-Mucha A
Vascular Health and Risk Management 2017, 13:421-426
Published Date: 21 November 2017
Treatment of pulmonary hypertension with left heart disease: a concise review
Desai A, Desouza SA
Vascular Health and Risk Management 2017, 13:415-420
Published Date: 6 November 2017
Quick reference guide to apixaban [Corrigendum]
Hurst KV, O'Callaghan JM, Handa A
Vascular Health and Risk Management 2017, 13:413-414
Published Date: 26 October 2017
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
Yugar-Toledo JC, Modolo R, de Faria AP, Moreno H
Vascular Health and Risk Management 2017, 13:403-411
Published Date: 16 October 2017
Implementing clinical process management of vascular wounds in a tertiary facility: impact evaluation of a performance improvement project
Avruscio G, Tocco-Tussardi I, Bordignon G, Vindigni V
Vascular Health and Risk Management 2017, 13:393-401
Published Date: 16 October 2017
Factors associated with high brachial–ankle pulse wave velocity in non-hypertensive and appropriately treated hypertensive patients with atherosclerotic risk factors
Ato D, Sawayama T
Vascular Health and Risk Management 2017, 13:383-392
Published Date: 10 October 2017
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
Yandrapalli S, Andries G, Biswas M, Khera S
Vascular Health and Risk Management 2017, 13:369-382
Published Date: 5 October 2017
Evaluation of vitamin D levels in relation to coronary CT angiographic findings in an Iranian population
Moradi M, Foroutanfar A
Vascular Health and Risk Management 2017, 13:361-367
Published Date: 4 October 2017
Right ventricular systolic function in hypertensive heart failure
Oketona OA, Balogun MO, Akintomide AO, Ajayi OE, Adebayo RA, Mene-Afejuku TO, Oketona OT, Bamikole OJ
Vascular Health and Risk Management 2017, 13:353-360
Published Date: 27 September 2017
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
Catapano AL, Pirillo A, Norata GD
Vascular Health and Risk Management 2017, 13:343-351
Published Date: 4 September 2017
Evaluation of bleeding in patients receiving direct oral anticoagulants
Hellenbart EL, Faulkenberg KD, Finks SW
Vascular Health and Risk Management 2017, 13:325-342
Published Date: 23 August 2017
Endothelial dysfunction in patients with Buerger disease
Igari K, Kudo T, Toyofuku T, Inoue Y
Vascular Health and Risk Management 2017, 13:317-323
Published Date: 23 August 2017
Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure
Ojji DB, Lecour S, Adeyemi OM, Sliwa K
Vascular Health and Risk Management 2017, 13:311-316
Published Date: 16 August 2017
Evaluation of pain during endovenous laser ablation of the great saphenous vein with ultrasound-guided femoral nerve block
Al Wahbi AM
Vascular Health and Risk Management 2017, 13:305-309
Published Date: 10 August 2017
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
Aghel N, Delgado DH, Lipton JH
Vascular Health and Risk Management 2017, 13:293-303
Published Date: 4 August 2017
Reversal of direct oral anticoagulants
Almegren M
Vascular Health and Risk Management 2017, 13:287-292
Published Date: 19 July 2017
Hypertension and blood pressure variability management practices among physicians in Singapore
Setia S, Subramaniam K, Tay JC, Teo BW
Vascular Health and Risk Management 2017, 13:275-285
Published Date: 17 July 2017
Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization
Kray JE, Dombrovskiy VY, Vogel TR
Vascular Health and Risk Management 2017, 13:269-274
Published Date: 14 July 2017
Quick reference guide to apixaban
Hurst KV, O'Callaghan JM, Handa A
Vascular Health and Risk Management 2017, 13:263-267
Published Date: 10 July 2017
Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow
Yılmaz M, Dağlı MN, Uku Ö, Bilen MN, Korkmaz H, Erdem K, Kurtoğlu E
Vascular Health and Risk Management 2017, 13:255-261
Published Date: 7 July 2017
Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy
Jetty V, Glueck CJ, Lee K, Goldenberg N, Prince M, Kumar A, Goldenberg M, Anand I, Wang P
Vascular Health and Risk Management 2017, 13:247-253
Published Date: 6 July 2017
Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study
Ermini G, Perrone V, Veronesi C, Degli Esposti L, Di Pasquale G
Vascular Health and Risk Management 2017, 13:239-246
Published Date: 5 July 2017
Annual deterioration of renal function in hypertensive patients with and without diabetes
Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S
Vascular Health and Risk Management 2017, 13:231-237
Published Date: 26 June 2017
Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism
Mesquita PN, Dornelas Leão Leite AP, Chagas Crisostomo S, Veras Filho E, Cunha Xavier L, Bandeira F
Vascular Health and Risk Management 2017, 13:225-229
Published Date: 22 June 2017
Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery
Krog AH, Sahba M, Pettersen EM, Wisloff T, Sundhagen JO, Kazmi SSH
Vascular Health and Risk Management 2017, 13:217-224
Published Date: 19 June 2017
Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial [Erratum]
Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS
Vascular Health and Risk Management 2017, 13:215-216
Published Date: 19 June 2017
Worksite-based cardiovascular risk screening and management: a feasibility study
Padwal R, Rashead M, Snider J, Morrin L, Lehman A, Campbell NRC
Vascular Health and Risk Management 2017, 13:209-213
Published Date: 12 June 2017
Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation method
Fernández-Cidón B, Padró-Miquel A, Alía-Ramos P, Castro-Castro MJ, Fanlo-Maresma M, Dot-Bach D, Valero-Politi J, Pintó-Sala X, Candás-Estébanez B
Vascular Health and Risk Management 2017, 13:201-207
Published Date: 6 June 2017
Totally laparoscopic aortobifemoral bypass surgery in the treatment of aortoiliac occlusive disease or abdominal aortic aneurysms – a systematic review and critical appraisal of literature
Helgetveit I, Krog AH
Vascular Health and Risk Management 2017, 13:187-199
Published Date: 18 May 2017
Pediatric ventricular assist devices: current challenges and future prospects
Burki S, Adachi I
Vascular Health and Risk Management 2017, 13:177-185
Published Date: 15 May 2017
Patient-perceived health-related quality of life before and after laparoscopic aortobifemoral bypass
Kazmi SSH, Krog AH, Berge ST, Sundhagen JO, Sahba M, Falk RS
Vascular Health and Risk Management 2017, 13:169-176
Published Date: 12 May 2017
Infrainguinal open reconstruction: a review of surgical considerations and expected outcomes
Komshian SR, Lu K, Pike SL, Siracuse JJ
Vascular Health and Risk Management 2017, 13:161-168
Published Date: 8 May 2017
Pulmonary hypertension in Nigerian adults with sickle cell anemia
Amadi VN, Balogun MO, Akinola NO, Adebayo RA, Akintomide AO
Vascular Health and Risk Management 2017, 13:153-160
Published Date: 8 May 2017
The changing trend of cardiovascular disease and its clinical characteristics in Ethiopia: hospital‑based observational study
Tefera YG, Abegaz TM, Abebe TB, Mekuria AB
Vascular Health and Risk Management 2017, 13:143-151
Published Date: 21 April 2017
Impact of around-the-clock in-house cardiology fellow coverage on door-to-balloon time in an academic medical center
Kohan LC, Nagarajan V, Millard MA, Loguidice MJ, Fauber NM, Keeley EC
Vascular Health and Risk Management 2017, 13:139-142
Published Date: 18 April 2017
High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
Goss F, Brachmann J, Hamm CW, Haerer W, Reifart N, Levenson B
Vascular Health and Risk Management 2017, 13:127-137
Published Date: 6 April 2017
DPP-4 inhibitor treatment: β-cell response but not HbA1c reduction is dependent on the duration of diabetes
Kozlovski P, Bhosekar V, Foley JE
Vascular Health and Risk Management 2017, 13:123-126
Published Date: 31 March 2017
New pharmacological and technological management strategies in heart failure
Chaudhry SP, Stewart GC
Vascular Health and Risk Management 2017, 13:111-121
Published Date: 21 March 2017
Early discharge compared with ordinary discharge after percutaneous coronary intervention – a systematic review and meta-analysis of safety and cost
Abdelnoor M, Andersen JG, Arnesen H, Johansen O
Vascular Health and Risk Management 2017, 13:101-109
Published Date: 20 March 2017
Aerobic fitness is associated with low cardiovascular disease risk: the impact of lifestyle on early risk factors for atherosclerosis in young healthy Swedish individuals – the Lifestyle, Biomarker, and Atherosclerosis study
Fernström M, Fernberg U, Eliason G, Hurtig-Wennlöf A
Vascular Health and Risk Management 2017, 13:91-99
Published Date: 15 March 2017
Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
Alipour A, Wintgens LIS, Swaans MJ, Balt JC, Rensing BJWM, Boersma LVA
Vascular Health and Risk Management 2017, 13:81-90
Published Date: 6 March 2017
Prognostic indices among hypertensive heart failure patients in Nigeria: the roles of 24-hour Holter electrocardiography and 6-minute walk test
Mene-Afejuku TO, Balogun MO, Akintomide AO, Adebayo RA
Vascular Health and Risk Management 2017, 13:71-79
Published Date: 27 February 2017
Questionable accuracy of home blood pressure measurements in the obese population – Validation of the Microlife WatchBP O3® and Omron RS6® devices according to the European Society of Hypertension-International Protocol
Azaki A, Diab R, Harb A, Asmar R, Chahine MN
Vascular Health and Risk Management 2017, 13:61-69
Published Date: 27 February 2017
Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation
Salzwedel A, Heidler MD, Haubold K, Schikora M, Reibis R, Wegscheider K, Jöbges M, Völler H
Vascular Health and Risk Management 2017, 13:55-60
Published Date: 23 February 2017
An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes
Messana JA, Schwartz SS, Townsend RR
Vascular Health and Risk Management 2017, 13:43-54
Published Date: 17 February 2017
Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
Tarantino N, Santoro F, De Gennaro L, Correale M, Guastafierro F, Gaglione A, Di Biase M, Brunetti ND
Vascular Health and Risk Management 2017, 13:29-41
Published Date: 16 February 2017
An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia
Bove M, Cicero AFG, Veronesi M, Borghi C
Vascular Health and Risk Management 2017, 13:23-28
Published Date: 8 February 2017
Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006–2012
An R, Wang PP
Vascular Health and Risk Management 2017, 13:15-21
Published Date: 20 January 2017
Complex neurological symptoms in bilateral thalamic stroke due to Percheron artery occlusion
Caruso P, Manganotti P, Moretti R
Vascular Health and Risk Management 2017, 13:11-14
Published Date: 22 December 2016
Inverse relationship of cardioankle vascular index with BMI in healthy Japanese subjects: a cross-sectional study
Nagayama D, Imamura H, Sato Y, Yamaguchi T, Ban N, Kawana H, Ohira M, Saiki A, Shirai K, Tatsuno I
Vascular Health and Risk Management 2017, 13:1-9
Published Date: 21 December 2016
Prevalence of cardiovascular risk factors among workers at a private tertiary center in Angola
Paquissi FC, Manuel V, Manuel A, Mateus GL, David B, Béu G, Castela A
Vascular Health and Risk Management 2016, 12:497-503
Published Date: 14 December 2016
Results of a venous thromboembolism prophylaxis program for hospitalized patients
Cardoso LF, Krokoscz DV, Paiva EF, Furtado IS, Mattar Jr J, de Souza e Sá MM, de Lira AC
Vascular Health and Risk Management 2016, 12:491-496
Published Date: 12 December 2016
Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia
Benes LB, Bassi NS, Davidson MH
Vascular Health and Risk Management 2016, 12:481-490
Published Date: 12 December 2016
Platelet count and platelet indices in women with preeclampsia
AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I
Vascular Health and Risk Management 2016, 12:477-480
Published Date: 21 November 2016
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
Schellings DAAM, Adiyaman A, Dambrink JH, Gosselink ATM, Kedhi E, Roolvink V, Ottervanger JP, van't Hof AWJ
Vascular Health and Risk Management 2016, 12:471-476
Published Date: 21 November 2016
Advances in the management of heart failure: the role of ivabradine
Müller-Werdan U, Stöckl G, Werdan K
Vascular Health and Risk Management 2016, 12:453-470
Published Date: 17 November 2016
Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence
Antza C, Stabouli S, Kotsis V
Vascular Health and Risk Management 2016, 12:443-451
Published Date: 15 November 2016
A stress-related explanation to the increased blood pressure and its course following ischemic stroke
Kvistad CE, Oygarden H, Logallo N, Thomassen L, Waje-Andreassen U, Moen G, Naess H
Vascular Health and Risk Management 2016, 12:435-442
Published Date: 11 November 2016
Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders
Gupta S
Vascular Health and Risk Management 2016, 12:421-433
Published Date: 10 November 2016
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus
Derosa G, Maffioli P
Vascular Health and Risk Management 2016, 12:415-419
Published Date: 9 November 2016
Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S
Vascular Health and Risk Management 2016, 12:407-413
Published Date: 27 October 2016
Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure
Reed JW
Vascular Health and Risk Management 2016, 12:393-405
Published Date: 27 October 2016
International normalized ratio self-testing and self-management: improving patient outcomes
Pozzi M, Mitchell J, Henaine AM, Hanna N, Safi O, Henaine R
Vascular Health and Risk Management 2016, 12:387-392
Published Date: 12 October 2016
Carbohydrate composition of circulating multiple-modified low-density lipoprotein
Zakiev ER, Sobenin IA, Sukhorukov VN, Myasoedova VA, Ivanova EA, Orekhov AN
Vascular Health and Risk Management 2016, 12:379-385
Published Date: 14 October 2016
Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial
Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS
Vascular Health and Risk Management 2016, 12:371-378
Published Date: 26 September 2016
Overview of guidelines for the management of dyslipidemia: EU perspectives
Giner-Galvañ V, Esteban-Giner MJ, Pallarés-Carratalá V
Vascular Health and Risk Management 2016, 12:357-369
Published Date: 6 September 2016
Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease
Herten M, Torsello GB, Schönefeld E, Stahlhoff S
Vascular Health and Risk Management 2016, 12:341-356
Published Date: 29 August 2016
Blood pressure and fasting lipid changes after 24 weeks’ treatment with vildagliptin: a pooled analysis in >2,000 previously drug-naïve patients with type 2 diabetes mellitus
Evans M, Schweizer A, Foley JE
Vascular Health and Risk Management 2016, 12:337-340
Published Date: 18 August 2016
Risk impact of edoxaban in the management of stroke and venous thromboembolism
Hurst KV, O’Callaghan JM, Handa A
Vascular Health and Risk Management 2016, 12:329-335
Published Date: 11 August 2016
Predictors of high central blood pressure in young with isolated systolic hypertension
Radchenko GD, Torbas OO, Sirenko YM
Vascular Health and Risk Management 2016, 12:321-328
Published Date: 2 August 2016
Effect of nitroglycerin administration on cardio-ankle vascular index
Shimizu K, Yamamoto T, Takahashi M, Sato S, Noike H, Shirai K
Vascular Health and Risk Management 2016, 12:313-319
Published Date: 3 August 2016
Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method
Špan M, Geršak G, Millasseau SC, Meža M, Košir A
Vascular Health and Risk Management 2016, 12:305-311
Published Date: 29 July 2016
Biomarkers and the prediction of atrial fibrillation: state of the art
O’Neal WT, Venkatesh S, Broughton ST, Griffin WF, Soliman EZ
Vascular Health and Risk Management 2016, 12:297-303
Published Date: 18 July 2016
Matrix metalloproteinases in exercise and obesity
Jaoude J, Koh Y
Vascular Health and Risk Management 2016, 12:287-295
Published Date: 14 July 2016
Association between perceived lifetime risk of cardiovascular disease and calculated risk in a male population in Brazil
de Lima Jr MM, da Silva GR, Jansem Filho SS, Granja F
Vascular Health and Risk Management 2016, 12:279-286
Published Date: 22 June 2016
Noninvasive FFR derived from coronary CT angiography in the management of coronary artery disease: technology and clinical update
Nakanishi R, Budoff MJ
Vascular Health and Risk Management 2016, 12:269-278
Published Date: 22 June 2016
Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxar
Cheng JWM
Vascular Health and Risk Management 2016, 12:263-268
Published Date: 14 June 2016
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study
Haider A, Yassin A, Haider KS, Doros G, Saad F, Rosano GM
Vascular Health and Risk Management 2016, 12:251-261
Published Date: 14 June 2016
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
Gurgle HE, White K, McAdam-Marx C
Vascular Health and Risk Management 2016, 12:239-249
Published Date: 4 June 2016
Elevated risk of venous thromboembolic events in patients with inflammatory myopathies
Nowak M, Królak-Nowak K, Sobolewska-Włodarczyk A, Fichna J, Włodarczyk M
Vascular Health and Risk Management 2016, 12:233-238
Published Date: 3 June 2016
Risk factors for amputation in extremities vascular injuries in Saudi Arabia
Al Wahbi A, Aldakhil S, Al Turki S, El Kayali A, Al Kohlani H, Al Showmer A
Vascular Health and Risk Management 2016, 12:229-232
Published Date: 24 May 2016
Cardiovascular risk factor control is insufficient in young patients with coronary artery disease
Christiansen MK, Jensen JM, Brøndberg AK, Bøtker HE, Jensen HK
Vascular Health and Risk Management 2016, 12:219-227
Published Date: 25 May 2016
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study
Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, Vogtländer K, Turpie AGG
Vascular Health and Risk Management 2016, 12:209-218
Published Date: 18 May 2016
Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date
Barkat M, Torella F, Antoniou GA
Vascular Health and Risk Management 2016, 12:199-208
Published Date: 12 May 2016
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
Blom DJ, Dent R, Castro RC, Toth PP
Vascular Health and Risk Management 2016, 12:185-197
Published Date: 9 May 2016
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Toth PP
Vascular Health and Risk Management 2016, 12:171-183
Published Date: 6 May 2016
Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
Henry CA, Lyon RA, Ling H
Vascular Health and Risk Management 2016, 12:163-169
Published Date: 19 April 2016
Management of intracerebral hemorrhage – use of statins
Van Matre ET, Sherman DS, Kiser TH
Vascular Health and Risk Management 2016, 12:153-161
Published Date: 18 April 2016
Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry
Goldstein P, Grieco N, Ince H, Danchin N, Ramos Y, Goedicke J, Clemmensen P
Vascular Health and Risk Management 2016, 12:143-151
Published Date: 19 April 2016
Targeting heart failure with preserved ejection fraction: current status and future prospects
Kanwar M, Walter C, Clarke M, Patarroyo-Aponte M
Vascular Health and Risk Management 2016, 12:129-141
Published Date: 15 April 2016
Endovascular revascularization for aortoiliac atherosclerotic disease
Aggarwal V, Waldo SW, Armstrong EJ
Vascular Health and Risk Management 2016, 12:117-127
Published Date: 29 March 2016
Cognitive impairment and stroke in elderly patients
Lo Coco D, Lopez G, Corrao S
Vascular Health and Risk Management 2016, 12:105-116
Published Date: 24 March 2016
A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
Maeder MT, Schoch OD, Rickli H
Vascular Health and Risk Management 2016, 12:85-103
Published Date: 21 March 2016
Prevalence and correlates of coronary heart disease: first population-based study in Lebanon
Zeidan RK, Farah R, Chahine MN, Asmar R, Hosseini H, Salameh P, Pathak A
Vascular Health and Risk Management 2016, 12:75-84
Published Date: 17 March 2016
Atrial fibrillation and silent stroke: links, risks, and challenges
Hahne K, Mönnig G, Samol A
Vascular Health and Risk Management 2016, 12:65-74
Published Date: 7 March 2016
Type II endoleaks: challenges and solutions
Brown A, Saggu GK, Bown MJ, Sayers RD, Sidloff DA
Vascular Health and Risk Management 2016, 12:53-63
Published Date: 2 March 2016
Edoxaban in venous thromboembolism and stroke prevention: an appraisal
Proietti M, Lip GYH
Vascular Health and Risk Management 2016, 12:45-51
Published Date: 29 February 2016
Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
Hu TY, Vaidya VR, Asirvatham SJ
Vascular Health and Risk Management 2016, 12:35-44
Published Date: 17 February 2016
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
Toth PP
Vascular Health and Risk Management 2016, 12:23-34
Published Date: 10 February 2016
The cost of inpatient death associated with acute coronary syndrome
Page II RL, Ghushchyan V, Van Den Bos J, Gray TJ, Hoetzer GL, Bhandary D, Nair KV
Vascular Health and Risk Management 2016, 12:13-21
Published Date: 3 February 2016
Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?
Foley JE, Bhosekar V, Kawamori R
Vascular Health and Risk Management 2016, 12:9-12
Published Date: 21 January 2016
Critical evaluation of the MitraClip system in the management of mitral regurgitation
Deuschl F, Schofer N, Lubos E, Blankenberg S, Schäfer U
Vascular Health and Risk Management 2016, 12:1-8
Published Date: 11 January 2016
Fractional flow reserve-guided percutaneous coronary intervention: where to after FAME 2?
van de Hoef TP, Meuwissen M, Piek JJ
Vascular Health and Risk Management 2015, 11:613-622
Published Date: 3 December 2015
Personalized medicine and stroke prevention: where are we?
Kim J, Thrift AG, Nelson MR, Bladin CF, Cadilhac DA
Vascular Health and Risk Management 2015, 11:601-611
Published Date: 2 December 2015
Preseason preparation training and endothelial function in elite professional soccer players
Androulakis NE, Koundourakis NE, Nioti E, Spatharaki P, Hatzisymeon D, Miminas I, Alexandrakis MG
Vascular Health and Risk Management 2015, 11:595-599
Published Date: 26 November 2015
Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
Blaes AH, Rehman A, Vock DM, Luo X, Menge M, Yee D, Missov E, Duprez D
Vascular Health and Risk Management 2015, 11:591-594
Published Date: 24 November 2015
Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine
Herath HMM, Weerarathna TP, Umesha D
Vascular Health and Risk Management 2015, 11:583-589
Published Date: 13 November 2015
Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report
Okeahialam BN
Vascular Health and Risk Management 2015, 11:579-581
Published Date: 6 November 2015
Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
Pfohl M, Siegmund T, Pscherer S, Pegelow K, Seufert J
Vascular Health and Risk Management 2015, 11:569-578
Published Date: 6 November 2015
Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
Sangsawang T, Sriwijitkamol A
Vascular Health and Risk Management 2015, 11:563-567
Published Date: 4 November 2015
Managing atrial fibrillation in the very elderly patient: challenges and solutions
Karamichalakis N, Letsas KP, Vlachos K, Georgopoulos S, Bakalakos A, Efremidis M, Sideris A
Vascular Health and Risk Management 2015, 11:555-562
Published Date: 27 October 2015
Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study
Bosevski M, Stojanovska L
Vascular Health and Risk Management 2015, 11:549-553
Published Date: 16 October 2015
A comparative cohort study of totally laparoscopic and open aortobifemoral bypass for the treatment of advanced atherosclerosis
Kazmi SS, Jørgensen JJ, Sundhagen JO, Krog AH, Flørenes TL, Kollerøs D, Abdelnoor M
Vascular Health and Risk Management 2015, 11:541-547
Published Date: 18 September 2015
The MGuard coronary stent: safety, efficacy, and clinical utility
Gracida M, Romaguera R, Jacobi F, Gómez-Hospital JA, Cequier A
Vascular Health and Risk Management 2015, 11:533-539
Published Date: 18 September 2015
LDL electronegativity index: a potential novel index for predicting cardiovascular disease
Ivanova EA, Bobryshev YV, Orekhov AN
Vascular Health and Risk Management 2015, 11:525-532
Published Date: 28 August 2015
Comparison of bioavailability of krill oil versus fish oil and health effect
Ulven SM, Holven KB
Vascular Health and Risk Management 2015, 11:511-524
Published Date: 28 August 2015
Comparing withdrawal and not withdrawal of life-sustaining treatment among patients who died from stroke
Helvig E, Thomassen L, Waje-Andreassen U, Naess H
Vascular Health and Risk Management 2015, 11:507-510
Published Date: 3 September 2015
Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Noubiap JJ, Nansseu JR
Vascular Health and Risk Management 2015, 11:503-506
Published Date: 25 August 2015
New developments in atherosclerosis: clinical potential of PCSK9 inhibition
Giunzioni I, Tavori H
Vascular Health and Risk Management 2015, 11:493-501
Published Date: 24 August 2015
Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
Blann A
Vascular Health and Risk Management 2015, 11:489-492
Published Date: 20 August 2015
Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia
Siviero-Miachon AA, Spinola-Castro AM, Lee ML, Monteiro CM, Carvalho AC, Calixto AR, Geloneze B, Guerra-Junior G
Vascular Health and Risk Management 2015, 11:479-488
Published Date: 18 August 2015
Prevention of venous thromboembolism in patients undergoing bariatric surgery
Bartlett MA, Mauck KF, Daniels PR
Vascular Health and Risk Management 2015, 11:461-477
Published Date: 17 August 2015
Assessing the risk of recurrent venous thromboembolism – a practical approach
Fahrni J, Husmann M, Gretener SB, Keo HH
Vascular Health and Risk Management 2015, 11:451-459
Published Date: 17 August 2015
Secondary stroke prevention: challenges and solutions
Esenwa C, Gutierrez J
Vascular Health and Risk Management 2015, 11:437-450
Published Date: 7 August 2015
Sex differences in predictors of ischemic stroke: current perspectives
Samai AA, Martin-Schild S
Vascular Health and Risk Management 2015, 11:427-436
Published Date: 27 July 2015
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
Detournay B, Halimi S, Robert J, Deschaseaux C, Dejager S
Vascular Health and Risk Management 2015, 11:417-425
Published Date: 17 July 2015
Preeclampsia: long-term consequences for vascular health
Amaral LM, Cunningham Jr MW, Cornelius DC, LaMarca B
Vascular Health and Risk Management 2015, 11:403-415
Published Date: 15 July 2015
Feasibility and safety of rehabilitation after venous thromboembolism
Noack F, Schmidt B, Amoury M, Stoevesandt D, Gielen S, Pflaumbaum B, Girschick C, Völler H, Schlitt A
Vascular Health and Risk Management 2015, 11:397-401
Published Date: 13 July 2015
Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
Bishu K, Armstrong EJ
Vascular Health and Risk Management 2015, 11:387-395
Published Date: 13 July 2015
Preoperative optimization of the vascular surgery patient
Zhan HT, Purcell ST, Bush RL
Vascular Health and Risk Management 2015, 11:379-385
Published Date: 1 July 2015
Role of diclofenac in the prevention of postpericardiotomy syndrome after cardiac surgery
Sevuk U, Baysal E, Altindag R, Yaylak B, Adiyaman MS, Ay N, Alp V, Beyazit U
Vascular Health and Risk Management 2015, 11:373-378
Published Date: 30 June 2015
Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study
Duclos M, Dejager S, Postel-Vinay N, di Nicola S, Quéré S, Fiquet B
Vascular Health and Risk Management 2015, 11:361-371
Published Date: 29 June 2015
Heart rate variability and arrhythmic patterns of 24-hour Holter electrocardiography among Nigerians with cardiovascular diseases
Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Ajayi OE, Adeyeye VO, Mene-Afejuku TO, Bamikole OJ, Ogunyemi SA, Ajibare AO, Oketona OA
Vascular Health and Risk Management 2015, 11:353-359
Published Date: 29 June 2015
Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism
Chan NC, Bhagirath V, Eikelboom JW
Vascular Health and Risk Management 2015, 11:343-351
Published Date: 26 June 2015
Lipidomics in vascular health: current perspectives
Kolovou G, Kolovou V, Mavrogeni S
Vascular Health and Risk Management 2015, 11:333-342
Published Date: 12 June 2015
Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
Ment J
Vascular Health and Risk Management 2015, 11:317-332
Published Date: 10 June 2015
Blood pressure control to prevent decline in cognition after stroke
Ihle-Hansen H, Thommessen B, Fagerland MW, Øksengård AR, Wyller TB, Engedal K, Fure B
Vascular Health and Risk Management 2015, 11:311-316
Published Date: 9 June 2015
Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
Setia S, Fung SSW, Waters DD
Vascular Health and Risk Management 2015, 11:303-310
Published Date: 4 June 2015
High-flow bypass and wrap-clipping for ruptured blood blister-like aneurysm of the internal carotid artery using intraoperative monitoring of cerebral hemodynamics
Kubo Y, Koji T, Yoshida K, Saito H, Ogawa A, Ogasawara K
Vascular Health and Risk Management 2015, 11:297-302
Published Date: 3 June 2015
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
Singh JSS, Lang CC
Vascular Health and Risk Management 2015, 11:283-295
Published Date: 1 June 2015
Current and emerging strategies in the management of venous thromboembolism: benefit–risk assessment of dabigatran
Fanola CL
Vascular Health and Risk Management 2015, 11:271-282
Published Date: 27 May 2015
Epoprostenol sodium for treatment of pulmonary arterial hypertension
Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H
Vascular Health and Risk Management 2015, 11:265-270
Published Date: 14 May 2015
Lipid-modifying therapy in the elderly
Hamilton-Craig I, Colquhoun D, Kostner K, Woodhouse S, d'Emden M
Vascular Health and Risk Management 2015, 11:251-263
Published Date: 14 May 2015
Comparison of the BPLab® sphygmomanometer for ambulatory blood pressure monitoring with mercury sphygmomanometry in pregnant women: validation study according to the British Hypertension Society protocol
Dorogova IV, Panina ES
Vascular Health and Risk Management 2015, 11:245-249
Published Date: 13 April 2015
Alogliptin benzoate for management of type 2 diabetes
Saisho Y
Vascular Health and Risk Management 2015, 11:229-243
Published Date: 10 April 2015
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
Sandoo A, Kitas GD, Carmichael AR
Vascular Health and Risk Management 2015, 11:223-228
Published Date: 7 April 2015
Endovascular repair of a life-threatening radiation-induced ruptured false aneurysm of the intrathoracic left subclavian artery: case report
Hizette P, Horn D, Lemaitre J, Segers B
Vascular Health and Risk Management 2015, 11:219-222
Published Date: 31 March 2015
Experimental study of sutureless vascular anastomosis with use of glued prosthesis in rabbits
Vokrri L, Qavdarbasha A, Rudari H, Ahmetaj H, Manxhuka-Kërliu S, Hyseni N, Porcu P, Cinquin P, Sessa C
Vascular Health and Risk Management 2015, 11:211-217
Published Date: 27 March 2015
Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
Scherer DJ, Nicholls SJ
Vascular Health and Risk Management 2015, 11:203-209
Published Date: 25 March 2015
Virtual reality simulation for the optimization of endovascular procedures: current perspectives
Rudarakanchana N, Van Herzeele I, Desender L, Cheshire NJW
Vascular Health and Risk Management 2015, 11:195-202
Published Date: 10 March 2015
Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease
Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR
Vascular Health and Risk Management 2015, 11:185-193
Published Date: 3 March 2015
Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms
Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC
Vascular Health and Risk Management 2015, 11:173-183
Published Date: 27 February 2015
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control
Bays HE, Brinton EA, Triscari J, Chen E, Maccubbin D, MacLean AA, Gibson KL, Ruck RA, Johnson-Levonas AO, O’Neill EA, Mitchel YB
Vascular Health and Risk Management 2015, 11:165-172
Published Date: 24 February 2015
Strokes in young adults: epidemiology and prevention
Smajlović D
Vascular Health and Risk Management 2015, 11:157-164
Published Date: 24 February 2015
Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study
Saab C, Al-Saber FA, Haddad J, Jallo MK, Steitieh H, Bader G, Ibrahim M
Vascular Health and Risk Management 2015, 11:149-155
Published Date: 24 February 2015
Platelet function tests: a comparative review
Paniccia R, Priora R, Alessandrello Liotta A, Abbate R
Vascular Health and Risk Management 2015, 11:133-148
Published Date: 18 February 2015
Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia – a review of its characteristics
Ramadan WH, Kabbara WK
Vascular Health and Risk Management 2015, 11:125-132
Published Date: 11 February 2015
The role of factor Xa inhibitors in venous thromboembolism treatment
Cabral KP, Ansell JE
Vascular Health and Risk Management 2015, 11:117-123
Published Date: 30 January 2015
Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
Joseph JJ, Donner TW
Vascular Health and Risk Management 2015, 11:107-116
Published Date: 28 January 2015
Prevention of stent thrombosis: challenges and solutions
Reejhsinghani R, Lotfi AS
Vascular Health and Risk Management 2015, 11:93-106
Published Date: 27 January 2015
Scaffolds in vascular regeneration: current status
Thottappillil N, Nair PD
Vascular Health and Risk Management 2015, 11:79-91
Published Date: 19 January 2015
Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho BL, Ueng KC, DiTommaso S, Shete A
Vascular Health and Risk Management 2015, 11:71-78
Published Date: 21 January 2015
Adiponectin as a potential biomarker of vascular disease
Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z
Vascular Health and Risk Management 2015, 11:55-70
Published Date: 16 January 2015
Validation of two automatic devices for the self-measurement of blood pressure according to the ANSI/AAMI/ISO81060-2:2009 guidelines: the Omron BP765 (HEM-7311-ZSA) and the Omron BP760N (HEM-7320-Z)
Takahashi H, Yoshika M, Yokoi T
Vascular Health and Risk Management 2015, 11:49-53
Published Date: 9 January 2015
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA
Vascular Health and Risk Management 2015, 11:35-48
Published Date: 6 January 2015
Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both
Ghushchyan V, Nair KV, Page RL II
Vascular Health and Risk Management 2015, 11:25-34
Published Date: 24 December 2014
Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
Toth PP
Vascular Health and Risk Management 2015, 11:9-23
Published Date: 23 December 2014
Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE
Vascular Health and Risk Management 2015, 11:1-8
Published Date: 17 December 2014
Effects of exercise timing on sleep architecture and nocturnal blood pressure in prehypertensives
Fairbrother K, Cartner B, Alley JR, Curry CD, Dickinson DL, Morris DM, Collier SR
Vascular Health and Risk Management 2014, 10:691-698
Published Date: 12 December 2014
Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S
Vascular Health and Risk Management 2014, 10:683-689
Published Date: 9 December 2014
Complications of the endovascular management of acute ischemic stroke
Gill HL, Siracuse JJ, Parrack IK, Huang ZS, Meltzer AJ
Vascular Health and Risk Management 2014, 10:675-681
Published Date: 28 November 2014
Macitentan for the treatment of pulmonary arterial hypertension
Kholdani CA, Fares WH, Trow TK
Vascular Health and Risk Management 2014, 10:665-673
Published Date: 25 November 2014
Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes
Blüher M, Schweizer A, Bader G, Foley JE
Vascular Health and Risk Management 2014, 10:661-664
Published Date: 20 November 2014
Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis
Jeffers BW, Bhambri R, Robbins J
Vascular Health and Risk Management 2014, 10:651-659
Published Date: 14 November 2014
N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes [Corrigendum]
Hamano K, Nakadaira I, Suzuki J, Gonai M
Vascular Health and Risk Management 2014, 10:649-650
Published Date: 13 November 2014
A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity
Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J
Vascular Health and Risk Management 2014, 10:641-647
Published Date: 7 November 2014
Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E
Vascular Health and Risk Management 2014, 10:627-639
Published Date: 7 November 2014
Improving medication adherence in hypercholesterolemia: challenges and solutions
Gatwood J, Bailey JE
Vascular Health and Risk Management 2014, 10:615-625
Published Date: 6 November 2014
Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis
Lamparello BM, Erickson CR, Kulthia A, Virparia V, Thet Z
Vascular Health and Risk Management 2014, 10:609-613
Published Date: 4 November 2014
Optimal management of infrainguinal arterial occlusive disease
Pennywell DJ, Tan TW, Zhang WW
Vascular Health and Risk Management 2014, 10:599-608
Published Date: 24 October 2014
Consumption of water containing over 3.5 mg of dissolved hydrogen could improve vascular endothelial function
Sakai T, Sato B, Hara K, Hara Y, Naritomi Y, Koyanagi S, Hara H, Nagao T, Ishibashi T
Vascular Health and Risk Management 2014, 10:591-597
Published Date: 17 October 2014
N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes
Hamano K, Nakadaira I, Suzuki J, Gonai M
Vascular Health and Risk Management 2014, 10:585-589
Published Date: 3 October 2014
Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry
Bruno RM, Gori T, Ghiadoni L
Vascular Health and Risk Management 2014, 10:577-584
Published Date: 26 September 2014
Economic and outcomes consequences of TachoSil®: a systematic review
Colombo GL, Bettoni D, Di Matteo S, Grumi C, Molon C, Spinelli D, Mauro G, Tarozzo A, Bruno GM
Vascular Health and Risk Management 2014, 10:569-576
Published Date: 10 September 2014
Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center
Shammas NW, Shammas GA, Jerin M, Sharis P
Vascular Health and Risk Management 2014, 10:563-568
Published Date: 9 September 2014
Adding multiple risk factors improves Framingham coronary heart disease risk scores
Hu G, Root M, Duncan AW
Vascular Health and Risk Management 2014, 10:557-562
Published Date: 5 September 2014
A three-dimensional electronic report of a venous echo color Doppler of the lower limbs: MEVeC®
Galeandro AI, Scicchitano P, Zito A, Galeandro C, Gesualdo M, Ciciarello F, Cecere A, Marzullo A, Contursi V, Annicchiarico A, Ciccone MM
Vascular Health and Risk Management 2014, 10:549-555
Published Date: 1 September 2014
Perindopril for improving cardiovascular events
DiNicolantonio JJ, O’Keefe JH
Vascular Health and Risk Management 2014, 10:539-548
Published Date: 30 August 2014
Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women
Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A
Vascular Health and Risk Management 2014, 10:533-538
Published Date: 26 August 2014
Vasa vasorum anti-angiogenesis through H2O2, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain
Wihastuti TA, Sargowo D, Tjokroprawiro A, Permatasari N, Widodo MA, Soeharto S
Vascular Health and Risk Management 2014, 10:523-531
Published Date: 21 August 2014
A clinician’s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation – full speed ahead or proceed with caution?
Yang E
Vascular Health and Risk Management 2014, 10:507-522
Published Date: 21 August 2014
Thoracoabdominal aortic aneurysm repair: current endovascular perspectives
Orr N, Minion D, Bobadilla JL
Vascular Health and Risk Management 2014, 10:493-505
Published Date: 19 August 2014
Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
Abdelnoor M, Sandven I, Limalanathan S, Eritsland J
Vascular Health and Risk Management 2014, 10:477-491
Published Date: 8 August 2014
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes
Dardano A, Bianchi C, Del Prato S, Miccoli R
Vascular Health and Risk Management 2014, 10:465-475
Published Date: 5 August 2014
Heart rate variability measured early in patients with evolving acute coronary syndrome and 1-year outcomes of rehospitalization and mortality
Harris PR, Stein PK, Fung GL, Drew BJ
Vascular Health and Risk Management 2014, 10:451-464
Published Date: 5 August 2014
Diagnostic accuracy of sensitive or high-sensitive troponin on presentation for myocardial infarction: a meta-analysis and systematic review
Sethi A, Bajaj A, Malhotra G, Arora RR, Khosla S
Vascular Health and Risk Management 2014, 10:435-450
Published Date: 21 July 2014
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation
Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Eickels MV, Turpie AGG
Vascular Health and Risk Management 2014, 10:425-434
Published Date: 17 July 2014
Lower extremity amputation in peripheral artery disease: improving patient outcomes
Swaminathan A, Vemulapalli S, Patel MR, Jones WS
Vascular Health and Risk Management 2014, 10:417-424
Published Date: 16 July 2014
Carotid revascularization: risks and benefits
O'Brien M, Chandra A
Vascular Health and Risk Management 2014, 10:403-416
Published Date: 7 July 2014
Cardiac angiosarcoma: utility of [18F]fluorodeoxyglucose positron emission tomography–computed tomography in evaluation of residue, metastases, and treatment response
Tokmak H, Demir N, Demirkol MO
Vascular Health and Risk Management 2014, 10:399-401
Published Date: 27 June 2014
Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS
Baschiera F, Chang W, Brunel P
Vascular Health and Risk Management 2014, 10:389-397
Published Date: 25 June 2014
Epidemiology of stroke in a rural community in Southeastern Nigeria
Enwereji KO, Nwosu MC, Ogunniyi A, Nwani PO, Asomugha AL, Enwereji EE
Vascular Health and Risk Management 2014, 10:375-388
Published Date: 24 June 2014
Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia
Siracuse JJ, Huang ZS, Gill HL, Parrack I, Schneider DB, Connolly PH, Meltzer AJ
Vascular Health and Risk Management 2014, 10:367-374
Published Date: 23 June 2014
The triple line pattern on carotid intima media thickness imaging and its relationship to cardiovascular risk factors in patients on lipid lowering therapy
Singh TA, Villines TC, Taylor AJ
Vascular Health and Risk Management 2014, 10:363-366
Published Date: 20 June 2014
Update on ranolazine in the management of angina
Codolosa JN, Acharjee S, Figueredo VM
Vascular Health and Risk Management 2014, 10:353-362
Published Date: 24 June 2014
How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study
Penfornis A, Blicklé JF, Fiquet B, Quéré S, Dejager S
Vascular Health and Risk Management 2014, 10:341-352
Published Date: 13 June 2014
Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease
Steenhof N, Le Piane F, Leblanc K, Eisenberg NR, Kwan Y, Malmberg C, Papadopoulos A, Roche-Nagle G
Vascular Health and Risk Management 2014, 10:333-340
Published Date: 4 June 2014
Serum lipid profile and its association with hypertension in Bangladesh
Choudhury KN, Mainuddin AKM, Wahiduzzaman M, Islam SMS
Vascular Health and Risk Management 2014, 10:327-332
Published Date: 30 June 2014
A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study
Hassanein M, Abdallah K, Schweizer A
Vascular Health and Risk Management 2014, 10:319-326
Published Date: 28 May 2014
Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease
Sponder M, Fritzer-Szekeres M, Marculescu R, Mittlböck M, Uhl M, Köhler-Vallant B, Strametz-Juranek J
Vascular Health and Risk Management 2014, 10:311-317
Published Date: 13 May 2014
Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010
Bramlage P, Deutsch C, Krüger R, Wolf A, Müller P, Zwingers T, Beime B, Mengden T
Vascular Health and Risk Management 2014, 10:303-309
Published Date: 13 May 2014
Rivaroxaban in patients with a recent acute coronary syndrome event: integration of trial findings into clinical practice
Shivu GN, Ossei-Gerning N
Vascular Health and Risk Management 2014, 10:291-302
Published Date: 12 May 2014
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
Farnier M, Chen E, Johnson-Levonas AO, McCrary Sisk C, Mitchel YB
Vascular Health and Risk Management 2014, 10:279-290
Published Date: 7 May 2014
Influence of serological factors and BMI on the blood pressure/hematocrit association in healthy young men and women
Salazar Vázquez BY, Salazar Vázquez MA, Chávez-Negrete A, Escobedo G, Cabrales P, Subramaniam S, Intaglietta M, Pérez-Tamayo R
Vascular Health and Risk Management 2014, 10:271-277
Published Date: 6 May 2014
Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia
Vuorio A, Tikkanen MJ, Kovanen PT
Vascular Health and Risk Management 2014, 10:263-270
Published Date: 6 May 2014
Serum uric acid and target organ damage in essential hypertension
Ofori SN, Odia OJ
Vascular Health and Risk Management 2014, 10:253-261
Published Date: 2 May 2014
The 24-hour pulse wave velocity, aortic augmentation index, and central blood pressure in normotensive volunteers
Kuznetsova TY, Korneva VA, Bryantseva EN, Barkan VS, Orlov AV, Posokhov IN, Rogoza AN
Vascular Health and Risk Management 2014, 10:247-251
Published Date: 28 April 2014
Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US
Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR
Vascular Health and Risk Management 2014, 10:237-246
Published Date: 25 April 2014
Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM
Vascular Health and Risk Management 2014, 10:225-235
Published Date: 7 May 2014
Telemonitoring: use in the management of hypertension
Sivakumaran D, Earle KA
Vascular Health and Risk Management 2014, 10:217-224
Published Date: 10 April 2014
Current guidelines for high-density lipoprotein cholesterol in therapy and future directions
Subedi BH, Joshi PH, Jones SR, Martin SS, Blaha MJ, Michos ED
Vascular Health and Risk Management 2014, 10:205-216
Published Date: 8 April 2014
Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations
Jovanovic A, Stolic RV, Rasic DV, Markovic-Jovanovic SR, Peric VM
Vascular Health and Risk Management 2014, 10:201-204
Published Date: 8 April 2014
Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
Wang JG, Pimenta E, Chwallek F
Vascular Health and Risk Management 2014, 10:189-200
Published Date: 5 April 2014
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar
Cho JR, Rollini F, Franchi F, Ferrante E, Angiolillo DJ
Vascular Health and Risk Management 2014, 10:177-188
Published Date: 3 April 2014
Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa
Isaacson SH, Skettini J
Vascular Health and Risk Management 2014, 10:169-176
Published Date: 3 April 2014
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
Levitan B, Yuan Z, Turpie AGG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM
Vascular Health and Risk Management 2014, 10:157-167
Published Date: 26 March 2014
Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis
Cho EJ, Kim JH, Sutradhar S, Yunis C, Westergaard M
Vascular Health and Risk Management 2014, 10:145-156
Published Date: 26 March 2014
The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension
Posokhov IN, Kulikova NN, Starchenkova IV, Grigoricheva EA, Evdokimov VV, Orlov AV, Rogoza AN
Vascular Health and Risk Management 2014, 10:139-144
Published Date: 19 March 2014
Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study
Ogunmola OJ, Oladosu OY, Olamoyegun AM
Vascular Health and Risk Management 2014, 10:129-137
Published Date: 18 March 2014
Challenges associated with peripheral arterial disease in women
Barochiner J, Aparicio LS, Waisman GD
Vascular Health and Risk Management 2014, 10:115-128
Published Date: 10 March 2014
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
Haas S, Bode C, Norrving B, Turpie AGG
Vascular Health and Risk Management 2014, 10:101-114
Published Date: 10 March 2014
Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation
Evans M, Rumberger JA, Azumano I, Napolitano JJ, Citrolo D, Kamiya T
Vascular Health and Risk Management 2014, 10:89-100
Published Date: 27 February 2014
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM
Vascular Health and Risk Management 2014, 10:75-87
Published Date: 24 February 2014
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey
Petrella RJ, Tremblay G, De Backer G, Gill DP
Vascular Health and Risk Management 2014, 10:63-74
Published Date: 29 January 2014
Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study
Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, Thomsen RW, Kjær A, Weis N
Vascular Health and Risk Management 2014, 10:55-62
Published Date: 21 January 2014
Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?
Kvistad CE, Khanevski A, Nacu A, Thomassen L, Waje-Andreassen U, Naess H
Vascular Health and Risk Management 2014, 10:49-54
Published Date: 21 January 2014
Dabigatran and myocardial infarction: a foggy scenario
Pontillo D, Patruno N
Vascular Health and Risk Management 2014, 10:45-48
Published Date: 20 January 2014
Validation of four devices: Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypertension International Protocol
Topouchian J, Agnoletti D, Blacher J, Youssef A, Chahine MN, Ibanez I, Assemani N, Asmar R
Vascular Health and Risk Management 2014, 10:33-44
Published Date: 16 January 2014
Risk of stroke associated with nonsteroidal anti-inflammatory drugs
Park K, Bavry AA
Vascular Health and Risk Management 2014, 10:25-32
Published Date: 6 January 2014
Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan
Schweizer A, Halimi S, Dejager S
Vascular Health and Risk Management 2014, 10:15-24
Published Date: 24 December 2013
Accurate use of neutrophil/lymphocyte ratio from the perspective of laboratory experts
Sertoglu E, Uyanik M
Vascular Health and Risk Management 2014, 10:13-14
Published Date: 20 December 2013
Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression
Shukla A, Curtis AB
Vascular Health and Risk Management 2014, 10:1-12
Published Date: 16 December 2013
Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension
Adamu UG, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae AJ
Vascular Health and Risk Management 2013, 9:763-768
Published Date: 3 December 2013
Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients
Daud ZAM, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, Khosla P
Vascular Health and Risk Management 2013, 9:747-761
Published Date: 28 November 2013
Visceral obesity is not an independent risk factor of mortality in subjects over 65 years
Thomas F, Pannier B, Benetos A, Vischer UM
Vascular Health and Risk Management 2013, 9:739-745
Published Date: 22 November 2013
Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk
Lai H, Fishman EK, Gerstenblith G, Moore R, Brinker JA, Keruly JC, Chen S, Detrick B, Lai S
Vascular Health and Risk Management 2013, 9:729-737
Published Date: 15 November 2013
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K
Vascular Health and Risk Management 2013, 9:719-727
Published Date: 15 November 2013
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study
Seufert J, Pegelow K, Bramlage P
Vascular Health and Risk Management 2013, 9:711-717
Published Date: 13 November 2013
Lipid profiles and inflammatory markers after periodontal treatment in children with congenital heart disease and at risk for atherosclerosis
Bresolin AC, Pronsatti MM, Pasqualotto LN, Nassar PO, Jorge AS, Silva EA, Nassar CA
Vascular Health and Risk Management 2013, 9:703-709
Published Date: 11 November 2013
Titration of amlodipine to higher doses: a comparison of Asian and Western experience
Kario K, Robbins J, Jeffers BW
Vascular Health and Risk Management 2013, 9:695-701
Published Date: 5 November 2013
Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
von Websky K, Reichetzeder C, Hocher B
Vascular Health and Risk Management 2013, 9:681-694
Published Date: 1 November 2013
Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidence
Stauffer ME, Weisenfluh L, Morrison A
Vascular Health and Risk Management 2013, 9:671-680
Published Date: 31 October 2013
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes
Kones R
Vascular Health and Risk Management 2013, 9:617-670
Published Date: 21 October 2013
Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment
Clemens A, Fraessdorf M, Friedman J
Vascular Health and Risk Management 2013, 9:599-615
Published Date: 11 October 2013
Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery
Kuroda Y, Hirayama C, Hotoda H, Nishikawa Y, Nishiwaki A
Vascular Health and Risk Management 2013, 9:593-598
Published Date: 7 October 2013
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
Gialama F, Maniadakis N
Vascular Health and Risk Management 2013, 9:575-592
Published Date: 7 October 2013
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study
Offman E, Marenco T, Ferber S, Johnson J, Kling D, Curcio D, Davidson M
Vascular Health and Risk Management 2013, 9:563-573
Published Date: 1 October 2013
Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: a cross-sectional clinical study
Reece AS, Hulse GK
Vascular Health and Risk Management 2013, 9:551-561
Published Date: 2 October 2013
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial
Radchenko GD, Sirenko YM, Kushnir SM, Torbas OO, Dobrokhod AS
Vascular Health and Risk Management 2013, 9:535-549
Published Date: 27 September 2013
Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria
Dodiyi-Manuel ST, Akpa MR, Odia OJ
Vascular Health and Risk Management 2013, 9:529-533
Published Date: 25 September 2013
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
Segura J, Ruilope LM
Vascular Health and Risk Management 2013, 9:521-528
Published Date: 16 September 2013
Serum calcium levels are not associated with coronary heart disease
Jin Y, He L, Wang Q, Chen Y, Ren X, Tang H, Song X, Ding L, Qi Q, Huang Z, Yu J, Yao Y
Vascular Health and Risk Management 2013, 9:517-520
Published Date: 3 September 2013
Increased burden and severity of metabolic syndrome and arterial stiffness in treatment naïve HIV+ patients from Cameroon
Ngatchou W, Lemogoum D, Ndobo P, Yagnigni E, Tiogou E, Nga E, Kouanfack C, van de Borne P, Hermans MP
Vascular Health and Risk Management 2013, 9:509-516
Published Date: 4 September 2013
Spanish translation, cross-cultural adaptation, and validation of the Questionnaire for Diabetes-Related Foot Disease (Q-DFD)
Castillo-Tandazo W, Flores-Fortty A, Feraud L, Tettamanti D
Vascular Health and Risk Management 2013, 9:501-508
Published Date: 28 August 2013
Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection
Lai S, Fishman EK, Gerstenblith G, Brinker J, Tai H, Chen S, Li J, Tong W, Detrick B, Lai H
Vascular Health and Risk Management 2013, 9:493-500
Published Date: 26 August 2013
Perceptions of barriers to cardiac rehabilitation use in Brazil
Ghisi GLM, Santos RZ, Aranha EE, Nunes AD, Oh P, Benetti M, Grace SL
Vascular Health and Risk Management 2013, 9:485-491
Published Date: 30 August 2013
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE
Vascular Health and Risk Management 2013, 9:475-483
Published Date: 26 August 2013
Prognostic value of heart rate turbulence for risk assessment in patients with unstable angina and non-ST elevation myocardial infarction
Harris PRE, Stein PK, Fung GL, Drew BJ
Vascular Health and Risk Management 2013, 9:465-473
Published Date: 12 August 2013
Vacuum-venipuncture skills: time required and importance of tube order
Fujii C
Vascular Health and Risk Management 2013, 9:457-464
Published Date: 5 August 2013
Emerging families of biomarkers for coronary artery disease: inflammatory mediators
Yayan J
Vascular Health and Risk Management 2013, 9:435-456
Published Date: 31 July 2013
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
Zou C, Hu H
Vascular Health and Risk Management 2013, 9:429-433
Published Date: 25 July 2013
Current status of NADPH oxidase research in cardiovascular pharmacology
Rodiño-Janeiro BK, Paradela-Dobarro B, Castiñeiras-Landeira MI, Raposeiras-Roubín S, González-Juanatey JR, Álvarez E
Vascular Health and Risk Management 2013, 9:401-428
Published Date: 25 July 2013
The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report
Ferrario CM, Joyner J, Colby C, Exuzides A, Moore M, Simmons D, Bestermann Jr W, Frech-Tamas F
Vascular Health and Risk Management 2013, 9:391-400
Published Date: 22 July 2013
Clarification of the characteristics of needle-tip movement during vacuum venipuncture to improve safety
Fujii C
Vascular Health and Risk Management 2013, 9:381-390
Published Date: 23 July 2013
Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension
Maki KC, Rains TM, Schild AL, Dicklin MR, Park KM, Lawless AL, Kelley KM
Vascular Health and Risk Management 2013, 9:369-379
Published Date: 23 July 2013
Neutrophil/lymphocyte ratio in patients with atrial septal aneurysm
Demir M, Demir C
Vascular Health and Risk Management 2013, 9:365-368
Published Date: 19 July 2013
Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study
Saifan C, El-Charabaty E, El-Sayegh S
Vascular Health and Risk Management 2013, 9:361-364
Published Date: 17 July 2013
Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage
Mak CH, Lu YY, Wong GK
Vascular Health and Risk Management 2013, 9:353-359
Published Date: 11 July 2013
The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients
Ellis CR, Kaiser DW
Vascular Health and Risk Management 2013, 9:341-352
Published Date: 9 July 2013
Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria
Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA
Vascular Health and Risk Management 2013, 9:333-339
Published Date: 24 June 2013
Aldosterone receptor antagonists: current perspectives and therapies
Guichard JL, Clark III D, Calhoun DA, Ahmed MI
Vascular Health and Risk Management 2013, 9:321-331
Published Date: 24 June 2013
Statins in heart failure: do we need another trial?
Bonsu KO, Kadirvelu A, Reidpath DD
Vascular Health and Risk Management 2013, 9:303-319
Published Date: 17 June 2013
Persistent middle cerebral artery occlusion associated with lower body temperature on admission
Kvistad CE, Øygarden H, Thomassen L, Waje-Andreassen U, Naess H
Vascular Health and Risk Management 2013, 9:297-302
Published Date: 17 June 2013
Evaluation of vascular wall elasticity of human digital arteries using alternating current-signal photoplethysmography
Uangpairoj P, Shibata M
Vascular Health and Risk Management 2013, 9:283-295
Published Date: 5 June 2013
Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin
Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS
Vascular Health and Risk Management 2013, 9:273-282
Published Date: 29 May 2013
Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010
Takahashi H, Yoshika M, Yokoi T
Vascular Health and Risk Management 2013, 9:265-272
Published Date: 28 May 2013
Current and future initiatives for vascular health management in clinical practice
Cameron JD, Asmar R, Struijker-Boudier H, Shirai K, Sirenko Y, Kotovskaya Y, Topouchian J
Vascular Health and Risk Management 2013, 9:255-264
Published Date: 28 May 2013
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
Sylvester KW, Cheng JW, Mehra MR
Vascular Health and Risk Management 2013, 9:245-254
Published Date: 16 May 2013
Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus
Wang ZS, Song ZC, Bai JH, Li F, Wu T, Qi J, Hu J
Vascular Health and Risk Management 2013, 9:237-243
Published Date: 14 May 2013
Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension
Litvin AY, Sukmarova ZN, Elfimova EM, Aksenova AV, Galitsin PV, Rogoza AN, Chazova IE
Vascular Health and Risk Management 2013, 9:229-235
Published Date: 10 May 2013
Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients
Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E, Rocha E
Vascular Health and Risk Management 2013, 9:207-228
Published Date: 8 May 2013
Endoglin: a critical mediator of cardiovascular health
Kapur NK, Morine KJ, Letarte M
Vascular Health and Risk Management 2013, 9:195-206
Published Date: 6 May 2013
Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department
Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD
Vascular Health and Risk Management 2013, 9:187-193
Published Date: 1 May 2013
Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign
Omboni S, Carabelli G, Ghirardi E, Carugo S
Vascular Health and Risk Management 2013, 9:177-185
Published Date: 30 April 2013
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
Tsuji Y, Dobrev D
Vascular Health and Risk Management 2013, 9:165-175
Published Date: 23 April 2013
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
Ahrén B
Vascular Health and Risk Management 2013, 9:155-163
Published Date: 24 April 2013
Stress-induced cardiomyopathy (Takotsubo) – broken heart and mind?
Redfors B, Shao Y, Omerovic E
Vascular Health and Risk Management 2013, 9:149-154
Published Date: 17 April 2013
Short-term outcome of patients with preeclampsia
Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM
Vascular Health and Risk Management 2013, 9:143-148
Published Date: 15 April 2013
Long-term safety and efficacy of endovascular abdominal aortic aneurysm repair
Propper BW, Abularrage CJ
Vascular Health and Risk Management 2013, 9:135-141
Published Date: 3 April 2013
Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?
Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU
Vascular Health and Risk Management 2013, 9:125-133
Published Date: 24 March 2013
Hydrogen sulfide and sodium nitroprusside compete to activate/deactivate MMPs in bone tissue homogenates
Vacek TP, Qipshidze N, Tyagi SC
Vascular Health and Risk Management 2013, 9:117-123
Published Date: 19 March 2013
The influence of perivascular adipose tissue on vascular homeostasis
Szasz T, Bomfim GF, Webb RC
Vascular Health and Risk Management 2013, 9:105-116
Published Date: 28 March 2013
Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension
Billecke SS, Marcovitz PA
Vascular Health and Risk Management 2013, 9:95-104
Published Date: 16 March 2013
Comparison between oscillometric- and Doppler-ABI in elderly individuals
Takahashi I, Furukawa K, Ohishi W, Takahashi T, Matsumoto M, Fujiwara S
Vascular Health and Risk Management 2013, 9:89-94
Published Date: 8 March 2013
Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance
El-Helou N, Al-Hajje A, Ajrouche R, Awada S, Rachidi S, Zein S, Salameh P
Vascular Health and Risk Management 2013, 9:81-88
Published Date: 1 March 2013
Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry
Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K
Vascular Health and Risk Management 2013, 9:71-80
Published Date: 21 February 2013
Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching
Hayasaka M, Takahashi Y, Nishida Y, Yoshida Y, Hidaka S, Asai S
Vascular Health and Risk Management 2013, 9:65-70
Published Date: 18 February 2013
Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Schweizer A, Foley JE, Kothny W, Ahrén B
Vascular Health and Risk Management 2013, 9:57-64
Published Date: 15 February 2013
Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
Levitan EB, Gamboa C, Safford MM, Rizk DV, Brown TM, Soliman EZ, Muntner P
Vascular Health and Risk Management 2013, 9:47-55
Published Date: 5 February 2013
Metabolic biomarkers for predicting cardiovascular disease
Montgomery JE, Brown JR
Vascular Health and Risk Management 2013, 9:37-45
Published Date: 29 January 2013
Heel-rise test in the assessment of individuals with peripheral arterial occlusive disease
Monteiro DP, Britto RR, Lages AC, Basílio ML, Pires MC, Carvalho ML, Procópio RJ, Pereira DA
Vascular Health and Risk Management 2013, 9:29-35
Published Date: 23 January 2013
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W
Vascular Health and Risk Management 2013, 9:21-28
Published Date: 23 January 2013
Effectiveness of a quality improvement intervention targeting cardiovascular risk factors: are patients responsive to information and encouragement by mail or post?
Senesael E, Borgermans L, Van De Vijver E, Devroey D
Vascular Health and Risk Management 2013, 9:13-20
Published Date: 13 February 2013
Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence
Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM
Vascular Health and Risk Management 2013, 9:3-11
Published Date: 17 January 2013
Corrigendum
Basit A, Riaz M, Fawwad A
Vascular Health and Risk Management 2013, 9:1-2
Published Date: 27 December 2012
ESR rate can be a marker for coronary artery disease
Eghbal Eftekhaari T
Vascular Health and Risk Management 2012, 8:669-670
Published Date: 18 December 2012
Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sedentary women with metabolic syndrome
Carvalho RF, Uehara SK, Rosa G
Vascular Health and Risk Management 2012, 8:661-667
Published Date: 13 December 2012
Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
Bell DA, Hooper AJ, Watts GF, Burnett JR
Vascular Health and Risk Management 2012, 8:651-659
Published Date: 28 November 2012
Diagnosis of carotid artery stenosis with oculopneumoplethysmography alone and in combination with MRA
Elias RM, Wald JT, Kallmes DF
Vascular Health and Risk Management 2012, 8:631-639
Published Date: 23 November 2012
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
Chiquette E, Toth PP, Ramirez G, Cobble M, Chilton R
Vascular Health and Risk Management 2012, 8:621-629
Published Date: 12 November 2012
Treatment of prehypertension: lifestyle and/or medication
Collier SR, Landram MJ
Vascular Health and Risk Management 2012, 8:613-619
Published Date: 15 November 2012
Cerebral blood flow in Alzheimer’s disease
Roher AE, Debbins JP, Malek-Ahmadi M, Chen K, Pipe JG, Maze S, Belden C, Maarouf CL, Thiyyagura P, Mo H, Hunter JM, Kokjohn TA, Walker DG, Kruchowsky JC, Belohlavek M, Sabbagh MN, Beach TG
Vascular Health and Risk Management 2012, 8:599-611
Published Date: 23 October 2012
Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices
Ewen E, Zhang Z, Simon TA, Kolm P, Liu X, Weintraub WS
Vascular Health and Risk Management 2012, 8:587-598
Published Date: 19 October 2012
Prevalence and risk factors associated with peripheral artery disease in elderly patients undergoing peritoneal dialysis
Kuang DW, Li CL, Kuok UI, Cheung K, Lio WI, Xin J
Vascular Health and Risk Management 2012, 8:581-586
Published Date: 19 October 2012
The potential benefit of stem cell therapy after stroke: an update
Banerjee S, Williamson DA, Habib N, Chataway J
Vascular Health and Risk Management 2012, 8:569-580
Published Date: 10 October 2012
Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study
Goudev A, Berrou J-P, Pathak A
Vascular Health and Risk Management 2012, 8:563-568
Published Date: 25 September 2012
The prevention and regression of atherosclerotic plaques: emerging treatments
Kalanuria AA, Nyquist P, Ling G
Vascular Health and Risk Management 2012, 8:549-561
Published Date: 25 September 2012
Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in Switzerland
Rey A, Thoenes M, Fimmers R, Meier CA, Bramlage P
Vascular Health and Risk Management 2012, 8:541-547
Published Date: 21 September 2012
The complex regulation of TGF-ß in cardiovascular disease
Redondo S, Navarro-Dorado J, Ramajo M, Medina Ú, Tejerina T
Vascular Health and Risk Management 2012, 8:533-539
Published Date: 13 September 2012
Rivaroxaban in atrial fibrillation
Giorgi MA, Miguel LS
Vascular Health and Risk Management 2012, 8:525-531
Published Date: 30 August 2012
Avanafil for treatment of erectile dysfunction: review of its potential
Burke RM, Evans JD
Vascular Health and Risk Management 2012, 8:517-523
Published Date: 29 August 2012
Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway
Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S
Vascular Health and Risk Management 2012, 8:505-515
Published Date: 24 August 2012
The ClaudicatioNet concept: design of a national integrated care network providing active and healthy aging for patients with intermittent claudication
Lauret GJ, Gijsbers HJ, Hendriks EJ, Bartelink ML, de Bie RA, Teijink JA
Vascular Health and Risk Management 2012, 8:495-503
Published Date: 24 August 2012
Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib
Miyares MA, Davis K
Vascular Health and Risk Management 2012, 8:483-493
Published Date: 23 August 2012
Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients
Reibis R, Treszl A, Wegscheider K, Bestehorn K, Karmann B, Voeller H
Vascular Health and Risk Management 2012, 8:473-481
Published Date: 17 August 2012
Glimepiride: evidence-based facts, trends, and observations
Basit A, Riaz M, Fawwad A
Vascular Health and Risk Management 2012, 8:463-472
Published Date: 15 August 2012
Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans
Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, Ellenga-Mbolla B, Vangu DN, Fuele SM
Vascular Health and Risk Management 2012, 8:455-461
Published Date: 15 August 2012
Endotoxin-induced and vaccine-induced systemic inflammation both impair endothelium-dependent vasodilation, but not pulse wave reflection
Lind L, Hulthe J, Johansson A, Hedner E
Vascular Health and Risk Management 2012, 8:447-453
Published Date: 24 July 2012
Corrigendum
De Caterina AR, Harper AR, Cuculi F
Vascular Health and Risk Management 2012, 8:443-445
Published Date: 19 July 2012
Proof of concept in cardiovascular risk: the paradoxical findings in blood pressure and lipid abnormalities
Fuchs FD, Fuchs SC, Moreira LB, Gus M
Vascular Health and Risk Management 2012, 8:437-442
Published Date: 12 July 2012
Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance
Utsunomiya K
Vascular Health and Risk Management 2012, 8:429-436
Published Date: 4 July 2012
Ezetimibe therapy: mechanism of action and clinical update
Phan BAP, Dayspring TD, Toth PP
Vascular Health and Risk Management 2012, 8:415-427
Published Date: 3 July 2012
The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: The Bergen Stroke Study
Naess H, Lunde L, Brogger J
Vascular Health and Risk Management 2012, 8:407-413
Published Date: 27 June 2012
Everolimus-eluting stents in interventional cardiology
Townsend JC, Rideout P, Steinberg DH
Vascular Health and Risk Management 2012, 8:393-405
Published Date: 27 June 2012
Lift the quilt in case of atrial fibrillation and disc prolapse
Bastovansky A, Ziegler K, Stöllberger C, Finsterer J
Vascular Health and Risk Management 2012, 8:389-392
Published Date: 22 June 2012
Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension
Shuster JE, Bleske BE, Dorsch MP
Vascular Health and Risk Management 2012, 8:381-387
Published Date: 13 June 2012
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
Volpe M, Tocci G
Vascular Health and Risk Management 2012, 8:371-380
Published Date: 11 June 2012
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
Turpie AG, Schmidt AC, Kreutz R, Lassen MR, Jamal W, Mantovani L, Haas S
Vascular Health and Risk Management 2012, 8:363-370
Published Date: 1 June 2012
Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency
Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T
Vascular Health and Risk Management 2012, 8:357-361
Published Date: 5 June 2012
Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action
Al-Omran M
Vascular Health and Risk Management 2012, 8:349-355
Published Date: 28 May 2012
Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus
Dejager S, Schweizer A, Foley JE
Vascular Health and Risk Management 2012, 8:339-348
Published Date: 18 May 2012
Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study
Kvistad CE, Thomassen L, Waje-Andreassen U, Naess H
Vascular Health and Risk Management 2012, 8:333-338
Published Date: 1 June 2012
Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases
Shinkai H
Vascular Health and Risk Management 2012, 8:323-331
Published Date: 15 May 2012
Use of carvedilol in hypertension: an update
Leonetti G, Egan CG
Vascular Health and Risk Management 2012, 8:307-322
Published Date: 18 May 2012
Critical evaluation of the efficacy and tolerability of azilsartan
De Caterina AR, Harper AR, Cuculi F
Vascular Health and Risk Management 2012, 8:299-305
Published Date: 14 May 2012
Smoking status and sex as indicators of differences in 2582 obese patients presenting for weight management
Abunassar MJ, Wells GA, Dent RR
Vascular Health and Risk Management 2012, 8:291-298
Published Date: 7 May 2012
Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion
Lichtenberg M, Käunicke M, Hailer B
Vascular Health and Risk Management 2012, 8:283-289
Published Date: 4 May 2012
Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patients
Nuti M, Spontoni P, Grigoratos C, Dell'Omo G, Balbarini A, Pedrinelli R
Vascular Health and Risk Management 2012, 8:275-281
Published Date: 1 May 2012
Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation
Gitt A, Jannowitz C, Karoff M, Karmann B, Horack M, Völler H
Vascular Health and Risk Management 2012, 8:265-274
Published Date: 24 April 2012
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
Gaebler JA, Soto-Campos G, Alperin P, Cohen M, Blickensderfer A, Wintle M, Maggs D, Hoogwerf B, Han J, Pencek R, Peskin B
Vascular Health and Risk Management 2012, 8:255-264
Published Date: 23 April 2012
Mixed dyslipidemias in primary care patients in France
Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E
Vascular Health and Risk Management 2012, 8:247-254
Published Date: 19 April 2012
Accuracy of the ankle-brachial index using the SCVL®, an arm and ankle automated device with synchronized cuffs, in a population with increased cardiovascular risk
Rosenbaum D, Rodriguez-Carranza S, Laroche P, Bruckert E, Giral P, Girerd X
Vascular Health and Risk Management 2012, 8:239-246
Published Date: 17 April 2012
The predictive power of depression screening procedures for veterans with coronary artery disease
Shankman SA, Nadelson J, McGowan SK, Sovari AA, Vidovich MI
Vascular Health and Risk Management 2012, 8:233-238
Published Date: 17 April 2012
Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease
Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J
Vascular Health and Risk Management 2012, 8:225-232
Published Date: 17 April 2012
Erythrocyte sedimentation rate as a marker for coronary heart disease
Yayan J
Vascular Health and Risk Management 2012, 8:219-223
Published Date: 11 April 2012
Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure
Hebl V, Zakharova MY, Canoniero M, Duprez D, Garcia S
Vascular Health and Risk Management 2012, 8:213-218
Published Date: 10 April 2012
Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center
Shammas NW, Shammas GA , Nader E, Jerin M, Mrad L, Marogil P, Henn C, Dvorak A, Chintalapani A, Meriner S
Vascular Health and Risk Management 2012, 8:205-211
Published Date: 11 April 2012
Hemocompatibility of stent materials: alterations in electrical parameters of erythrocyte membranes
Basoli A, Cametti C, Ginnari Satriani F, Mariani P, Severino P
Vascular Health and Risk Management 2012, 8:197-204
Published Date: 21 March 2012
Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients
Mat Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosla P, Sheyman M
Vascular Health and Risk Management 2012, 8:187-195
Published Date: 20 March 2012
Barriers to cardiovascular risk prevention and management in Germany – an analysis of the EURIKA study
Schmieder RE, Goebel M, Bramlage P
Vascular Health and Risk Management 2012, 8:177-186
Published Date: 15 March 2012
Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure
Takami T, Yamano S, Okada S, Sakuma M, Morimoto T, Hashimoto H, Somekawa S, Saito Y
Vascular Health and Risk Management 2012, 8:169-176
Published Date: 14 March 2012
Lower extremity venous thrombosis in patients younger than 50 years of age
Kreidy R, Salameh P, Waked M
Vascular Health and Risk Management 2012, 8:161-167
Published Date: 13 March 2012
Nebivolol: impact on cardiac and endothelial function and clinical utility
Toblli JE, DiGennaro F, Giani JF, Dominici FP
Vascular Health and Risk Management 2012, 8:151-160
Published Date: 13 March 2012
CVD and obesity in transitional Syria: a perspective from the Middle East
Barakat H, Barakat H, Baaj MK
Vascular Health and Risk Management 2012, 8:145-150
Published Date: 6 March 2012
Differential pharmacology and benefit/risk of azilsartan compared to other sartans
Kurtz TW, Kajiya T
Vascular Health and Risk Management 2012, 8:133-143
Published Date: 28 February 2012
Absorbable stent: focus on clinical applications and benefits
Gonzalo N, Macaya C
Vascular Health and Risk Management 2012, 8:125-132
Published Date: 29 February 2012
Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty
Shah A, Feldman DN
Vascular Health and Risk Management 2012, 8:115-123
Published Date: 27 February 2012
Challenges for heart disease stem cell therapy
Hoover-Plow J, Gong Y
Vascular Health and Risk Management 2012, 8:99-113
Published Date: 17 February 2012
Sudden death in eating disorders
Jáuregui-Garrido B, Jáuregui-Lobera I
Vascular Health and Risk Management 2012, 8:91-98
Published Date: 15 February 2012
Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
Fintel DJ
Vascular Health and Risk Management 2012, 8:77-89
Published Date: 15 February 2012
Evolving role of platelet function testing in coronary artery interventions
Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD
Vascular Health and Risk Management 2012, 8:65-75
Published Date: 8 February 2012
Doppler ultrasound venous mapping of the lower limbs
Galeandro AI, Quistelli G, Scicchitano P, Gesualdo M, Zito A, Caputo P, Carbonara R, Galgano G, Ciciarello F, Mandolesi S, Franceschi C, Ciccone MM
Vascular Health and Risk Management 2012, 8:59-64
Published Date: 7 February 2012
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders
Dahl OE
Vascular Health and Risk Management 2012, 8:45-57
Published Date: 25 January 2012
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy
Toth PP, Thakker KM, Jiang P, Padley RJ
Vascular Health and Risk Management 2012, 8:39-44
Published Date: 25 January 2012
Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women
Maki KC, Dicklin MR, Davidson MH, Mize PD, Kulkarni KR
Vascular Health and Risk Management 2012, 8:31-38
Published Date: 16 January 2012
Predictors of poor blood pressure control assessed by 24 hour monitoring in patients with type B acute aortic dissection
Delsart P, Midulla M, Sobocinski J, Achere C, Haulon S, Claisse G, Mounier-Vehier C
Vascular Health and Risk Management 2012, 8:23-30
Published Date: 10 January 2012
Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients
Bai Q, Lai X, Zhang AH, Lu XH, Tian SL, Fan MH, Wang Y, Wang T
Vascular Health and Risk Management 2012, 8:15-21
Published Date: 6 January 2012
The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients
Khafaji HARH, Bener A, Osman M, Al Merri A, Al Suwaidi J
Vascular Health and Risk Management 2012, 8:7-14
Published Date: 30 December 2011
Blood pressure and blood viscosity are not correlated in normal healthy subjects
Salazar Vázquez BY
Vascular Health and Risk Management 2012, 8:1-6
Published Date: 30 December 2011
Benefits of once-daily therapies in the treatment of hypertension
Flack JM, Nasser SA
Vascular Health and Risk Management 2011, 7:777-787
Published Date: 21 December 2011
The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive
Falskov B, Hermann TS, Rask-Madsen C, Major-Pedersen A, Christiansen B, Raunsø J, Køber L, Torp-Pedersen C, Dominguez H
Vascular Health and Risk Management 2011, 7:771-776
Published Date: 19 December 2011
Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon
Mengden T, Hübner R, Bramlage P
Vascular Health and Risk Management 2011, 7:761-769
Published Date: 12 December 2011
Differential clinical profile of candesartan compared to other angiotensin receptor blockers
Cernes R, Mashavi M, Zimlichman R
Vascular Health and Risk Management 2011, 7:749-759
Published Date: 12 December 2011
Critical review of cancer risk associated with angiotensin receptor blocker therapy
Wuerzner G, Burnier M, Waeber B
Vascular Health and Risk Management 2011, 7:741-747
Published Date: 12 December 2011
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension
Palatini P, Casiglia E, Gąsowski J, Głuszek J, Jankowski P, Narkiewicz K, Saladini F, Stolarz-Skrzypek K, Tikhonoff V, Van Bortel L, Wojciechowska W, Kawecka-Jaszcz K
Vascular Health and Risk Management 2011, 7:725-739
Published Date: 7 December 2011
Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium
Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ
Vascular Health and Risk Management 2011, 7:719-724
Published Date: 2 December 2011
Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension
Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R
Vascular Health and Risk Management 2011, 7:709-717
Published Date: 30 November 2011
Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ
Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R
Vascular Health and Risk Management 2011, 7:701-708
Published Date: 24 November 2011
Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A
Vascular Health and Risk Management 2011, 7:693-699
Published Date: 22 November 2011
Effect of alcohol and tobacco use on vascular dementia: a matched case control study
Takahashi PY, Caldwell CR, Targonski PV
Vascular Health and Risk Management 2011, 7:685-691
Published Date: 15 November 2011
Telmisartan and cardioprotection
Akhrass PR, McFarlane SI
Vascular Health and Risk Management 2011, 7:677-683
Published Date: 15 November 2011
Vitamin D status and peripheral arterial disease: evidence so far
Chua GT, Chan YC, Cheng SW
Vascular Health and Risk Management 2011, 7:671-675
Published Date: 15 November 2011
Hemorrhagic infarction at 33 days after birth in a healthy full-term neonate
Kubo Y, Ogasawara K, Kurose A, Kashimura H, Koji T, Otawara Y, Kamei J, Akasaka M, Sasaki M, Ogawa A
Vascular Health and Risk Management 2011, 7:667-670
Published Date: 8 November 2011
Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
Mohammadi A, Sedani HH, Ghasemi-Rad M
Vascular Health and Risk Management 2011, 7:661-665
Published Date: 7 November 2011
Aneurysm of the tibial-saphenous fistula in hemodialysis patient: the results of surgical treatment
Günday M
Vascular Health and Risk Management 2011, 7:657-660
Published Date: 1 November 2011
Central aortic blood pressure, augmentation index, and reflected wave transit time: reproducibility and repeatability of data obtained by oscillometry
Ageenkova OA, Purygina MA
Vascular Health and Risk Management 2011, 7:649-656
Published Date: 1 November 2011
Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level
Bestehorn K, Jannowitz C, Horack M, Karmann B, Halle M, Völler H
Vascular Health and Risk Management 2011, 7:639-647
Published Date: 31 October 2011
Effects of smoking cessation on central blood pressure and arterial stiffness
Takami T, Saito Y
Vascular Health and Risk Management 2011, 7:633-638
Published Date: 20 October 2011
Prevalence of significant carotid artery stenosis in Iranian patients with peripheral arterial disease
Bavil AS, Ghabili K, Daneshmand SE, Nemati M, Bavil MS, Namdar H, Shaafi S
Vascular Health and Risk Management 2011, 7:629-632
Published Date: 11 October 2011
Retrograde rotational thrombectomy with the Rotarex® catheter system: treatment option for an acute thrombotic occlusion of a subclavian artery
Lichtenberg M, Kaeunicke M, Lukat M, Hailer B
Vascular Health and Risk Management 2011, 7:623-627
Published Date: 30 September 2011
Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk
Farsang C
Vascular Health and Risk Management 2011, 7:605-622
Published Date: 26 September 2011
Troponin elevation in conditions other than acute coronary syndromes
Tanindi A, Cemri M
Vascular Health and Risk Management 2011, 7:597-603
Published Date: 22 September 2011
Signs for early diagnosis of heart failure in primary health care
Devroey D, Van Casteren V
Vascular Health and Risk Management 2011, 7:591-596
Published Date: 14 September 2011
Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism
Kreidy R, Stephan E, Salameh P, Waked M
Vascular Health and Risk Management 2011, 7:585-589
Published Date: 15 September 2011
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials
Grossman E, Laudon M, Zisapel N
Vascular Health and Risk Management 2011, 7:577-584
Published Date: 15 September 2011
Superficial venous thrombosis: disease progression and evolving treatment approaches
Litzendorf ME, Satiani B
Vascular Health and Risk Management 2011, 7:569-575
Published Date: 31 August 2011
Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
Pham PA, Pham PT, Pham PC, Miller JM, Pham PM, Pham SV
Vascular Health and Risk Management 2011, 7:551-567
Published Date: 26 August 2011
Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production
Brown MD, Feairheller DL, Thakkar S, Veerabhadrappa P, Park JY
Vascular Health and Risk Management 2011, 7:541-550
Published Date: 26 August 2011
Extended-release ranolazine: critical evaluation of its use in stable angina
Truffa AAM, Newby LK, Melloni C
Vascular Health and Risk Management 2011, 7:535-539
Published Date: 25 August 2011
Lipid-lowering therapy: who can benefit
Lewis SJ
Vascular Health and Risk Management 2011, 7:525-534
Published Date: 24 August 2011
Arterial function of carotid and brachial arteries in postmenopausal vegetarians
Su TC, Torng PL, Jeng JS, Chen MF, Liau CS
Vascular Health and Risk Management 2011, 7:517-523
Published Date: 23 August 2011
Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital
Lotze U, Lemm H, Heyer A, Müller K
Vascular Health and Risk Management 2011, 7:509-515
Published Date: 19 August 2011
Renal artery stenosis in kidney transplants: assessment of the risk factors
Etemadi J, Rahbar K, Haghighi AN, Bagheri N, Falaknazi K, Ardalan MR, Ghabili K, Shoja MM
Vascular Health and Risk Management 2011, 7:503-507
Published Date: 10 August 2011
Comparing patients with spinal cord infarction and cerebral infarction: clinical characteristics, and short-term outcome
Naess H, Romi F
Vascular Health and Risk Management 2011, 7:497-502
Published Date: 4 August 2011
Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study
Radaideh G, Choueiry P, Ismail A, Eid E, Berrou JP, Sedefdjian A, Sévenier F, Pathak A
Vascular Health and Risk Management 2011, 7:491-495
Published Date: 1 August 2011
Incident prediabetes/diabetes and blood pressure in urban and rural communities in the Democratic Republic of Congo
Hightower JD, Hightower CM, Salazar Vázquez BY, Intaglietta M
Vascular Health and Risk Management 2011, 7:483-489
Published Date: 22 July 2011
Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects
Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G
Vascular Health and Risk Management 2011, 7:475-482
Published Date: 19 July 2011
Pre-eclampsia: pathophysiology, diagnosis, and management
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M
Vascular Health and Risk Management 2011, 7:467-474
Published Date: 19 July 2011
Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
Kwong LM
Vascular Health and Risk Management 2011, 7:461-466
Published Date: 18 July 2011
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
Hillegass WB, Brott BC, Dobbs JC, Papapietro SE, Misra VK, Zoghbi GJ
Vascular Health and Risk Management 2011, 7:445-459
Published Date: 18 July 2011
Depression in vascular pathologies: the neurologist's point of view
Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G
Vascular Health and Risk Management 2011, 7:433-443
Published Date: 12 July 2011
Racial differences in the responses to shear stress in human umbilical vein endothelial cells
Feairheller DL, Park J-Y, Rizzo V, Kim B, Brown MD
Vascular Health and Risk Management 2011, 7:425-431
Published Date: 11 July 2011
Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, Iran
Sadeghi-Bazargani H, Jafarzadeh H, Fallah M, Hekmat S, Bashiri J, Hosseingolizadeh GH, Soltanmohammadzadeh MS, Mortezazadeh A, Shaker A, Danehzan M, Zohouri A, Khosravi O, Nasimidoust R, Malekpour N, Kharazmi E, Babaei M, Nadirmohammadi M, Mashhadi-Abdoll H
Vascular Health and Risk Management 2011, 7:417-424
Published Date: 11 July 2011
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
Mason RP
Vascular Health and Risk Management 2011, 7:405-416
Published Date: 24 June 2011
Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
Kwan J, Htun WW, Huang Y, Ko W, Kwan T
Vascular Health and Risk Management 2011, 7:399-404
Published Date: 24 June 2011
Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials
Baumhäkel M, Böhm M
Vascular Health and Risk Management 2011, 7:391-397
Published Date: 23 June 2011
Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
Takami T, Saito Y
Vascular Health and Risk Management 2011, 7:383-390
Published Date: 17 June 2011
Stiffness of the large arteries in individuals with and without Down syndrome
Rodrigues AN, Coelho LC, Goncalves WLS, Gouvea SA, Vasconcellos MJR, Cunha RS, Abreu GR
Vascular Health and Risk Management 2011, 7:375-381
Published Date: 9 June 2011
Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out
Codreanu I, Robson MD, Rider OJ, Pegg TJ, Jung BA, Dasanu CA, Clarke K, Holloway CJ
Vascular Health and Risk Management 2011, 7:365-373
Published Date: 8 June 2011
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
Nappi J, Sieg A
Vascular Health and Risk Management 2011, 7:353-363
Published Date: 8 June 2011
Stentless aortic valve replacement: an update
Kobayashi J
Vascular Health and Risk Management 2011, 7:345-351
Published Date: 2 June 2011
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
Sezer ED, Sozmen EY, Nart D, Onat T
Vascular Health and Risk Management 2011, 7:333-343
Published Date: 1 June 2011
The occurrence of left ventricular hypertrophy in normotensive individuals in a community setting in North-East Trinidad
Bacchus R, Singh K, Ogeer I, Mungrue K
Vascular Health and Risk Management 2011, 7:327-332
Published Date: 6 July 2011
Early follow-up results of arteriovenous fistulae created for hemodialysis
Iyem H
Vascular Health and Risk Management 2011, 7:321-325
Published Date: 19 May 2011
Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
Ram C
Vascular Health and Risk Management 2011, 7:315-319
Published Date: 15 May 2011
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
Siragy HM
Vascular Health and Risk Management 2011, 7:297-313
Published Date: 19 May 2011
Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods
Barbosa J, Rodrigues A, Mota C, Barbosa M, Simoes e Silva AC
Vascular Health and Risk Management 2011, 7:287-295
Published Date: 10 May 2011
Cognitive evolution in hypertensive patients: a six-year follow-up
Vicario A, del Sueldo MA, Zilberman JM, Cerezo GH
Vascular Health and Risk Management 2011, 7:281-285
Published Date: 5 May 2011
Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta
Xue Y-L, Shi H-X, Murad F, Bian K
Vascular Health and Risk Management 2011, 7:273-280
Published Date: 28 April 2011
Relating patenting and peer-review publications: an extended perspective on the vascular health and risk management literature
Mucke HAM
Vascular Health and Risk Management 2011, 7:265-272
Published Date: 18 April 2011
Surgery in current therapy for infective endocarditis
Head SJ, Mokhles MM, Osnabrugge RLJ, Bogers AJJC, Kappetein AP
Vascular Health and Risk Management 2011, 7:255-263
Published Date: 19 April 2011
The causes, consequences, and treatment of left or right heart failure
Pazos-Lopez P, Peteiro-Vazquez J, Garcia-Campos A, Garcia-Bueno L, Abugattas-de-Torres JP, Castro-Beiras A
Vascular Health and Risk Management 2011, 7:237-254
Published Date: 4 April 2011
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program
Abraham I, MacDonald K, Hermans C, Aerts A, Lee C, Brié H, Vancayzeele S
Vascular Health and Risk Management 2011, 7:209-235
Published Date: 31 March 2011
Doppler study of cerebral arteries in hypercholesterolemia
Farhoudi M, Mehrvar K, Aslanabadi N, Ghabili K, Baghmishe NR, Ilkhchoei F
Vascular Health and Risk Management 2011, 7:203-207
Published Date: 31 March 2011
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation
Schmidt C, Kisselbach J, Schweizer PA, Katus HA, Thomas D
Vascular Health and Risk Management 2011, 7:193-202
Published Date: 31 March 2011
Olmesartan/amlodipine: a review of its use in the management of hypertension
Kreutz R
Vascular Health and Risk Management 2011, 7:183-192
Published Date: 29 March 2011
Olmesartan medoxomil for the treatment of hypertension in children and adolescents
Tocci G, Volpe M
Vascular Health and Risk Management 2011, 7:177-181
Published Date: 31 March 2011
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD
Vascular Health and Risk Management 2011, 7:169-176
Published Date: 28 March 2011
Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization
Grigorios Tsigkas, Panagiota Mylona, Periklis Davlouros, et al
Vascular Health and Risk Management 2011, 7:165-167
Published Date: 22 March 2011
Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications
Carlos V Serrano Jr, Karina Tiemi Setani, Erica Sakamoto, et al
Vascular Health and Risk Management 2011, 7:159-164
Published Date: 16 March 2011
Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience
Hikmat N Abdel-Razeq, Asem H Mansour, Yousef M Ismael
Vascular Health and Risk Management 2011, 7:153-158
Published Date: 15 March 2011
Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification
Carlos V Serrano Jr, Marcelo Oranges, Vitor Brunaldi, et al
Vascular Health and Risk Management 2011, 7:143-151
Published Date: 9 March 2011
Treatment options for hypertension in high-risk patients
Wei-Chuan Tsai
Vascular Health and Risk Management 2011, 7:137-141
Published Date: 9 March 2011
Coronary sinus intervention for the treatment of refractory angina pectoris
Yoav Paz, Amihay Shinfeld
Vascular Health and Risk Management 2011, 7:135-136
Published Date: 3 March 2011
Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease
Marco Matteo Ciccone, Asabella Artor Niccoli, Pietro Scicchitano, et al
Vascular Health and Risk Management 2011, 7:129-134
Published Date: 4 March 2011
The value of blood D-dimer test in the diagnosis of walk-in patients with venous thromboembolism
Shozo Yasuoka, Shunichiro Kubota
Vascular Health and Risk Management 2011, 7:125-127
Published Date: 1 March 2011
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
Zeenat Safdar
Vascular Health and Risk Management 2011, 7:119-124
Published Date: 2 March 2011
Novel drug-eluting stents in the treatment of de novo coronary lesions
Davide Capodanno, Fabio Dipasqua, Corrado Tamburino
Vascular Health and Risk Management 2011, 7:103-118
Published Date: 25 February 2011
Endothelial function in a cardiovascular risk population with borderline ankle–brachial index
Kari Syvänen, Päivi Korhonen, Auli Partanen, et al
Vascular Health and Risk Management 2011, 7:97-101
Published Date: 23 February 2011
Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)
Gerd Bönner, Bernhard Landers, Peter Bramlage
Vascular Health and Risk Management 2011, 7:85-95
Published Date: 17 February 2011
Decline of arterial cerebral infarction among young women: the Bergen Stroke Study
Halvor Naess, Annette Fromm, Ole Erik Iversen, et al
Vascular Health and Risk Management 2011, 7:81-84
Published Date: 15 February 2011
Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus
Samuel O Olusi, Sunila George
Vascular Health and Risk Management 2011, 7:75-80
Published Date: 15 February 2011
Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study
Ersen B Colkesen, Bart S Ferket, Jan GP Tijssen, et al
Vascular Health and Risk Management 2011, 7:67-74
Published Date: 9 February 2011
Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus
Asli Tanindi, Hilal Olgun, Ayse Tuncel, et al
Vascular Health and Risk Management 2011, 7:59-65
Published Date: 6 February 2011
Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Anja Schweizer, Sylvie Dejager, James E Foley, et al
Vascular Health and Risk Management 2011, 7:49-57
Published Date: 4 February 2011
Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer
Devi Charan Shetty, Puneet Ahuja, DK Taneja, et al
Vascular Health and Risk Management 2011, 7:41-47
Published Date: 27 January 2011
Congenital agenesis of internal carotid artery with ipsilateral Horner presenting as focal neurological symptoms
Wassim Farhat, Rechdi Ahdab, Hassan Hosseini
Vascular Health and Risk Management 2011, 7:37-40
Published Date: 26 January 2011
Hyperhomocysteinemia decreases bone blood flow
Neetu Tyagi, Thomas P Vacek, John T Fleming, et al
Vascular Health and Risk Management 2011, 7:31-35
Published Date: 25 January 2011
Antiplatelet combinations for prevention of atherothrombotic events
Mario Bollati, Fiorenzo Gaita, Matteo Anselmino
Vascular Health and Risk Management 2011, 7:23-30
Published Date: 12 January 2011
ACE up the sleeve – are vascular patients medically optimized
AP Coveney, GC O'Brien, GJ Fulton
Vascular Health and Risk Management 2011, 7:15-21
Published Date: 7 January 2011
Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits
Clodagh SM O’Gorman, Michael B O’Neill, Louise S Conwell
Vascular Health and Risk Management 2011, 7:1-14
Published Date: 20 December 2010
COSEHC global vascular risk management quality improvement program: rationale and design
Carlos M Ferrario, Michael A Moore, William Bestermann Jr, et al
Vascular Health and Risk Management 2010, 6:1135-1145
Published Date: 13 December 2010
Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing
Emily Dey-Hazra, Barbara Hertel, Torsten Kirsch, et al
Vascular Health and Risk Management 2010, 6:1125-1133
Published Date: 6 December 2010
Inhaled treprostinil and pulmonary arterial hypertension
Samuel T Nadler, Jeffrey D Edelman
Vascular Health and Risk Management 2010, 6:1115-1124
Published Date: 3 December 2010
Stent-grafts in the management of life-threatening hemorrhage following inadvertent femoral catheterization in high-risk patients: report of two cases and review of the literature
Abdullah Al Wahbi
Vascular Health and Risk Management 2010, 6:1111-1114
Published Date: 3 December 2010
Lower extremity arterial injuries over a six-year period: outcomes, risk factors, and management
Aşkin Ender Topal, Mehmet Nesimi Eren, Yusuf Celik
Vascular Health and Risk Management 2010, 6:1103-1110
Published Date: 3 December 2010
Insulin therapy in critically ill patients
Samer Ellahham
Vascular Health and Risk Management 2010, 6:1089-1101
Published Date: 1 December 2010
Optimal management of familial hypercholesterolemia: treatment and management strategies
Mohammad Hassan Nemati, Behrooz Astaneh
Vascular Health and Risk Management 2010, 6:1079-1088
Published Date: 3 December 2010
Percutaneous coronary intervention of a single coronary artery arising from the right sinus of Valsalva
Mehmet Akif Cakar, Ersan Tatli, Bilhan Ozalp, et al
Vascular Health and Risk Management 2010, 6:1077-1078
Published Date: 25 November 2010
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
William Insull Jr, Peter P Toth, H Robert Superko, et al
Vascular Health and Risk Management 2010, 6:1065-1075
Published Date: 24 November 2010
Cardio classics revisited – focus on the role of candesartan
Maria Leonarda De Rosa
Vascular Health and Risk Management 2010, 6:1047-1063
Published Date: 23 November 2010
Computerized history-taking as a tool to manage dyslipidemia
David Zakim, Christine Fritz, Niko Braun, et al
Vascular Health and Risk Management 2010, 6:1039-1046
Published Date: 12 November 2010
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
Ian Hamilton-Craig, Karam Kostner, David Colquhoun, et al
Vascular Health and Risk Management 2010, 6:1023-1037
Published Date: 10 November 2010
Prognostic value of changes in arterial stiffness in men with coronary artery disease
Iana A Orlova, Eradzh Yu Nuraliev, Elena B Yarovaya, et al
Vascular Health and Risk Management 2010, 6:1015-1021
Published Date: 4 November 2010
Effects of safflower seed extract on arterial stiffness
Katsuya Suzuki, Shigekazu Tsubaki, Masami Fujita, et al
Vascular Health and Risk Management 2010, 6:1007-1014
Published Date: 3 November 2010
Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
Jun Sasaki
Vascular Health and Risk Management 2010, 6:997-1005
Published Date: 2 November 2010
Low high-density lipoprotein cholesterol: current status and future strategies for management
Vibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al
Vascular Health and Risk Management 2010, 6:979-996
Published Date: 29 October 2010
Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
Eitan Abergel, Eugenia Nikolsky
Vascular Health and Risk Management 2010, 6:963-977
Published Date: 19 October 2010
Hypothyroidism and the risk of lower extremity arterial disease
Michael A Mazzeffi, Hung-Mo Lin, Brigid C Flynn, et al
Vascular Health and Risk Management 2010, 6:957-962
Published Date: 20 October 2010
Risk assessment and aspirin use in Asian and Western populations
Runlin Gao, Xiaoying Li
Vascular Health and Risk Management 2010, 6:943-956
Published Date: 14 October 2010
Diagnostic accuracy of dual-source CT angiography and coronary risk stratification
Xia Yang, Lu-yue Gai, Ping Li, et al
Vascular Health and Risk Management 2010, 6:935-941
Published Date: 14 October 2010
Impact of a diabetic foot care education program on lower limb amputation rate
Abdullah M Al-Wahbi
Vascular Health and Risk Management 2010, 6:923-934
Published Date: 11 October 2010
Small coronary vessel angioplasty: outcomes and technical considerations
Sudhir Rathore
Vascular Health and Risk Management 2010, 6:915-922
Published Date: 11 October 2010
Costs and outcomes of noncardioembolic ischemic stroke in a managed care population
Nicole M Engel-Nitz, Stephen D Sander, Carolyn Harley, et al
Vascular Health and Risk Management 2010, 6:905-913
Published Date: 5 October 2010
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
Christina Voulgari, Dimitrios Papadogiannis, Nicholas Tentolouris
Vascular Health and Risk Management 2010, 6:883-903
Published Date: 11 October 2010
New class of agents for treatment of hypertension: Focus on direct renin inhibition
Roberto Fogari, Annalisa Zoppi
Vascular Health and Risk Management 2010, 6:869-882
Published Date: 1 October 2010
Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update
Juan V Llau, Raquel Ferrandis, Pilar Sierra, et al
Vascular Health and Risk Management 2010, 6:855-867
Published Date: 29 September 2010
Benefits of statin therapy and compliance in high risk cardiovascular patients
Joel A Lardizabal, Prakash C Deedwania
Vascular Health and Risk Management 2010, 6:843-853
Published Date: 23 September 2010
Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study
Laura J Gray, Jennifer R Tringham, Melanie J Davies, et al
Vascular Health and Risk Management 2010, 6:837-842
Published Date: 20 September 2010
Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis
Jørn Ditzel, Hans-Henrik Lervang
Vascular Health and Risk Management 2010, 6:829-836
Published Date: 17 September 2010
Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
Maurizio Destro, Nora Crikelair, Joseph Yen, et al.
Vascular Health and Risk Management 2010, 6:821-827
Published Date: 6 September 2010
Argatroban in the management of heparin-induced thrombocytopenia
Luciano Babuin, Vittorio Pengo
Vascular Health and Risk Management 2010, 6:813-819
Published Date: 1 September 2010
Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
Peter Bramlage, Wolf-Peter Wolf, Thomas Stuhr, et al
Vascular Health and Risk Management 2010, 6:803-811
Published Date: 27 August 2010
Management of acute attacks of hereditary angioedema: potential role of icatibant
Hilary J Longhurst
Vascular Health and Risk Management 2010, 6:795-802
Published Date: 6 September 2010
Role of endothelin receptor A and NADPH oxidase in vascular abnormalities
De-Zai Dai, Yin Dai
Vascular Health and Risk Management 2010, 6:787-794
Published Date: 3 September 2010
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review
Suzanne A Ligthart, Eric P Moll van Charante, Willem A Van Gool, et al
Vascular Health and Risk Management 2010, 6:775-785
Published Date: 17 August 2010
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization
Richard Kones
Vascular Health and Risk Management 2010, 6:749-774
Published Date: 12 August 2010
Effectiveness of percutaneous laser revascularization therapy for refractory angina
Michael McGillion, Allison Cook, J Charles Victor, et al
Vascular Health and Risk Management 2010, 6:735-747
Published Date: 26 August 2010
Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells
Myriam Iglewski, Stephen R Grant
Vascular Health and Risk Management 2010, 6:723-734
Published Date: 11 August 2010
Aliskiren and valsartan combination therapy for the management of hypertension
Benjamin J Epstein
Vascular Health and Risk Management 2010, 6:711-722
Published Date: 11 August 2010
Role of olmesartan in combination therapy in blood pressure control and vascular function
Carlos M Ferrario, Ronald D Smith
Vascular Health and Risk Management 2010, 6:701-709
Published Date: 9 August 2010
The utility of troponin measurement to detect myocardial infarction: review of the current findings
Melissa A Daubert, Allen Jeremias
Vascular Health and Risk Management 2010, 6:691-699
Published Date: 5 August 2010
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment
Curtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo
Vascular Health and Risk Management 2010, 6:671-690
Published Date: 5 August 2010
Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
Ajoy Kumar, Vibhuti Singh
Vascular Health and Risk Management 2010, 6:665-669
Published Date: 30 July 2010
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al
Vascular Health and Risk Management 2010, 6:657-663
Published Date: 26 August 2010
Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities
Richard Kones
Vascular Health and Risk Management 2010, 6:635-656
Published Date: 15 July 2010
MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort
Michel R Hoenig
Vascular Health and Risk Management 2010, 6:629-633
Published Date: 16 July 2010
Estimating glomerular filtration rate in a population-based study
Anoop Shankar, Kristine E Lee, Barbara EK Klein, et al
Vascular Health and Risk Management 2010, 6:619-627
Published Date: 16 July 2010
Management of high-risk popliteal vascular blunt trauma: clinical experience with 62 cases
Ali Pourzand, Bassir A Fakhri, Ramin Azhough, et al
Vascular Health and Risk Management 2010, 6:613-618
Published Date: 14 July 2010
Cardiac risk stratification: Role of the coronary calcium score
Rakesh K Sharma, Rajiv K Sharma, Donald J Voelker, et al
Vascular Health and Risk Management 2010, 6:603-611
Published Date: 14 July 2010
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
Claudio A Muratore, Adrian Baranchuk
Vascular Health and Risk Management 2010, 6:593-601
Published Date: 14 July 2010
Using noncontrast cardiac CT and coronary artery calcification measurements for cardiovascular risk assessment and management in asymptomatic adults
John A Rumberger
Vascular Health and Risk Management 2010, 6:579-591
Published Date: 7 July 2010
Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome
Kanako Bokuda, Atsuhiro Ichihara, Mariyo Sakoda, et al
Vascular Health and Risk Management 2010, 6:571-578
Published Date: 5 July 2010
Practical recommendations for treatment of hypertension in older patients
Philip A Kithas, Mark A Supiano
Vascular Health and Risk Management 2010, 6:561-569
Published Date: 29 June 2010
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination
Francesca Cagnoni, Christian Achiri Ngu Njwe, Augusto Zaninelli, et al
Vascular Health and Risk Management 2010, 6:549-559
Published Date: 28 June 2010
Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience
James E Foley, Jens Jordan
Vascular Health and Risk Management 2010, 6:541-548
Published Date: 1 July 2010
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
Elisavet Moutzouri, Anastazia Kei, Moses S Elisaf, et al
Vascular Health and Risk Management 2010, 6:525-539
Published Date: 29 June 2010
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
Deborah Wolbrette, Mario Gonzalez, Soraya Samii, et al
Vascular Health and Risk Management 2010, 6:517-523
Published Date: 28 June 2010
Clinical profile of hypertension at a University Teaching Hospital in Nigeria
Arthur C Onwuchekwa, Sunday Chinenye
Vascular Health and Risk Management 2010, 6:511-516
Published Date: 1 July 2010
Transradial approach to lower extremity interventions
Ravikiran Korabathina, Sidharth S Yadav, John T Coppola, et al
Vascular Health and Risk Management 2010, 6:503-509
Published Date: 1 July 2010
Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG
Sandra Eifert, Helmut Mair, Anne-Laure Boulesteix, et al
Vascular Health and Risk Management 2010, 6:495-501
Published Date: 29 June 2010
Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection
Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al
Vascular Health and Risk Management 2010, 6:479-494
Published Date: 22 June 2010
Congestive heart failure in subjects with thyrotoxicosis in a black community
R C Anakwue, B J C Onwubere, B C Anisiuba, et al
Vascular Health and Risk Management 2010, 6:473-477
Published Date: 5 July 2010
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
Hugo Van Herendael, Paul Dorian
Vascular Health and Risk Management 2010, 6:465-472
Published Date: 21 June 2010
Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review
Ahmed S Awad, Michael E Goldberg
Vascular Health and Risk Management 2010, 6:457-464
Published Date: 9 June 2010
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
Inder S Anand, Anita Deswal, Dean J Kereiakes, et al
Vascular Health and Risk Management 2010, 6:449-455
Published Date: 1 June 2010
Novel approaches for the surgical treatment of atrial fibrillation: Time for a guideline revision?
Carlo Nicola De Cecco, Vitaliano Buffa, Vincenzo David, et al
Vascular Health and Risk Management 2010, 6:439-447
Published Date: 9 June 2010
Influence of demographic and metabolic variables on forearm blood flow and vascular conductance in individuals without overt heart disease
Thiago E Sartori, Rafael AB Nunes, Gisela T da Silva, et al
Vascular Health and Risk Management 2010, 6:431-437
Published Date: 31 May 2010
Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor
Margaret M Marczewski, Marek Postula, Dariusz Kosior
Vascular Health and Risk Management 2010, 6:419-429
Published Date: 24 May 2010
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
A Palazzuoli, M Gallotta, I Quatrini, et al
Vascular Health and Risk Management 2010, 6:411-418
Published Date: 26 May 2010
An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
Katarina Raslova
Vascular Health and Risk Management 2010, 6:399-410
Published Date: 24 May 2010
Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine
David Feldman, Terry S Elton, Doron M Menachemi, et al
Vascular Health and Risk Management 2010, 6:387-397
Published Date: 24 May 2010
Isolated spontaneous dissection of the celiac trunk in a patient with bicuspid aortic valve
Abdel-Rauf Zeina, Alicia Nachtigal, Anton Troitsa, et al
Vascular Health and Risk Management 2010, 6:383-386
Published Date: 19 May 2010
Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes
Magnus Dencker, Martin Stagmo, Mozhgan Dorkhan
Vascular Health and Risk Management 2010, 6:373-382
Published Date: 18 May 2010
Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence
Janet B McGill
Vascular Health and Risk Management 2010, 6:363-372
Published Date: 26 May 2010
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
Peter Alagona Jr
Vascular Health and Risk Management 2010, 6:351-362
Published Date: 13 May 2010
New options with dabigatran etexilate in anticoagulant therapy
Lars Maegdefessel, Joshua M Spin, Junya Azuma, et al
Vascular Health and Risk Management 2010, 6:339-349
Published Date: 10 May 2010
Should we screen for masked hypertension in patient with vascular disease?
Pascal Delsart, Philippe Marboeuf, Cedric Delhaye, et al
Vascular Health and Risk Management 2010, 6:333-338
Published Date: 10 May 2010
Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics
Mabrouka El Oudi, Zied Aouni, Haroun Ouertani, et al
Vascular Health and Risk Management 2010, 6:327-332
Published Date: 13 May 2010
Optimizing blood pressure control through the use of fixed combinations
Rainer Düsing
Vascular Health and Risk Management 2010, 6:321-325
Published Date: 10 May 2010
Volumetric capnography: In the diagnostic work-up of chronic thromboembolic disease
Marcos Mello Moreira, Renato Giuseppe Giovanni Terzi, Laura Cortellazzi, et al
Vascular Health and Risk Management 2010, 6:317-319
Published Date: 17 May 2010
Coronary computed tomographic angiography (CCTA) in community hospitals: “current and emerging role”
Rakesh K Sharma, Donald J Voelker, Rajiv K Sharma, et al
Vascular Health and Risk Management 2010, 6:307-316
Published Date: 10 May 2010
Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)
Marco Matteo Ciccone, Ambrogio Aquilino, Francesca Cortese, et al
Vascular Health and Risk Management 2010, 6:297-305
Published Date: 28 April 2010
Mortality following operations for lower extremity peripheral arterial disease
Tracie C Collins, David Nelson, Jasjit S Ahluwalia
Vascular Health and Risk Management 2010, 6:287-296
Published Date: 3 May 2010
Predictors of obstructive sleep apnea in males with metabolic syndrome
Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al
Vascular Health and Risk Management 2010, 6:281-286
Published Date: 20 April 2010
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
Jeremy A Falk, Kiran J Philip, Ernst R Schwarz
Vascular Health and Risk Management 2010, 6:273-280
Published Date: 20 April 2010
Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial
Richard Grimm, Mobin Malik, Carla Yunis, et al
Vascular Health and Risk Management 2010, 6:261-271
Published Date: 16 April 2010
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update
Maurizio Destro, Francesca Cagnoni, Antonio D’Ospina, et al
Vascular Health and Risk Management 2010, 6:253-260
Published Date: 14 April 2010
Managing anemia in patients with chronic heart failure: what do we know?
Ankur Sandhu, Sandeep Soman, Michael Hudson, et al
Vascular Health and Risk Management 2010, 6:237-252
Published Date: 7 April 2010
Atorvastatin in stroke: a review of SPARCL and subgroup analysis
Branko N Huisa, Andrew B Stemer, Justin A Zivin
Vascular Health and Risk Management 2010, 6:229-236
Published Date: 30 March 2010
Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function
Poulami Basu, Utpal Sen, Neetu Tyagi, et al
Vascular Health and Risk Management 2010, 6:215-228
Published Date: 30 March 2010
Recent achievements in the management of Raynaud’s phenomenon
Magnus Baumhäkel, Michael Böhm
Vascular Health and Risk Management 2010, 6:207-214
Published Date: 30 March 2010
Does plasmin have anticoagulant activity?
Jane Hoover-Plow
Vascular Health and Risk Management 2010, 6:199-205
Published Date: 26 March 2010
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
Toshikazu Yamanouchi
Vascular Health and Risk Management 2010, 6:189-197
Published Date: 23 March 2010
Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies
François Schiele
Vascular Health and Risk Management 2010, 6:179-187
Published Date: 26 March 2010
Advances in the treatment of Raynaud’s phenomenon
Terri L Levien
Vascular Health and Risk Management 2010, 6:167-177
Published Date: 11 March 2010
Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients
Pongsathorn Gojaseni, Angkana Phaopha, Worawon Chailimpamontree, et al
Vascular Health and Risk Management 2010, 6:157-165
Published Date: 11 March 2010
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
Ajikumar V Aryangat, John E Gerich
Vascular Health and Risk Management 2010, 6:145-155
Published Date: 9 March 2010
The diagnostic value of endothelial function as a potential sensor of fatigue in health
Yoshiko Ohno, Teruto Hashiguchi, Ryuichi Maenosono, et al
Vascular Health and Risk Management 2010, 6:135-144
Published Date: 9 March 2010
New standards in hypertension and cardiovascular risk management: focus on telmisartan
Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al
Vascular Health and Risk Management 2010, 6:113-133
Published Date: 4 March 2010
Aspirin and clopidogrel resistance: methodological challenges and opportunities
Armen Yuri Gasparyan
Vascular Health and Risk Management 2010, 6:109-112
Published Date: 2 March 2010
A newly designed hydroxyapatite ceramic burr-hole button
Hiroshi Kashimura, Kuniaki Ogasawara, Yoshitaka Kubo, et al
Vascular Health and Risk Management 2010, 6:105-108
Published Date: 3 March 2010
Modern role for clopidogrel in management of atrial fibrillation and stroke reduction
Lars Maegdefessel, Junya Azuma, Philip S Tsao
Vascular Health and Risk Management 2010, 6:95-103
Published Date: 26 February 2010
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
Roberto Fogari, Amedeo Mugellini, Paola Preti, et al
Vascular Health and Risk Management 2010, 6:87-93
Published Date: 22 February 2010
Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
Yun Lin, Shaymaa S Mousa, Nabil Elshourbagy, et al
Vascular Health and Risk Management 2010, 6:73-85
Published Date: 12 February 2010
On the antiatherogenic effects of vitamin E: the search for the Holy Grail
Francesco Galli, Dimitrios Kirmizis, Dimitrios Chatzidimitriou
Vascular Health and Risk Management 2010, 6:69-71
Published Date: 16 February 2010
Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A
Hans-Christoph Rossbach
Vascular Health and Risk Management 2010, 6:59-68
Published Date: 29 January 2010
Inhaled insulin: overview of a novel route of insulin administration
Lucy D Mastrandrea
Vascular Health and Risk Management 2010, 6:47-58
Published Date: 15 January 2010
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
Jennifer Vergara-Jimenez, Pierluigi Tricoci
Vascular Health and Risk Management 2010, 6:39-45
Published Date: 2 March 2010
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care
Frederic Kontny, Terje Risanger, Arne Bye, et al
Vascular Health and Risk Management 2010, 6:31-38
Published Date: 15 January 2010
Successful management of late right ventricular perforation after pacemaker implantation
Amir K Bigdeli, Andres Beiras-Fernandez, Ingo Kaczmarek, et al
Vascular Health and Risk Management 2010, 6:27-30
Published Date: 6 January 2010
Impact of data from recent clinical trials on strategies for treating patients with type 2 diabetes mellitus
Pasquale J Palumbo, Jonathan M Wert
Vascular Health and Risk Management 2010, 6:17-26
Published Date: 6 January 2010
Role of ICAM-1 and E-selectin gene polymorphisms in pathogenesis of PAOD in Egyptian patients
Olfat Shaker, Amr Zahra, Ahmed Sayed, et al
Vascular Health and Risk Management 2010, 6:9-15
Published Date: 24 December 2009
Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients
Jamison Wyatt, Shailesh Nandish, Rene Oliveros, et al
Vascular Health and Risk Management 2010, 6:1-8
Published Date: 23 December 2009
Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program
R Michael Kirchner, J Dawn Abbott
Vascular Health and Risk Management 2009, 5:1089-1097
Published Date: 16 December 2009
Nitric oxide and coronary vascular endothelium adaptations in hypertension
Andrew S Levy, Justin CS Chung, Jeffrey T Kroetsch, et al
Vascular Health and Risk Management 2009, 5:1075-1087
Published Date: 16 December 2009
Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea
Jean-Philippe Baguet, Marie Nadra, Gilles Barone-Rochette, et al
Vascular Health and Risk Management 2009, 5:1063-1073
Published Date: 11 December 2009
Persistent high fever and systemic inflammation induced by percutaneous coronary intervention-related periaortitis
Takamori Kakino, Tomohiro Nakayama, Hideo Yamamoto
Vascular Health and Risk Management 2009, 5:1059-1062
Published Date: 8 December 2009
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Thomas Mengden, Sakir Uen, Peter Bramlage
Vascular Health and Risk Management 2009, 5:1043-1058
Published Date: 30 November 2009
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Venkata Narla, Michael J Blaha, Roger S Blumenthal, et al
Vascular Health and Risk Management 2009, 5:1033-1042
Published Date: 27 November 2009
Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence
Daniel J Moore, Justin M Gregory, Yaa A Kumah-Crystal, et al
Vascular Health and Risk Management 2009, 5:1015-1031
Published Date: 18 November 2009
Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India
Krishna K Sharma, Rajeev Gupta, Aachu Agrawal, et al
Vascular Health and Risk Management 2009, 5:1007-1014
Published Date: 20 November 2009
Seasonal hematocrit variation and health risks in the adult population of Kinshasa, Democratic Republic of Congo
C Makena Hightower, Joyce D Hightower, Beatriz Y Salazar Vázquez, et al
Vascular Health and Risk Management 2009, 5:1001-1005
Published Date: 17 November 2009
Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice
Roland E Schmieder, Markus Schwertfeger, Peter Bramlage
Vascular Health and Risk Management 2009, 5:991-1000
Published Date: 12 November 2009
Vascular health in children and adolescents: effects of obesity and diabetes
Kevin R Short, Piers R Blackett, Andrew W Gardner, et al
Vascular Health and Risk Management 2009, 5:973-990
Published Date: 10 November 2009
Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
Rakesh K Sharma, Hanumanth K Reddy, Vibhuti N Singh, et al
Vascular Health and Risk Management 2009, 5:965-972
Published Date: 9 November 2009
The treatment of diabetic foot infections: focus on ertapenem
Michael Edmonds
Vascular Health and Risk Management 2009, 5:949-963
Published Date: 6 November 2009
Comparative assessment of angiotensin receptor blockers in different clinical settings
Paolo Verdecchia, Fabio Angeli, Salvatore Repaci, et al
Vascular Health and Risk Management 2009, 5:939-948
Published Date: 6 November 2009
Erratum
Zeina AR, Slobodin G, Naschitz JE et al.
Vascular Health and Risk Management 2009, 5:937-938
Published Date: 3 November 2009
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Yasushi Saito
Vascular Health and Risk Management 2009, 5:921-936
Published Date: 3 November 2009
Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea
Sanja Jelic, David J Lederer, Tessa Adams, et al.
Vascular Health and Risk Management 2009, 5:909-920
Published Date: 3 November 2009
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Klaus G Parhofer
Vascular Health and Risk Management 2009, 5:901-908
Published Date: 3 November 2009
Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
Nikolaos Östlund Papadogeorgos, Mattias Bengtsson, Majid Kalani
Vascular Health and Risk Management 2009, 5:893-899
Published Date: 28 October 2009
Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control
Dion Zappe, Cheraz Cherif Papst, Philippe Ferber, et al.
Vascular Health and Risk Management 2009, 5:883-892
Published Date: 22 October 2009
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Nicholas B Norgard, Mazen Abu-Fadel
Vascular Health and Risk Management 2009, 5:873-882
Published Date: 21 October 2009
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies
Matthias Meier, Michael Hummel
Vascular Health and Risk Management 2009, 5:859-871
Published Date: 19 October 2009
Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects
Lars Maegdefessel, Axel Schlitt, Susanna Pippig, et al
Vascular Health and Risk Management 2009, 5:849-857
Published Date: 9 October 2009
Treatment of congenital fibrinogen deficiency: overview and recent findings
Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, et al
Vascular Health and Risk Management 2009, 5:843-848
Published Date: 5 October 2009
Ankle Brachial Pressure Index (ABPI): An update for practitioners
Mo Al-Qaisi, David M Nott, David H King, et al
Vascular Health and Risk Management 2009, 5:833-841
Published Date: 30 September 2009
Update on the clinical use of the low-molecular-weight heparin, parnaparin
Giuseppe Camporese, Enrico Bernardi, Franco Noventa
Vascular Health and Risk Management 2009, 5:819-831
Published Date: 25 September 2009
Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice
Cláudia Maria Vilas Freire, Antonio Luiz Pinho Ribeiro, Felipe Batista Lima Barbosa, et al
Vascular Health and Risk Management 2009, 5:811-817
Published Date: 24 September 2009
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy
Jeetesh V Patel, Inessa Tracey, Elizabeth A Hughes, et al
Vascular Health and Risk Management 2009, 5:801-810
Published Date: 21 September 2009
Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
Rakesh K Sharma, Vibhuti N Singh, Hanumanth K Reddy
Vascular Health and Risk Management 2009, 5:793-799
Published Date: 21 September 2009
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
Gerald V Naccarelli, Frank Peacock
Vascular Health and Risk Management 2009, 5:783-791
Published Date: 11 September 2009
Protein C preserves microcirculation in a model of neonatal septic shock
Doris Fischer, Marcel F Nold, Claudia A Nold-Petry, et al
Vascular Health and Risk Management 2009, 5:775-781
Published Date: 10 September 2009
Antiatherogenic effects of vitamin E: the search for the Holy Grail
Dimitrios Kirmizis, Dimitrios Chatzidimitriou
Vascular Health and Risk Management 2009, 5:767-774
Published Date: 10 September 2009
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
Jesús Millán, Xavier Pintó, Anna Muñoz, et al
Vascular Health and Risk Management 2009, 5:757-765
Published Date: 10 September 2009
HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al
Vascular Health and Risk Management 2009, 5:751-756
Published Date: 8 September 2009
Pattern of heart failure in a Nigerian teaching hospital
Arthur C Onwuchekwa, Godspower E Asekomeh
Vascular Health and Risk Management 2009, 5:745-750
Published Date: 7 September 2009
Metabolic syndrome and cardiovascular disease in South Asians
Danny Eapen, Girish L Kalra, Nadya Merchant, et al
Vascular Health and Risk Management 2009, 5:731-743
Published Date: 3 September 2009
Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
Vivencio Barrios, Carlos Escobar, Alberto Calderon, et al
Vascular Health and Risk Management 2009, 5:723-729
Published Date: 27 August 2009
Cardiovascular disease in patients with chronic kidney disease
Julian Wright, Alastair Hutchison
Vascular Health and Risk Management 2009, 5:713-722
Published Date: 26 August 2009
Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study
Ramona S DeJesus, Rajeev Chaudhry, Dorinda J Leutink, et al
Vascular Health and Risk Management 2009, 5:705-711
Published Date: 24 August 2009
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants
Andrew D Blann, Chee W Khoo
Vascular Health and Risk Management 2009, 5:693-704
Published Date: 4 September 2009
Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
Shailja V Parikh, Ellen C Keeley
Vascular Health and Risk Management 2009, 5:677-691
Published Date: 19 August 2009
Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: A case control study
Mohammad Shojaie, Morteza Pourahmad, Ahad Eshraghian, et al
Vascular Health and Risk Management 2009, 5:673-676
Published Date: 11 August 2009
RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension
Scott A Barman, Shu Zhu, Richard E White
Vascular Health and Risk Management 2009, 5:663-671
Published Date: 9 August 2009
Validation of reported physical activity for cholesterol control using two different physical activity instruments
Amy Z Fan, Sandra A Ham, Shravani Reddy Muppidi, et al
Vascular Health and Risk Management 2009, 5:649-661
Published Date: 6 August 2009
Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country
Ambarish Pandey, Nivedita Patni, Mansher Singh, et al
Vascular Health and Risk Management 2009, 5:643-648
Published Date: 5 August 2009
Dronedarone for atrial fibrillation: a new therapeutic agent
Pawan D Patel, Rohit Bhuriya, Dipal D Patel, et al
Vascular Health and Risk Management 2009, 5:635-642
Published Date: 5 August 2009
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?
R Kreidy, N Irani-Hakime
Vascular Health and Risk Management 2009, 5:627-633
Published Date: 31 July 2009
Should embolectomy be performed in late acute lower extremity arterial occlusions?
Hikmet Iyem, M Nesimi Eren
Vascular Health and Risk Management 2009, 5:621-626
Published Date: 31 July 2009
Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient
Christopher J Valerio, John G Coghlan
Vascular Health and Risk Management 2009, 5:607-619
Published Date: 5 August 2009
A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
Ji-Guang Wang
Vascular Health and Risk Management 2009, 5:593-605
Published Date: 23 July 2009
Irbesartan improves arterial compliance more than lisinopril
Khalid Ali, Chakravarthi Rajkumar, Francesco Fantin, Rebekah Schiff, Christopher J Bulpitt
Vascular Health and Risk Management 2009, 5:587-592
Published Date: 13 July 2009
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension
Martin Thoenes, Jan-Christian Reil, Bobby Varkey Khan, Peter Bramlage, et al.
Vascular Health and Risk Management 2009, 5:577-585
Published Date: 13 July 2009
Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers
Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.
Vascular Health and Risk Management 2009, 5:567-575
Published Date: 2 July 2009
Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome
Marco Matteo Ciccone, Stefano Favale, Anish Bhuva, Pietro Scicchitano, et al.
Vascular Health and Risk Management 2009, 5:561-566
Published Date: 25 June 2009
The role of insulin detemir in overweight type 2 diabetes management
Yared N Demssie, Naveed Younis, Handrean Soran
Vascular Health and Risk Management 2009, 5:553-560
Published Date: 29 June 2009
Pleiotropic effects of statins in atrial fibrillation patients: the evidence
Hadi AR Hadi, Wael Al Mahmeed, Jassim Al Suwaidi, Samer Ellahham
Vascular Health and Risk Management 2009, 5:533-551
Published Date: 17 June 2009
Histopathologic changes of the radial artery wall secondary to transradial catheterization
Cezar S Staniloae, Kanika P Mody, Kintur Sanghvi, Catalin Mindrescu, et al.
Vascular Health and Risk Management 2009, 5:527-532
Published Date: 23 June 2009
LETTER: A commentary on “A young man with acute dilated cardiomyopathy associated with methylphenidate”
Ahmad Ghanizadeh
Vascular Health and Risk Management 2009, 5:525-526
Published Date: 5 June 2009
Treatment of pediatric pulmonary hypertension
Amy Hawkins, Robert Tulloh
Vascular Health and Risk Management 2009, 5:509-524
Published Date: 3 June 2009
Reducing morbidity and mortality in high risk patients with statins
Vibhuti Singh, Prakash Deedwania
Vascular Health and Risk Management 2009, 5:495-507
Published Date: 5 June 2009
Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts
Nader Nouri-Majalan, Ehsan Fotouhi Ardakani, Khalil Forouzannia, Hosein Moshtaghian
Vascular Health and Risk Management 2009, 5:489-494
Published Date: 27 May 2009
Hematocrit and mean arterial blood pressure in pre- and postmenopause women
Beatriz Y Salazar Vázquez, Miguel A Salazar Vázquez, Marcos Intaglietta, Ulf de Faire, et al.
Vascular Health and Risk Management 2009, 5:483-488
Published Date: 25 May 2009
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel
Zuzana Motovska, Petr Widimsky
Vascular Health and Risk Management 2009, 5:475-481
Published Date: 21 May 2009
Inhaled iloprost for the control of pulmonary hypertension
Sabine Krug, Armin Sablotzki, Stefan Hammerschmidt, Hubert Wirtz, Hans-Juergen Seyfarth
Vascular Health and Risk Management 2009, 5:465-473
Published Date: 19 May 2009
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Eduardo Pimenta, Suzanne Oparil
Vascular Health and Risk Management 2009, 5:453-463
Published Date: 19 May 2009
The use of sibutramine in the management of obesity and related disorders: An update
Konstantinos Tziomalos, Gerasimos E Krassas, Themistoklis Tzotzas
Vascular Health and Risk Management 2009, 5:441-452
Published Date: 14 May 2009
Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension
Amber Lundy, Nahla Lutfi, Cherylyn Beckey
Vascular Health and Risk Management 2009, 5:429-440
Published Date: 8 May 2009
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia
Vascular Health and Risk Management 2009, 5:411-427
Published Date: 8 May 2009
Safety and efficacy of alteplase in the treatment of acute ischemic stroke
Giuseppe Micieli, Simona Marcheselli, Piera Angela Tosi
Vascular Health and Risk Management 2009, 5:397-409
Published Date: 8 May 2009
Safety and efficacy of rosiglitazone in the elderly diabetic patient
Adie Viljoen, Alan Sinclair
Vascular Health and Risk Management 2009, 5:389-395
Published Date: 30 April 2009
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
Madhuri Devabhaktuni, Sripal Bangalore
Vascular Health and Risk Management 2009, 5:377-387
Published Date: 27 April 2009
Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
Naila Goldenberg, Charles Glueck
Vascular Health and Risk Management 2009, 5:369-376
Published Date: 29 April 2009
Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial
Ming-Sheng Zhou, Ivonne Hernandez Schulman
Vascular Health and Risk Management 2009, 5:361-368
Published Date: 16 April 2009
Arterial stiffness, hypertension, and rational use of nebivolol
Enrico Agabiti-Rosei, Enzo Porteri, Damiano Rizzoni
Vascular Health and Risk Management 2009, 5:353-360
Published Date: 19 May 2009
Efficacy and safety of rosuvastatin in the management of dyslipidemia
Paolo Rubba, Gennaro Marotta, Marco Gentile
Vascular Health and Risk Management 2009, 5:343-352
Published Date: 7 April 2009
Lipid-soluble cigarette smoking particles induce expression of inflammatory and extracellular-matrix-related genes in rat cerebral arteries
Petter Vikman, Cang-Bao Xu, Lars Edvinsson
Vascular Health and Risk Management 2009, 5:333-341
Published Date: 7 April 2009
Review of inhaled iloprost for the control of pulmonary artery hypertension in children
Cecile Tissot, Maurice Beghetti
Vascular Health and Risk Management 2009, 5:325-331
Published Date: 8 April 2009
Prasugrel for the treatment of patients with acute coronary syndrome
Filippo Marzot, Vittorio Pengo
Vascular Health and Risk Management 2009, 5:321-324
Published Date: 6 April 2009
Association between body mass index and chronic kidney disease: A population-based, cross-sectional study of a Japanese community
Ikuo Nomura, Johji Kato, Kazuo Kitamura
Vascular Health and Risk Management 2009, 5:315-320
Published Date: 1 April 2009
Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
Carlos Ferrario
Vascular Health and Risk Management 2009, 5:301-314
Published Date: 26 March 2009
Prevention of atherosclerosis in patients living with HIV
Ferruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, Brian Gazzard, John L McGregor, Kevin Shotliff, Han Xiao
Vascular Health and Risk Management 2009, 5:287-300
Published Date: 26 March 2009
Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
Arijit Dasgupta, Debabrata Mukherjee
Vascular Health and Risk Management 2009, 5:275-286
Published Date: 19 March 2009
Corrigendum
Dove Medical Press Editorial
Vascular Health and Risk Management 2009, 5:273-274
Published Date: 18 March 2009
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
Jacob George, Allan D Struthers
Vascular Health and Risk Management 2009, 5:265-272
Published Date: 5 March 2009
Candesartan cilexetil in the treatment of chronic heart failure
Jean-Philippe Baguet, Gilles Barone-Rochette, Yannick Neuder
Vascular Health and Risk Management 2009, 5:257-264
Published Date: 4 March 2009
Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
Giovanni Melandri, Fabio Vagnarelli, Daniela Calabrese, Franco Semprini, Samuele Nanni, Angelo Branzi
Vascular Health and Risk Management 2009, 5:249-256
Published Date: 26 February 2009
Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial nfarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: A pooled Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data
Maria De Vita, Francesco Burzotta, Giuseppe GL Biondi-Zoccai, Thierry Lefevre, Dariusz Dudek, et al
Vascular Health and Risk Management 2009, 5:243-247
Published Date: 26 February 2009
The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man
Alessandra Del Fiorentino, Silvana Cianchetti, Alessandro Celi, Giulia Dell’Omo, Roberto Pedrinelli
Vascular Health and Risk Management 2009, 5:233-242
Published Date: 8 February 2009
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
Steve Fordan, Philip Raskin
Vascular Health and Risk Management 2009, 5:225-231
Published Date: 19 February 2009
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
Peter Bramlage
Vascular Health and Risk Management 2009, 5:213-224
Published Date: 11 February 2009
Potential of liraglutide in the treatment of patients with type 2 diabetes
Carolyn F Deacon
Vascular Health and Risk Management 2009, 5:199-211
Published Date: 2 February 2009
Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis
R J M W Rennenberg, A G H Kessels, L J Schurgers, J M A van Engelshoven, P W de Leeuw, A A Kroon
Vascular Health and Risk Management 2009, 5:185-197
Published Date: 22 January 2009
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study
JP Baguet, R Asmar, P Valensi, S Nisse-Durgeat, JM Mallion
Vascular Health and Risk Management 2009, 5:175-183
Published Date: 21 January 2009
Amlodipine and valsartan as components of a rational and effective fixed-dose combination
Bernard Waeber, Luis M Ruilope
Vascular Health and Risk Management 2009, 5:165-174
Published Date: 27 March 2009
The management of gestational diabetes
N Wah Cheung
Vascular Health and Risk Management 2009, 5:153-164
Published Date: 15 January 2009
Redefining the role of thiazolidinediones in the management of type 2 diabetes
Anthony H Barnett
Vascular Health and Risk Management 2009, 5:141-151
Published Date: 18 January 2009
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study
Prasad Bichu, Ravi Nistala, Asma Khan, James R Sowers, Adam Whaley-Connell
Vascular Health and Risk Management 2009, 5:129-140
Published Date: 22 December 2008
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Odd Erik Johansen, Pål Johan Vanberg, Bente Kvarv Kilhovd, Anders Palmstrøm Jørgensen
Vascular Health and Risk Management 2009, 5:121-128
Published Date: 18 December 2008
Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization
Clarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, Bieito Campos, Dominick J Angiolillo, Manel Sabaté
Vascular Health and Risk Management 2009, 5:101-119
Published Date: 11 January 2009
Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial
Nader Nouri-Majalan, Reza Nafisi, Sarasadat Moghadasi-Mousavi
Vascular Health and Risk Management 2009, 5:97-100
Published Date: 10 December 2008
The independent relationship between triglycerides and coronary heart disease
Alan Morrison, John E Hokanson
Vascular Health and Risk Management 2009, 5:89-95
Published Date: 23 October 2008
Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women
Asha A Gader, Abed Elrahium D Haggaz, Ishag Adam
Vascular Health and Risk Management 2009, 5:85-87
Published Date: 4 December 2008
Differential expression of Gs in a murine model of homocysteinemic heart failure
Thomas P Vacek, Utpal Sen, Neetu Tyagi, Jonathan C Vacek, Munish Kumar, et al
Vascular Health and Risk Management 2009, 5:79-84
Published Date: 4 December 2008
Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors
Divina G Brillante, Anthony J O’Sullivan, Laurence G Howes
Vascular Health and Risk Management 2009, 5:73-78
Published Date: 4 December 2008
Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive protein
Miguel Arturo Salazar, Vázquez, Beatriz Yadira Salazar, Vázquez, M Intaglietta, Pedro Cabrales
Vascular Health and Risk Management 2009, 5:65-72
Published Date: 30 September 2008
Current management of type B aortic dissection
T Paul Tran, Ali Khoynezhad
Vascular Health and Risk Management 2009, 5:53-63
Published Date: 10 October 2008
Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples
Marjorie K Mau, Karynna Asao, Jimmy Efird, Erin Saito, Robert Ratner, et al
Vascular Health and Risk Management 2009, 5:45-52
Published Date: 7 December 2008
Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin
Jennifer G Robinson
Vascular Health and Risk Management 2009, 5:31-43
Published Date: 4 December 2008
Results of the ONTARGET and TRANSCEND studies: an update and discussion
David Fitchett
Vascular Health and Risk Management 2009, 5:21-29
Published Date: 4 December 2008
Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: How come?
Mahsa Mohammadi, Inger Ekman, Maria Schaufelberger
Vascular Health and Risk Management 2009, 5:13-19
Published Date: 2 December 2008
Alveolar dead space and capnographic variables before and after thrombolysis in patients with acute pulmonary embolism
Marcos Mello Moreira, Renato G G Terzi, Carlos Heitor N Carvalho, Antonio Francisco de Oliveira Neto, Mônica Corso Pereira, Ilma Aparecida Paschoal
Vascular Health and Risk Management 2009, 5:9-12
Published Date: 24 November 2008
Stress echocardiogaphy: A useful test for assessing cardiac risk in diabetes
Rajan Sharma, Denis Pellerin
Vascular Health and Risk Management 2009, 5:1-7
Published Date: 24 November 2008
Corrigendum
Dove Medical Press Editorial
Vascular Health and Risk Management 2008, 4:1481-1481
Published Date: 5 December 2008
Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature
Kathleen Stergiopoulos, Joseph J Brennan, Robin Mathews, John F Setaro, Smadar Kort
Vascular Health and Risk Management 2008, 4:1475-1480
Published Date: 5 December 2008
Association of angiitis of central nervous system, cerebral amyloid angiopathy, and Alzheimer’s disease: Report of an autopsy case
Cédric Annweiler, Marc Paccalin, Gilles Berrut, Caroline Hommet, Christian Lavigne, et al
Vascular Health and Risk Management 2008, 4:1471-1474
Published Date: 5 December 2008
Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: A pilot study
Karim Zouaoui Boudjeltia, Brice Faraut, Patricia Stenuit, Maria José Esposito, Michal Dyzma, et al
Vascular Health and Risk Management 2008, 4:1467-1470
Published Date: 5 December 2008
Characterization of the vasodilatory action of testosterone in the human pulmonary circulation
Alyson M Smith, Robert T Bennett, T Hugh Jones, Mike E Cowen, Kevin S Channer, Richard D Jones
Vascular Health and Risk Management 2008, 4:1459-1466
Published Date: 5 December 2008
Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes
Sandra Beer, François Feihl, Juan Ruiz, Irène Juhan-Vague, Marie-Françoise Aillaud, et al
Vascular Health and Risk Management 2008, 4:1449-1458
Published Date: 5 December 2008
Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia
Catalin Mindrescu, Rakesh P Gupta, Eileen V Hermance, Mary C DeVoe, Vikas R Soma, et al
Vascular Health and Risk Management 2008, 4:1439-1447
Published Date: 5 December 2008
Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm
Bernd Muehling, Alexander Oberhuber, Hubert Schelzig, Gisela Bischoff, Nikolaus Marx, et al
Vascular Health and Risk Management 2008, 4:1433-1437
Published Date: 5 December 2008
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis
Naheed Aryaeian, Farhad Shahram, Mahmoud Djalali, Mohammad R Eshragian, Abolghasem Djazayeri, et al
Vascular Health and Risk Management 2008, 4:1423-1432
Published Date: 5 December 2008
The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions
Oyku Gulmez, Ilyas Atar, Bülent Ozin, Mehmet Emin Korkmaz, Asli Atar, et al
Vascular Health and Risk Management 2008, 4:1417-1422
Published Date: 5 December 2008
Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study
Toivo Laks, Ester Keba, Mariann Leiner, Eero Merilind, Mall Petersen, et al
Vascular Health and Risk Management 2008, 4:1407-1416
Published Date: 5 December 2008
Dual factor pulse pressure: body mass index and outcome in type 2 diabetic subjects on maintenance hemodialysis. A longitudinal study 2003–2006
Lydia Foucan, Kheira Hue, Jocelyn Inamo, Jacqueline Deloumeaux, Anne Blanchet-Deverly, et al
Vascular Health and Risk Management 2008, 4:1401-1406
Published Date: 5 December 2008
Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
William H Frishman, Linda S Henderson, Mary Ann Lukas
Vascular Health and Risk Management 2008, 4:1387-1400
Published Date: 5 December 2008
Emergence of new oral antithrombotics: a critical appraisal of their clinical potential
Michael Rud Lassen, Volker Laux
Vascular Health and Risk Management 2008, 4:1373-1386
Published Date: 5 December 2008
Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease
Michael R Graham, Peter Evans, Bruce Davies, Julien S Baker
Vascular Health and Risk Management 2008, 4:1361-1371
Published Date: 5 December 2008
Vildagliptin: a new oral treatment for type 2 diabetes mellitus
Chantal Mathieu, Evy Degrande
Vascular Health and Risk Management 2008, 4:1349-1360
Published Date: 5 December 2008
Thrombosis in the critically ill neonate: incidence, diagnosis, and management
Alex Veldman, Marcel F Nold, Ina Michel-Behnke
Vascular Health and Risk Management 2008, 4:1337-1348
Published Date: 5 December 2008
Mechanisms of endothelial dysfunction in obstructive sleep apnea
Amy Atkeson, Sanja Jelic
Vascular Health and Risk Management 2008, 4:1327-1335
Published Date: 5 December 2008
The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target
Jean-Jacques Mourad
Vascular Health and Risk Management 2008, 4:1315-1325
Published Date: 5 December 2008
Pathophysiology of placentation abnormalities in pregnancy-induced hypertension
Mitsuko Furuya, Junji Ishida, Ichiro Aoki, Akiyoshi Fukamizu
Vascular Health and Risk Management 2008, 4:1301-1313
Published Date: 5 December 2008
Role of TGF-β on cardiac structural and electrical remodeling
Roberto Ramos-Mondragón, Carlos A Galindo, Guillermo Avila
Vascular Health and Risk Management 2008, 4:1289-1300
Published Date: 5 December 2008
Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications?
Lina Nordquist, M Johansson
Vascular Health and Risk Management 2008, 4:1283-1288
Published Date: 5 December 2008
Role of stress fibers and focal adhesions as a mediator for mechano-signal transduction in endothelial cells in situ
Kazuo Katoh, Yumiko Kano, Shigeo Ookawara
Vascular Health and Risk Management 2008, 4:1273-1282
Published Date: 5 December 2008
Beta-glucans in the treatment of diabetes and associated cardiovascular risks
Jiezhong Chen, Kenneth Raymond
Vascular Health and Risk Management 2008, 4:1265-1272
Published Date: 5 December 2008
Managing hypercholesterolemia and its correlation with carotid plaque morphology in patients undergoing carotid endarterectomy
Kittipan Rerkasem, Patrick J Gallagher, Robert F Grimble, Philip C Calder, Clifford P Shearman
Vascular Health and Risk Management 2008, 4:1259-1264
Published Date: 5 December 2008
Long-acting nifedipine in the management of the hypertensive patient
Morgan E Snider, Donald S Nuzum, Angie Veverka
Vascular Health and Risk Management 2008, 4:1249-1257
Published Date: 5 December 2008
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
Luis M Ruilope
Vascular Health and Risk Management 2008, 4:1237-1248
Published Date: 5 December 2008
Cardiometabolic risk in psoriasis: differential effects of biologic agents
Mariana J Kaplan
Vascular Health and Risk Management 2008, 4:1229-1235
Published Date: 5 December 2008
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential
Nasser Mikhail
Vascular Health and Risk Management 2008, 4:1221-1227
Published Date: 5 December 2008
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
Kalathil K Sureshkumar
Vascular Health and Risk Management 2008, 4:1205-1220
Published Date: 5 December 2008
Safety and efficacy of cilostazol in the management of intermittent claudication
Yung-Wei Chi, Carl J Lavie, Richard V Milani, Christopher J White
Vascular Health and Risk Management 2008, 4:1197-1203
Published Date: 5 December 2008
Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
Floris Alexander van de Laar
Vascular Health and Risk Management 2008, 4:1189-1195
Published Date: 5 December 2008
Peripheral artery disease: potential role of ACE-inhibitor therapy
Giuseppe Coppola, Giuseppe Romano, Egle Corrado, Rosa Maria Grisanti, Salvatore Novo
Vascular Health and Risk Management 2008, 4:1179-1187
Published Date: 5 December 2008
Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
Marc K Israel, Eva Istvan, Michelle A Baron
Vascular Health and Risk Management 2008, 4:1167-1178
Published Date: 5 December 2008
Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine
Menno T Pruijm, Marc P Maillard, Michel Burnier
Vascular Health and Risk Management 2008, 4:1159-1166
Published Date: 5 December 2008
Update on the use of Trandolapril in the management of cardiovascular disorders
Ariel Diaz, Anique Ducharme
Vascular Health and Risk Management 2008, 4:1147-1158
Published Date: 5 December 2008
ISVH – October Newsletter
Prof. Roland Asmar, David Oldfield
Vascular Health and Risk Management 2008, 4:1145-1146
Published Date: 10 October 2008
Aberrant positioning of a central venous dialysis catheter to reveal a left-sided partial anomalous pulmonary venous connection
Manohar R Chintu, Shammikumar Chinnappa, Sunil Bhandari
Vascular Health and Risk Management 2008, 4:1141-1143
Published Date: 10 October 2008
Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study
Toshiyuki Oshitari, Noriko Asaumi, Masaru Watanabe, Ken Kumagai, Yoshinori Mitamura
Vascular Health and Risk Management 2008, 4:1137-1140
Published Date: 10 October 2008
Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience
Glen J Pearson, Kari L Olson, Nicole E Panich, Sumit R Majumdar, Ross T Tsuyuki, et al
Vascular Health and Risk Management 2008, 4:1127-1135
Published Date: 10 October 2008
Validation of the Oregon Scientific BPU 330 for self-monitoring of blood pressure according to the International Protocol
Li Li, XinYu Zhang, ChunHong Yan, QingXiang Liang
Vascular Health and Risk Management 2008, 4:1121-1125
Published Date: 10 October 2008
Under- and overreporting of energy in a group of candidates for CABG surgery and its association with some anthropometric and sociodemographic factors, Tehran, Iran
Bahareh Amirkalali, Mehdi Najafi, Asal Ataie-Jafari, Saeed Hosseini, Ramin Heshmat
Vascular Health and Risk Management 2008, 4:1115-1120
Published Date: 10 October 2008
Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
Anne M Keogh, Andrew Jabbour, Christopher S Hayward, Peter S Macdonald
Vascular Health and Risk Management 2008, 4:1111-1113
Published Date: 10 October 2008
Compliance of the aorta in two diseases affecting vascular elasticity, familial hypercholesterolemia and diabetes: a MRI study
Sami Soljanlahti, Taina Autti, Laura Hyttinen, Alpo F Vuorio, Pekka Keto, Kirsi Lauerma
Vascular Health and Risk Management 2008, 4:1103-1109
Published Date: 10 October 2008
The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene
Yong Zhang, Kenneth S Ramos
Vascular Health and Risk Management 2008, 4:1095-1102
Published Date: 10 October 2008
Frequency of secondary dyslipidemia in obese children
Ulrike Korsten-Reck, Katrin Kromeyer-Hauschild, Katrin Korsten, Manfred W Baumstark, Hans-H Dickhuth, Aloys Berg
Vascular Health and Risk Management 2008, 4:1089-1094
Published Date: 10 October 2008
Postpartum thromboembolism: Severe events might be preventable using a new risk score model
Pelle G Lindqvist, Jelena Torsson, Åsa Almqvist, Ola Björgell
Vascular Health and Risk Management 2008, 4:1081-1087
Published Date: 10 October 2008
ST segment depression in hypertensive patients: A comparison of exercise test versus Holter ECG
Sakir Uen, Rolf Fimmers, Burkhard Weisser, Osman Balta, Georg Nickenig, Thomas Mengden
Vascular Health and Risk Management 2008, 4:1073-1080
Published Date: 10 October 2008
Single photon emission computed tomography: An alternative imaging modality in left ventricular evaluation
Hulya Yalçin, Sofiane Maza, Fatih Yalçin
Vascular Health and Risk Management 2008, 4:1069-1072
Published Date: 10 October 2008
The importance of endothelin-1 for microvascular dysfunction in diabetes
Majid Kalani
Vascular Health and Risk Management 2008, 4:1061-1068
Published Date: 10 October 2008
Arterial pulmonary hypertension in noncardiac intensive care unit
Mykola V Tsapenko, Arseniy V Tsapenko, Thomas BO Comfere, Girish K Mour, Sunil V Mankad, Ognjen Gajic
Vascular Health and Risk Management 2008, 4:1043-1060
Published Date: 10 October 2008
Current concepts in the management of hepatopulmonary syndrome
Vincent Ho
Vascular Health and Risk Management 2008, 4:1035-1041
Published Date: 10 October 2008
Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities
Todd C Rideout, Scott V Harding, Peter JH Jones, Ming Z Fan
Vascular Health and Risk Management 2008, 4:1023-1033
Published Date: 10 October 2008
Effects of study design and trends for EVAR versus OSR
Robert Hopkins, James Bowen, Kaitryn Campbell, Gord Blackhouse, Guy De Rose, et al
Vascular Health and Risk Management 2008, 4:1011-1022
Published Date: 10 October 2008
Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin
Anbu Pandian, Anjali Arora, Laurence S Sperling, Bobby V Khan
Vascular Health and Risk Management 2008, 4:1001-1009
Published Date: 10 October 2008
Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
Michel Farnier
Vascular Health and Risk Management 2008, 4:991-1000
Published Date: 10 October 2008
Clinical use of parnaparin in major and minor orthopedic sugery: a review
Stefano Bugamelli, Elena Zangheri, Milena Montebugnoli, Lucia Guerra
Vascular Health and Risk Management 2008, 4:983-990
Published Date: 10 October 2008
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Giorgio Gentile, Gianpaolo Reboldi
Vascular Health and Risk Management 2008, 4:971-981
Published Date: 10 October 2008
Habitual coffee consumption and blood pressure: An epidemiological perspective
Johanna M Geleijnse
Vascular Health and Risk Management 2008, 4:963-970
Published Date: 10 October 2008
Excess coronary artery disease risk in South Asian immigrants: Can dysfunctional high-density lipoprotein explain increased risk?
Sunita Dodani
Vascular Health and Risk Management 2008, 4:953-961
Published Date: 10 October 2008
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
M Kathryn Steiner, Ioana R Preston
Vascular Health and Risk Management 2008, 4:943-952
Published Date: 10 October 2008
Early detection and efficient therapy of cardiac angiosarcoma due to routine transesophageal echocardiography after cerebrovascular stroke
Dirk Vogelgesang, Johannes B Dahm, Holm Großmann, Andre Hippe, Astrid Hummel, et al
Vascular Health and Risk Management 2008, 4:937-941
Published Date: 8 August 2008
Subtemporal approach to basilar tip aneurysm with division of posterior communicating artery: Technical note
Shunsuke Kakino, Kuniaki Ogasawara, Yoshitaka Kubo, Hideaki Nishimoto, Akira Ogawa
Vascular Health and Risk Management 2008, 4:931-935
Published Date: 8 August 2008
Aorta of young and middle-aged heterozygous familial hypercholesterolemia patients shows no functional or morphological impairment assessed by MRI
Sami Soljanlahti, Taina Autti, Alpo F Vuorio, Pekka Keto, Hannu Turtola, Kirsi Lauerma
Vascular Health and Risk Management 2008, 4:923-929
Published Date: 8 August 2008
Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients
Pedro Cabrales, Miguel A Salazar Vázquez, Beatriz Y Salazar Vázquez, Martha Rodríguez-Morán, Marcos Intaglietta, Fernando Guerrero-Romero
Vascular Health and Risk Management 2008, 4:917-922
Published Date: 8 August 2008
Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
André C Schmidt, Burkhard Flick, Elke Jahn, Peter Bramlage
Vascular Health and Risk Management 2008, 4:905-915
Published Date: 8 August 2008
Comparative evaluation of 64-slice CT angiography and digital subtraction angiography in assessing the cervicocranial vasculature
Randolf Klingebiel, Max Kentenich, Hans-Christian Bauknecht, Florian Masuhr, Eberhard Siebert, et al
Vascular Health and Risk Management 2008, 4:901-907
Published Date: 8 August 2008
Determination of RBC membrane and serum lipid composition in trinidadian type II diabetics with and without nephropathy
B Shivananda Nayak, Vishi Y Beharry, Shivani Armoogam, Melinda Nancoo, Kevin Ramadhin, et al
Vascular Health and Risk Management 2008, 4:893-899
Published Date: 8 August 2008
Is continuous insulin treatment safe in aneurysmal subarachnoid hemorrhage?
Florian Schlenk, Asita S Sarrafzadeh
Vascular Health and Risk Management 2008, 4:885-891
Published Date: 8 August 2008
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Alberto Palazzuoli, Maddalena Gallotta, Giuseppe Guerrieri, Ilaria Quatrini, Beatrice Franci, et al
Vascular Health and Risk Management 2008, 4:877-883
Published Date: 8 August 2008
Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis
Li-Tao Cheng, Li-Jun Tang, Hui-Min Chen, Wen Tang, Tao Wang
Vascular Health and Risk Management 2008, 4:871-876
Published Date: 8 August 2008
The interleukin-6 –174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study
Mark PS Sie, Francesco US Mattace-Raso, André G Uitterlinden, Pascal P Arp, Albert Hofman, et al
Vascular Health and Risk Management 2008, 4:863-869
Published Date: 8 August 2008
New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban
Lars Carl Borris
Vascular Health and Risk Management 2008, 4:855-862
Published Date: 8 August 2008
Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
Vivencio Barrios, Carlos Escobar, Rocio Echarri
Vascular Health and Risk Management 2008, 4:847-853
Published Date: 8 August 2008
Tobacco smoking cessation management: integrating varenicline in current practice
Laurence M Galanti
Vascular Health and Risk Management 2008, 4:837-845
Published Date: 8 August 2008
Detection of metabolic syndrome features among childhood cancer survivors: A target to prevent disease
Adriana Aparecida Siviero-Miachon, Angela Maria Spinola-Castro, Gil Guerra-Junior
Vascular Health and Risk Management 2008, 4:825-836
Published Date: 8 August 2008
Utility of ranolazine in chronic stable angina patients
Pawan D Patel, Rohit R Arora
Vascular Health and Risk Management 2008, 4:819-824
Published Date: 8 August 2008
TNF-α-mediated inflammation in cerebral aneurysms: A potential link to growth and rupture
Thottala Jayaraman, Andrew Paget, Yang Sam Shin, Xiaguai Li, Jillian Mayer, et al
Vascular Health and Risk Management 2008, 4:805-817
Published Date: 8 August 2008
The renin–angiotensin system and diabetes: An update
Antônio Ribeiro-Oliveira Jr, Anelise Impeliziere Nogueira, Regina Maria Pereira, Walkiria Wingester Vilas Boas, Robson Augusto Souza dos Santos, Ana Cristina Simões e Silva
Vascular Health and Risk Management 2008, 4:787-803
Published Date: 8 August 2008
Urotensin II in cardiovascular regulation
Fraser D Russell
Vascular Health and Risk Management 2008, 4:775-785
Published Date: 8 August 2008
Characterizing blood microparticles: Technical aspects and challenges
Arun S Shet
Vascular Health and Risk Management 2008, 4:769-774
Published Date: 8 August 2008
Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christian Lerch
Vascular Health and Risk Management 2008, 4:753-768
Published Date: 8 August 2008
New combination treatments in the management of diabetes: focus on sitagliptin – metformin
Jennifer Green, Mark Feinglos
Vascular Health and Risk Management 2008, 4:743-751
Published Date: 8 August 2008
Erratum
Erhardt L, Moller R, Puig JC. 2007
Vascular Health and Risk Management 2008, 4:741-741
Published Date: 6 June 2008
Diagnosis with ECG-gated MDCT of floating thrombus in aortic arch in a patient with type-A dissection
Domenico Lumia, Gianpaolo Carrafiello, Domenico Laganà, Andrea Musazzi, Andrea Giorgianni, et al
Vascular Health and Risk Management 2008, 4:735-739
Published Date: 6 June 2008
Intertester reliability of brachial artery flow-mediated vasodilation using upper and lower arm occlusion in healthy subjects
Ludmila M Cosio-Lima, Richard Seip, Paul D Thompson, Marie A Lagasse, Tabitha H Hodges
Vascular Health and Risk Management 2008, 4:731-734
Published Date: 6 June 2008
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease
Gjumrakch Aliev, Eldar Gasimov, Mark E Obrenovich, Kathryn Fischbach, Justin C Shenk, et al
Vascular Health and Risk Management 2008, 4:721-730
Published Date: 6 June 2008
Early seizures in patients with acute stroke: Frequency, predictive factors, and effect on clinical outcome
Andrea Alberti, Maurizio Paciaroni, Valeria Caso, Michele Venti, Francesco Palmerini, Giancarlo Agnelli
Vascular Health and Risk Management 2008, 4:715-720
Published Date: 6 June 2008
Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease
Ioannis Kallikazaros, Costas Tsioufis, Panagiotis Zambaras, Ioannis Skiadas, Marina Toutouza, et al
Vascular Health and Risk Management 2008, 4:705-714
Published Date: 6 June 2008
Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation
Marie-Louise Edvinsson, Sven E Andersson, Cang-Bao Xu, Lars Edvinsson
Vascular Health and Risk Management 2008, 4:699-704
Published Date: 6 June 2008
Five-year incidence of type 2 diabetes mellitus among cardiovascular disease-free Greek adults: Findings from the ATTICA study
Demosthenes B Panagiotakos, Christos Pitsavos, Yannis Skoumas, Yannis Lentzas, Christodoulos Stefanadis
Vascular Health and Risk Management 2008, 4:691-698
Published Date: 6 June 2008
The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
Joerg Tautenhahn, Ralf Lobmann, Brigitte Koenig, Zuhir Halloul, Hans Lippert, Thomas Buerger
Vascular Health and Risk Management 2008, 4:683-689
Published Date: 6 June 2008
Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
Bimal V Patel, R Scott Leslie, Patrick Thiebaud, Michael B Nichol, Simon SK Tang, et al
Vascular Health and Risk Management 2008, 4:673-681
Published Date: 6 June 2008
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
Claudio Borghi, Arrigo FG Cicero, Ettore Ambrosioni
Vascular Health and Risk Management 2008, 4:665-671
Published Date: 6 June 2008
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
Eduardo Pimenta, Suzanne Oparil
Vascular Health and Risk Management 2008, 4:653-654
Published Date: 6 June 2008
Measurement of endothelial function and its clinical utility for cardiovascular risk
Mo Al-Qaisi, Rajesh K Kharbanda, Tarun K Mittal, Ann E Donald
Vascular Health and Risk Management 2008, 4:647-652
Published Date: 6 June 2008
Antiplatelet drugs in cardiological practice: Established strategies and new developments
Florian Krötz, Hae-Young Sohn, Volker Klauss
Vascular Health and Risk Management 2008, 4:637-645
Published Date: 6 June 2008
Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation
Luca Masotti, Patrick Ray, Marc Righini, Gregoire Le Gal, Fabio Antonelli, et al
Vascular Health and Risk Management 2008, 4:629-636
Published Date: 6 June 2008
Perioperative hypertension management
Joseph Varon, Paul E Marik
Vascular Health and Risk Management 2008, 4:615-627
Published Date: 6 June 2008
Cardiovascular co-morbidity in rheumatic diseases
Carl Turesson, Lennart TH Jacobsson, Eric L Matteson
Vascular Health and Risk Management 2008, 4:605-614
Published Date: 6 June 2008
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?
Dimitar Divchev, Bernhard Schieffer
Vascular Health and Risk Management 2008, 4:597-604
Published Date: 6 June 2008
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
Camelia R Ban, Stephen M Twigg
Vascular Health and Risk Management 2008, 4:575-596
Published Date: 6 June 2008
Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
Kjeld Hermansen, Lene Sundahl Mortensen, Marie-Louise Hermansen
Vascular Health and Risk Management 2008, 4:561-574
Published Date: 6 June 2008
Drug-eluting stents in the management of peripheral arterial disease
Marc Bosiers, Catherine Cagiannos, Koen Deloose, Jürgen Verbist, Patrick Peeters
Vascular Health and Risk Management 2008, 4:553-559
Published Date: 6 June 2008
Early vascular aging (EVA): consequences and prevention
Peter M Nilsson
Vascular Health and Risk Management 2008, 4:547-552
Published Date: 6 June 2008
Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases
Ben van Steenkiste, Richard Grol, Trudy van der Weijden
Vascular Health and Risk Management 2008, 4:535-545
Published Date: 6 June 2008
Relative safety profiles of high dose statin regimens
Carlos Escobar, Rocio Echarri, Vivencio Barrios
Vascular Health and Risk Management 2008, 4:525-533
Published Date: 6 June 2008
Relaxin as a natural agent for vascular health
Daniele Bani
Vascular Health and Risk Management 2008, 4:515-524
Published Date: 6 June 2008
Treprostinil for pulmonary hypertension
Nika Skoro-Sajer, Irene Lang, Robert Naeije
Vascular Health and Risk Management 2008, 4:507-513
Published Date: 6 June 2008
Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
Ravi K Ramana, Bruce E Lewis
Vascular Health and Risk Management 2008, 4:493-505
Published Date: 6 June 2008
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet
Serge Halimi, Anja Schweizer, Biljana Minic, James Foley, Sylvie Dejager
Vascular Health and Risk Management 2008, 4:481-492
Published Date: 6 June 2008
A young man with acute dilated cardiomyopathy associated with methylphenidate
Tor-Bjarne Nymark, A Hovland, H Bjørnstad, E W Nielsen
Vascular Health and Risk Management 2008, 4:477-479
Published Date: 11 April 2008
Effect of ramipril on renal function in patients with intermittent claudication
Simon D Hobbs, Martin W Claridge, Antonius BM Wilmink, Donald J Adam, Mark E Thomas, Andrew W Bradbury
Vascular Health and Risk Management 2008, 4:471-475
Published Date: 11 April 2008
Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
Guliz Kozdag, Ercument Ciftci, Dilek Ural, Tayfun Sahin, Macit Selekler, et al
Vascular Health and Risk Management 2008, 4:463-469
Published Date: 11 April 2008
Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
Evelyn O Talbott, Jeanne Zborowski, Judy Rager, Juley R Stragand
Vascular Health and Risk Management 2008, 4:453-462
Published Date: 11 April 2008
Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study
Jean-Jacques Mourad, Dulce Lameira, Pierre-Jean Guillausseau
Vascular Health and Risk Management 2008, 4:443-451
Published Date: 11 April 2008
Time-dependent alterations in serum NO concentration after oral administration of L-arginine, L-NAME, and allopurinol in intestinal ischemia/reperfusion
Amalia E Yanni, Eleutherios Margaritis, Nikolaos Liarakos, Alkisti Pantopoulou, Maria Poulakou, et al
Vascular Health and Risk Management 2008, 4:437-441
Published Date: 11 April 2008
Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: A case-cohort study and meta-analyses
Mohammad Hadi Zafarmand, Yvonne T van der Schouw, Diederick E Grobbee, Peter W de Leeuw, Michiel L Bots
Vascular Health and Risk Management 2008, 4:427-436
Published Date: 11 April 2008
Kennedy space center cardiovascular disease risk reduction program evaluation
Kristine S Calderon, Charles Smallwood, David A Tipton
Vascular Health and Risk Management 2008, 4:421-426
Published Date: 11 April 2008
Japanese study to organize proper lifestyle modifications for metabolic syndrome (J-STOP-MetS): Design and method
Masanori Munakata, Hiroki Honma, Mitugu Akasi, Takaharu Araki, Takahiko Kawamura, et al
Vascular Health and Risk Management 2008, 4:415-420
Published Date: 11 April 2008
Preferred drug lists: Potential impact on healthcare economics
Kimberly Ovsag, Sabrina Hydery, Shaker A Mousa
Vascular Health and Risk Management 2008, 4:403-413
Published Date: 11 April 2008
Risk factors for vascular dementia: Hypotension as a key point
Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato
Vascular Health and Risk Management 2008, 4:395-402
Published Date: 11 April 2008
Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
Bo Ahrén
Vascular Health and Risk Management 2008, 4:383-394
Published Date: 11 April 2008
Vascular risk factors, cognitve decline, and dementia
E Duron, Olivier Hanon
Vascular Health and Risk Management 2008, 4:363-381
Published Date: 11 April 2008
Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk
Byron J Hoogwerf, Krupa B Doshi, Dima Diab
Vascular Health and Risk Management 2008, 4:355-362
Published Date: 11 April 2008
Clinical efficacy and safety of statins in managing cardiovascular risk
Navin K Kapur, Kiran Musunuru
Vascular Health and Risk Management 2008, 4:341-353
Published Date: 11 April 2008
Regadenoson in the detection of coronary artery disease
Christiane Buhr, Mario Gössl, Raimund Erbel, Holger Eggebrecht
Vascular Health and Risk Management 2008, 4:337-340
Published Date: 11 April 2008
Orlistat in the prevention of diabetes in the obese patient
Marcio C Mancini, Alfredo Halpern
Vascular Health and Risk Management 2008, 4:325-336
Published Date: 11 April 2008
Expert review on coronary calcium
Matthew J Budoff, Khawar M Gul
Vascular Health and Risk Management 2008, 4:315-324
Published Date: 11 April 2008
New anticoagulant strategies in ST elevation myocardial infarction: Trials and clinical implications
Conor J McCann, Ian BA Menown
Vascular Health and Risk Management 2008, 4:305-313
Published Date: 11 April 2008
Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
Francesco Chiarelli, Daniele Di Marzio
Vascular Health and Risk Management 2008, 4:297-304
Published Date: 11 April 2008
Early detection and management of the high-risk patient with elevated blood pressure
Cristina Sierra, Alejandro de la Sierra
Vascular Health and Risk Management 2008, 4:289-296
Published Date: 11 April 2008
Management of venous thromboembolism in patients with cancer: role of dalteparin
Lori-Ann Linkins
Vascular Health and Risk Management 2008, 4:279-287
Published Date: 11 April 2008
Combination therapy in cholesterol reduction: focus on ezetimibe and statins
Liliana Grigore, Giuseppe Danilo Norata, Alberico L Catapano
Vascular Health and Risk Management 2008, 4:267-278
Published Date: 11 April 2008
Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!
Claudia S Vetter-Kauczok, Philipp Ströbel, Eva B Bröcker, Jürgen C Becker
Vascular Health and Risk Management 2008, 4:263-266
Published Date: 8 February 2008
A hazardous finding of a rare anomalous left main coronary artery in a patient with a secundum atrial septal defect
Michael Emery, Waqas Ghumman, Shawn Teague, Jo Mahenthiran
Vascular Health and Risk Management 2008, 4:259-262
Published Date: 8 February 2008
Dissection of the ascending thoracic aorta as a complication of percutaneous coronary intervention
Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir
Vascular Health and Risk Management 2008, 4:253-257
Published Date: 8 February 2008
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension
Bernard Waeber, Jean-Jacques Mourad
Vascular Health and Risk Management 2008, 4:249-252
Published Date: 8 February 2008
Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy
B Shivananda Nayak, Heidi Duncan, Sunita Lalloo, Kevin Maraj, Vani Matmungal, et al
Vascular Health and Risk Management 2008, 4:243-247
Published Date: 8 February 2008
Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet
Oluwatosin A Adaramoye, Olajumoke Akintayo, Jonah Achem, Michael A Fafunso
Vascular Health and Risk Management 2008, 4:235-241
Published Date: 8 February 2008
Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
Giorgio L Colombo, Mauro Caruggi, Chiara Ottolini, Aldo P Maggioni
Vascular Health and Risk Management 2008, 4:223-234
Published Date: 8 February 2008
Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals
Steven G Denniss, Thomas D Haffner, Jeffrey T Kroetsch, Sara R Davidson, James WE Rush, Richard L Hughson
Vascular Health and Risk Management 2008, 4:213-222
Published Date: 8 February 2008
Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians
S Kanjilal, VS Rao, M Mukherjee, BK Natesha1, KS Renuka, et al
Vascular Health and Risk Management 2008, 4:199-211
Published Date: 8 February 2008
Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective
Saikat Kanjilal, Jayashree Shanker, Veena S Rao, Natesha B Khadrinarasimhaih, Manjari Mukherjee, et al
Vascular Health and Risk Management 2008, 4:189-197
Published Date: 8 February 2008
Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population
Deirdre F Waterhouse, Ronan A Cahill, Frances Sheehan, CJ McCreery
Vascular Health and Risk Management 2008, 4:177-187
Published Date: 8 February 2008
Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study
Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir
Vascular Health and Risk Management 2008, 4:173-176
Published Date: 8 February 2008
Therapeutic implications of transesophageal echocardiography after transthoracic echocardiography on acute stroke patients
Tiago Tribolet de Abreu, Sonia Mateus, Cecilia Carreteiro, Jose Correia
Vascular Health and Risk Management 2008, 4:167-172
Published Date: 8 February 2008
Adherence treatment factors in hypertensive African American women
Marie N Fongwa, Lorraines S Evangelista, Ron D Hays, David S Martins, David Elashoff, et al
Vascular Health and Risk Management 2008, 4:157-166
Published Date: 8 February 2008
Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
Michel R Hoenig
Vascular Health and Risk Management 2008, 4:143-156
Published Date: 8 February 2008
Update on the use of fibrates: focus on bezafibrate
Ilan Goldenberg, Michal Benderly, Uri Goldbourt
Vascular Health and Risk Management 2008, 4:131-141
Published Date: 8 February 2008
Heart failure in sub-Saharan Africa: A literature review with emphasis on individuals with diabetes
Andre Pascal Kengne, Anastase Dzudie, Eugene Sobngwi
Vascular Health and Risk Management 2008, 4:123-130
Published Date: 8 February 2008
Endoplasmic reticulum stress and diabetic retinopathy
Toshiyuki Oshitari, Natsuyo Hata, Shuichi Yamamoto
Vascular Health and Risk Management 2008, 4:115-122
Published Date: 8 February 2008
Chronic heart failure in Japan: Implications of the CHART studies
Nobuyuki Shiba, Hiroaki Shimokawa
Vascular Health and Risk Management 2008, 4:103-113
Published Date: 8 February 2008
Endothelial effects of antihypertensive treatment: focus on irbesartan
Roberto Negro
Vascular Health and Risk Management 2008, 4:89-101
Published Date: 8 February 2008
Diagnosis and surgical approach of popliteal artery entrapment syndrome: a retrospective study
Stavros Gourgiotis, John Aggelakas, Nikolaos Salemis, Charalabos Elias, Charalabos Georgiou
Vascular Health and Risk Management 2008, 4:83-88
Published Date: 8 February 2008
Perioperative use of statins in noncardiac surgery
YC Chan, SW Cheng, MG Irwin
Vascular Health and Risk Management 2008, 4:75-81
Published Date: 8 February 2008
Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
Cesare Cuspidi, Francesca Negri, Alberto Zanchetti
Vascular Health and Risk Management 2008, 4:67-73
Published Date: 8 February 2008
Current role of endovascular therapy in Marfan patients with previous aortic surgery
Ibrahim Akin, Stephan Kische, Tim C Rehders, Tushar Chatterjee, Henrik Schneider, et al
Vascular Health and Risk Management 2008, 4:59-66
Published Date: 8 February 2008
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
Navin K Kapur, Dominique Ashen, Roger S Blumenthal
Vascular Health and Risk Management 2008, 4:39-57
Published Date: 8 February 2008
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
Imad Sheiban, Gianluca Villata, Mario Bollati, Dario Sillano, Marzia Lotrionte, Giuseppe Biondi-Zoccai
Vascular Health and Risk Management 2008, 4:31-38
Published Date: 8 February 2008
Carvedilol in hypertension treatment
Panagiotis C Stafylas, Pantelis A Sarafidis
Vascular Health and Risk Management 2008, 4:23-30
Published Date: 8 February 2008
Androgen therapy and atherosclerotic cardiovascular disease
K-CY McGrath, LS McRobb, AK Heather
Vascular Health and Risk Management 2008, 4:11-21
Published Date: 8 February 2008
Gadofosveset-enhanced magnetic resonance angiography
Mathias Goyen
Vascular Health and Risk Management 2008, 4:1-9
Published Date: 8 February 2008
Smoking cessation: a European perspective
Eva Králíková (Guest Editor)
Institute of Hygiene and Epidemiology, and Tobacco Dependence Treatment Centre of the 3rd Medical Department, First Faculty of Medicine, Charles University and the General University Hospital of Prague
Vascular Health and Risk Management 2008, 4:1-23
Published Date: 24 July 2008
Isolated periaortitis: Clinical and imaging characteristics
Abdel-Rauf Zeina, Slobodin Gleb, Jochanan E Naschitz, Zeev Loberman, Elisha Barmeir
Vascular Health and Risk Management 2007, 3:1083-1086
Published Date: 15 January 2008
Acute management of poor condition subarachnoid hemorrhage patients
Archavlis Eleftherios, Carvi y Nievas Mario Nazareno
Vascular Health and Risk Management 2007, 3:1075-1082
Published Date: 15 January 2008
Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity
Barbara Ludolph, Wilhelm Bloch, Malte Kelm, Rainer Schulz, Petra Kleinbongard
Vascular Health and Risk Management 2007, 3:1069-1073
Published Date: 15 January 2008
Adult nontwin sib concordance rates for type 2 diabetes, hypertension and metabolic syndrome among Asian Indians: The Indian Atherosclerosis Research Study
Jayashree Shanker, Saikat Kanjilal, Veena S Rao, Ganapathy Perumal, Natesha B Khadrinarasimhiah, et al
Vascular Health and Risk Management 2007, 3:1063-1068
Published Date: 15 January 2008
Pathogenic role of cardiac mast cell activation/degranulation, TNF-α, and cell death in acute drug-related fatalities
Nasrin Perskvist, Carl Söderberg, Marianne van Hage, Erik Edston
Vascular Health and Risk Management 2007, 3:1053-1062
Published Date: 15 January 2008
Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction
Lena Björck, Catharina Welin, Annika Rosengren
Vascular Health and Risk Management 2007, 3:1045-1051
Published Date: 15 January 2008
Higher persistence with valsartan compared with enalapril in daily practice
Satu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, Zeba M Khan, Joëlle A Erkens, et al
Vascular Health and Risk Management 2007, 3:1039-1044
Published Date: 15 January 2008
Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy
John M Flack, Karl Duncan, Suzanne E Ohmit, Ruth Quah, Xuefeng Liu, et al
Vascular Health and Risk Management 2007, 3:1029-1037
Published Date: 15 January 2008
Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease
Mohammed Al-Omran
Vascular Health and Risk Management 2007, 3:1019-1027
Published Date: 15 January 2008
Rheumatic heart disease: 15 years of clinical and immunological follow-up
Roney O Sampaio, Kellen C Fae, Lea MF Demarchi, Pablo MA Pomerantzeff, Vera D Aiello, et al
Vascular Health and Risk Management 2007, 3:1007-1017
Published Date: 15 January 2008
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice
Maddalena Veronesi, Arrigo FG Cicero, Maria Grazia Prandin, Ada Dormi, Eugenio Cosentino, et al
Vascular Health and Risk Management 2007, 3:999-1005
Published Date: 15 January 2008
Rationale for multiple risk intervention: The need to move from theory to practice
Leif R Erhardt
Vascular Health and Risk Management 2007, 3:985-997
Published Date: 15 January 2008
Reduction of C-reactive protein and the use of anti-hypertensives
Carmine Savoia, Ernesto L Schiffrin
Vascular Health and Risk Management 2007, 3:975-983
Published Date: 15 January 2008
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
Behzad Molavi, Negah Rassouli, Suveer Bagwe, Neda Rasouli
Vascular Health and Risk Management 2007, 3:967-973
Published Date: 15 January 2008
The applicability of home blood pressure measurement in clinical practice: A review of literature
Willem J Verberk, Abraham A Kroon, Heidi A Jongen-Vancraybex, Peter W de Leeuw
Vascular Health and Risk Management 2007, 3:959-966
Published Date: 15 January 2008
Inhaled insulin for controlling blood glucose in patients with diabetes
Bernard L Silverman, Christopher J Barnes, Barbara N Campaigne, Douglas B Muchmore
Vascular Health and Risk Management 2007, 3:947-958
Published Date: 15 January 2008
Regulation of the renin–angiotensin system in coronary atherosclerosis: A review of the literature
Ramadan A Hammoud, Christopher S Vaccari, Sameer H Nagamia, Bobby V Khan
Vascular Health and Risk Management 2007, 3:937-945
Published Date: 15 January 2008
Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes
Nazia Raja-Khan, Sarah S Warehime, Robert A Gabbay
Vascular Health and Risk Management 2007, 3:919-935
Published Date: 15 January 2008
A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
John Cockcroft
Vascular Health and Risk Management 2007, 3:909-917
Published Date: 15 January 2008
Clinical trial update: focus on the ONTARGET study
David Fitchett
Vascular Health and Risk Management 2007, 3:901-908
Published Date: 15 January 2008
Review of bosentan in the management of pulmonary arterial hypertension
Eli Gabbay, John Fraser, Keith McNeil
Vascular Health and Risk Management 2007, 3:887-900
Published Date: 15 January 2008
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date
Antonio Gaddi, AFG Cicero, FO Odoo, A Poli A, R Paoletti
Vascular Health and Risk Management 2007, 3:877-886
Published Date: 15 January 2008
Endothelial dysfunction in diabetes mellitus
Hadi AR Hadi, Jassim Al Suwaidi
Vascular Health and Risk Management 2007, 3:853-876
Published Date: 15 January 2008
Atherogenic lipid profiles and its management in patients with rheumatoid arthritis
Michael T Nurmohamed
Vascular Health and Risk Management 2007, 3:845-852
Published Date: 15 January 2008
Review of duloxetine in the management of diabetic peripheral neuropathic pain
Timothy Smith, Robert A Nicholson
Vascular Health and Risk Management 2007, 3:833-844
Published Date: 15 January 2008
Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications
Brian C Cumbie, Kathie L Hermayer
Vascular Health and Risk Management 2007, 3:823-832
Published Date: 15 January 2008
Obesity management: Update on orlistat
Belinda S Drew, Andrew F Dixon, John B Dixon
Vascular Health and Risk Management 2007, 3:817-821
Published Date: 15 January 2008
Aliskiren – an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension
Kristina Allikmets
Vascular Health and Risk Management 2007, 3:809-815
Published Date: 15 January 2008
A review of nateglinide in the management of patients with type 2 diabetes
Nicholas Tentolouris, Christina Voulgari, Nicholas Katsilambros
Vascular Health and Risk Management 2007, 3:797-807
Published Date: 15 January 2008
Editorial: Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension
Vascular Health and Risk Management 2007, 3:783-795
Published Date: 15 January 2008
Acute coronary syndrome associated with Churg-Strauss syndrome
Annette Doris Wagner, Gerd Peter Meyer, Markus Rihl, Anke Rathmann, Ulrike Wittkop, et al
Vascular Health and Risk Management 2007, 3:775-779
Published Date: 15 November 2007
Emergency endovascular repair of acute descending thoracic aortic dissection
Muhammad Anees Sharif, Mark Edward O’Donnell, Paul Henry Blair, Peter Kennedy
Vascular Health and Risk Management 2007, 3:769-773
Published Date: 15 November 2007
Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function
Matthias Thielmann, Peter Hunold, Claudia Böhm, Parwis Massoudy, Heinz Jakob
Vascular Health and Risk Management 2007, 3:763-768
Published Date: 15 November 2007
Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting
Brandon A Van Noord, Andrew H Lin, Jeffery J Cavendish
Vascular Health and Risk Management 2007, 3:759-762
Published Date: 15 November 2007
Is general anesthesia a risk for myocardium? Effect of anesthesia on myocardial function as assessed by cardiac troponin-i in two different groups (isofluran+N2O inhalation and propofol+fentanyl iv anesthesia)
Demet Dogan Erol, Ibrahim Ozen
Vascular Health and Risk Management 2007, 3:755-758
Published Date: 15 November 2007
Determinants of outcome in patients eligible for thrombolysis for ischemic stroke
Valeria Caso, Maurizio Paciaroni, Michele Venti, Francesco Palmerini, Giorgio Silvestrelli, et al
Vascular Health and Risk Management 2007, 3:749-754
Published Date: 15 November 2007
Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans
Kevin P Newman, Syamal K Bhattacharya, Ahmad Munir, Richard C Davis, Judith E Soberman, et al
Vascular Health and Risk Management 2007, 3:743-747
Published Date: 15 November 2007
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
Harold Bays, Peter H Jones
Vascular Health and Risk Management 2007, 3:733-742
Published Date: 15 November 2007
A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes
Mozhgan Dorkhan, Anders Frid
Vascular Health and Risk Management 2007, 3:721-731
Published Date: 15 November 2007
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin
FD Richard Hobbs
Vascular Health and Risk Management 2007, 3:711-719
Published Date: 15 November 2007
Management of intracerebral hemorrhage
Ramandeep Sahni, Jesse Weinberger
Vascular Health and Risk Management 2007, 3:701-709
Published Date: 15 November 2007
Utilizing enoxaparin in the management of STEMI
Andrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale
Vascular Health and Risk Management 2007, 3:691-700
Published Date: 15 November 2007
Optimizing combination treatment in the management of type 2 diabetes
Giuseppe Derosa, Salvadeo Sibilla
Vascular Health and Risk Management 2007, 3:665-671
Published Date: 15 November 2007
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia
Man-Chiu Poon
Vascular Health and Risk Management 2007, 3:655-664
Published Date: 15 November 2007
Nebivolol in the treatment of chronic heart failure
Angie Veverka, Jennifer L Salinas
Vascular Health and Risk Management 2007, 3:647-654
Published Date: 15 November 2007
A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus
WH Wilson Tang
Vascular Health and Risk Management 2007, 3:639-645
Published Date: 15 November 2007
Ischemic preconditioning: Protection against myocardial necrosis and apoptosis
Efstathios K Iliodromitis, Antigone Lazou, Dimitrios Th Kremastinos
Vascular Health and Risk Management 2007, 3:629-637
Published Date: 15 November 2007
Cholesterol lowering for secondary prevention: What statin dose should we use?
Kiranbir Josan, Finlay A McAlister
Vascular Health and Risk Management 2007, 3:615-627
Published Date: 15 November 2007
Are pleiotropic effects of statins real?
Alberto Corsini, Nicola Ferri, Michele Cortellaro
Vascular Health and Risk Management 2007, 3:611-613
Published Date: 15 November 2007
Aldosterone antagonism in heart failure
Alan B Miller
Vascular Health and Risk Management 2007, 3:605-609
Published Date: 15 November 2007
Comprehensive cardiovascular risk management – what does it mean in practice?
Leif Erhardt, Robert Moller, Juan García Puig
Vascular Health and Risk Management 2007, 3:587-603
Published Date: 15 November 2007
Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
John D Bisognano, Trent McLaughlin, Craig S Roberts, Simon SK Tang
Vascular Health and Risk Management 2007, 3:579-585
Published Date: 15 November 2007
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
Paolo Gelosa, Mauro Cimino, Alice Pignieri, Elena Tremoli, Uliano Guerrini, et al
Vascular Health and Risk Management 2007, 3:567-577
Published Date: 15 November 2007
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of hemophilia A
Amy D Shapiro
Vascular Health and Risk Management 2007, 3:555-565
Published Date: 15 November 2007
ISVH Society September Newsletter
Vascular Health and Risk Management 2007, 3:0-0
Published Date: 15 November 2007
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
Ana T Rocha, Edison F Paiva, Arnaldo Lichtenstein, Rodolfo Milani Jr, Cyrillo Cavalheiro-Filho,
Francisco H Maffei
Vascular Health and Risk Management 2007, 3:533-553
Published Date: 15 September 2007
Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
Geir E Tjønnfjord, Pål Andre Holme
Vascular Health and Risk Management 2007, 3:527-531
Published Date: 15 September 2007
Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
José Tuñón, José Luis Martín-Ventura, Luis Miguel Blanco-Colio, Nieves Tarín, Jesús Egido
Vascular Health and Risk Management 2007, 3:521-526
Published Date: 15 September 2007
The burden of type 2 diabetes: strategies to prevent or delay onset
Nayyar Iqbal
Vascular Health and Risk Management 2007, 3:511-520
Published Date: 15 September 2007
Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
John M Stafford, Tom Elasy
Vascular Health and Risk Management 2007, 3:503-510
Published Date: 15 September 2007
Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease
Sven-Olof Olofsson, Olov Wiklund, Jan Borén
Vascular Health and Risk Management 2007, 3:491-502
Published Date: 15 September 2007
Update on stents: Recent studies on the TAXUS® stent system in small vessels
Shuzou Tanimoto, Joost Daemen, Patrick W Serruys
Vascular Health and Risk Management 2007, 3:481-490
Published Date: 15 September 2007
Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study
Anja Vogt, Ursula Kassner, Ulrike Hostalek, Elisabeth Steinhagen-Thiessen
Vascular Health and Risk Management 2007, 3:467-479
Published Date: 15 September 2007
Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
Sanjib Kumar Sharma, Piero Ruggenenti, Giuseppe Remuzzi
Vascular Health and Risk Management 2007, 3:453-465
Published Date: 15 September 2007
Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
Alaide Chieffo, Tiziana Claudia Aranzulla, Antonio Colombo
Vascular Health and Risk Management 2007, 3:441-451
Published Date: 15 September 2007
Bisoprolol in the treatment of chronic heart failure
Pascal de Groote, Pierre-Vladimir Ennezat, Fréderic Mouquet
Vascular Health and Risk Management 2007, 3:431-439
Published Date: 15 September 2007
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
Naylin Bissessor, Harvey White
Vascular Health and Risk Management 2007, 3:425-430
Published Date: 15 September 2007
Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus
Toshihiro Tsuruda, Johji Kato, Takahiro Sumi, Kazuya Mishima, Hiroyuki Masuyama, Hiroyuki Nakao, Takuroh Imamura, Tanenao Eto, Kazuo Kitamura
Vascular Health and Risk Management 2007, 3:417-423
Published Date: 15 September 2007
Occipital lobe infarctions are different
Halvor Naess, Ulrikke Waje-Andreassen, Lars Thomassen
Vascular Health and Risk Management 2007, 3:413-415
Published Date: 15 September 2007
Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis
Jerzy Krupinski, Marta M Turu, M Angels Font, Nesser Ahmed, Matthew Sullivan, Ana Luque, Francisco Rubio, Lina Badimon, Mark Slevin
Vascular Health and Risk Management 2007, 3:405-412
Published Date: 15 September 2007
Effect of continuous cisternal cerebrospinal fluid drainage for patients with thin subarachnoid hemorrhage
Yasunari Otawara, Kuniaki Ogasawara, Yoshitaka Kubo, Masayuki Sasoh, Akira Ogawa
Vascular Health and Risk Management 2007, 3:401-404
Published Date: 15 September 2007
Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension
Jalil Belghazi, Ramzi N El Feghali, Thérèse Moussalem, Maya Rejdych, Roland G Asmar
Vascular Health and Risk Management 2007, 3:389-400
Published Date: 15 September 2007
Arterial Stiffness and Pharmacological Interventions – The TRanscend Arterial stiffNess Substudy (TRANS study)
Jirar Topouchian, Ramzi El Feghali, Bruno Pannier, Shuyu Wang, Feng Zhao, Karel Smetana, Koon Teo, Roland Asmar
Vascular Health and Risk Management 2007, 3:381-388
Published Date: 15 September 2007
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy
Roland Asmar, Juan Garcia-Puig, Philippe Gosse, Yuri A Karpov, Peter Wilhem De Leeuw, Dieter Magometschniggs, Lajos Matos, Roland Schmieder
Vascular Health and Risk Management 2007, 3:371-380
Published Date: 15 September 2007
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study
Erland Erdmann, John Dormandy, Robert Wilcox, Massimo Massi-Benedetti, Bernard Charbonnel
Vascular Health and Risk Management 2007, 3:355-370
Published Date: 15 September 2007
Severe supraaortal atherosclerotic disease resembling Takayasu’s Arteritis
Bernhard Kis, Thomas Liebig, Peter Berlit
Vascular Health and Risk Management 2007, 3:351-354
Published Date: 15 July 2007
Noninvasive measurements of arterial stiffness: Repeatability and interrelationships with endothelial function and arterial morphology measures
Corey J Huck, Ulf G Bronas, Eric B Williamson, Christopher C Draheim, Daniel A Duprez, Donald R Dengel
Vascular Health and Risk Management 2007, 3:343-349
Published Date: 15 July 2007
Early retirement and the influence on healthcare budgets and insurance premiums in a diabetes population
Stefan Walzer
Vascular Health and Risk Management 2007, 3:331-341
Published Date: 15 July 2007
Management of acute coronary syndromes with fondaparinux
Harm Wienbergen, Uwe Zeymer
Vascular Health and Risk Management 2007, 3:321-329
Published Date: 15 July 2007
Multivariate risk assessment and risk score cards in hypertension
Giuliano Tocci, Valentina Valenti, Sebastiamo Sciarretta, Massimo Volpe
Vascular Health and Risk Management 2007, 3:313-320
Published Date: 15 July 2007
Rimonabant for treating tobacco dependence
Michael B Steinberg, Jonathan Foulds
Vascular Health and Risk Management 2007, 3:307-311
Published Date: 15 July 2007
Risk reduction with clopidogrel in the management of peripheral arterial disease
Keshav R Nayak, Jeffrey J Cavendish
Vascular Health and Risk Management 2007, 3:289-297
Published Date: 15 July 2007
Metoprolol succinate extended release/hydrochlorothiazide combination tablets
James W Hainer, Jennifer Sugg
Vascular Health and Risk Management 2007, 3:279-288
Published Date: 15 July 2007
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
Marc P Maillard, Michel Burnier
Vascular Health and Risk Management 2007, 3:265-278
Published Date: 15 July 2007
Manidipine–delapril combination in the management of hypertension
Manuel Luque Otero
Vascular Health and Risk Management 2007, 3:255-263
Published Date: 15 July 2007
Combining insulins for optimal blood glucose control in type 1 and 2 diabetes: focus on insulin glulisine
Heather Ulrich, Benjamin Snyder, Satish K Garg
Vascular Health and Risk Management 2007, 3:245-254
Published Date: 15 July 2007
Editorial: What future for vascular neurosurgery? || FREE PAPER ||
Matthew Crocker, Christos Tolias
Vascular Health and Risk Management 2007, 3:243-244
Published Date: 15 July 2007
Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial
Przemyslaw Kardas
Vascular Health and Risk Management 2007, 3:235-242
Published Date: 15 May 2007
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease
Nicolas W Shammas
Vascular Health and Risk Management 2007, 3:229-234
Published Date: 15 May 2007
Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome
Caroline Schmidt-Lucke, Heinz-Peter Schultheiss
Vascular Health and Risk Management 2007, 3:221-228
Published Date: 15 May 2007
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination
Andreas Pfützner, Birgit Wilhelm, Thomas Forst
Vascular Health and Risk Management 2007, 3:211-220
Published Date: 15 May 2007
Review of sitagliptin phosphate: a novel treatment for type 2 diabetes
Baptist Gallwitz
Vascular Health and Risk Management 2007, 3:203-210
Published Date: 15 May 2007
Sirolimus-eluting coronary stents: a review
Alexandre Abizaid
Vascular Health and Risk Management 2007, 3:191-201
Published Date: 15 May 2007
Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
Kirk A Bronander, Michael J Bloch
Vascular Health and Risk Management 2007, 3:181-190
Published Date: 15 May 2007
Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial
Jean-Jacques Mourad, Viet Nguyen, Marilucy Lopez-Sublet, Bernard Waeber
Vascular Health and Risk Management 2007, 3:173-180
Published Date: 15 March 2007
Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials
Ramzi EL Féghali, Sophie Nisse-Durgeat, Roland Asmar
Vascular Health and Risk Management 2007, 3:165-171
Published Date: 15 March 2007
Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2
Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, Karen A Grace
Vascular Health and Risk Management 2007, 3:159-164
Published Date: 15 March 2007
A review of sitaxsentan sodium in patients with pulmonary arterial hypertension
Aaron B Waxman
Vascular Health and Risk Management 2007, 3:151-157
Published Date: 15 March 2007
Overweight, physical activity and high blood pressure in children: a review of the literature
Brian Torrance, K Ashlee McGuire, Richard Lewanczuk, Jonathan McGavock
Vascular Health and Risk Management 2007, 3:139-149
Published Date: 15 March 2007
Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy
Christoph Schindler, Peter Bramlage, Wilhelm Kirch, Carlos M Ferrario
Vascular Health and Risk Management 2007, 3:125-137
Published Date: 15 March 2007
Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis
Peter J Little, Mandy L. Ballinger, Narin Osman
Vascular Health and Risk Management 2007, 3:117-124
Published Date: 15 March 2007
Management of atrial fibrillation
Puneet Kakar, Christopher J Boos, Gregory YH Lip
Vascular Health and Risk Management 2007, 3:109-116
Published Date: 15 March 2007
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
Jutta Dierkes, Claus Luley, Sabine Westphal
Vascular Health and Risk Management 2007, 3:99-108
Published Date: 15 March 2007
A review of picotamide in the reduction of cardiovascular events in diabetic patients
Andrea Celestini, Francesco Violi
Vascular Health and Risk Management 2007, 3:93-98
Published Date: 15 March 2007
Inhaled human insulin (Exubera®): clinical profile and patient considerations
Anthony H Barnett, Sri Bellary
Vascular Health and Risk Management 2007, 3:83-91
Published Date: 15 March 2007
Trandolapril/verapamil combination in hypertensive diabetic patients
José A García Donaire, Luis M Ruilope
Vascular Health and Risk Management 2007, 3:77-82
Published Date: 15 March 2007
Foot ulcers in the diabetic patient, prevention and treatment
Stephanie C Wu, Vickie R Driver, James S Wrobel, David G Armstrong
Vascular Health and Risk Management 2007, 3:65-76
Published Date: 15 March 2007
Cardiometabolic aspects of polycystic ovarian syndrome
Li Wei Cho, Harpal S Randeva, Stephen L Atkin
Vascular Health and Risk Management 2007, 3:55-63
Published Date: 15 March 2007
What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of: “All that is necessary for the triumph of evil is that good men do nothing?”
Chris R Triggle, David J Triggle
Vascular Health and Risk Management 2007, 3:39-53
Published Date: 15 March 2007
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-Pedersen
Vascular Health and Risk Management 2007, 3:31-37
Published Date: 15 March 2007
Moexipril and left ventricular hypertrophy
George S Chrysant, PK Nguyen
Vascular Health and Risk Management 2007, 3:23-30
Published Date: 15 March 2007
A review of pulmonary arterial hypertension: role of ambrisentan
Robyn J Barst
Vascular Health and Risk Management 2007, 3:11-22
Published Date: 15 March 2007
Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme
Luis Miguel Ruilope, Josep Redón, Roland Schmieder
Vascular Health and Risk Management 2007, 3:1-9
Published Date: 15 March 2007
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level
Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, Maria Carla Roncaglioni, on behalf of the Collaborative Group Risk and Prevention Study
Vascular Health and Risk Management 2006, 2:507-514
Published Date: 15 December 2006
Hypothyroidism in coronary heart disease and its relation to selected risk factors
Otto Mayer Jr, Jaroslav Šimon, Jan Filipovský, Markéta Plášková, Richard Pikner
Vascular Health and Risk Management 2006, 2:499-506
Published Date: 15 December 2006
Assessment of cognitive function in patients with essential hypertension treated with lercanidipine
J Tisaire-Sánchez, J Roma, Ignacio Camacho-Azcargorta, J Bueno-Gómez, J Mora-Maciá, Angel Navarro
Vascular Health and Risk Management 2006, 2:491-498
Published Date: 15 December 2006
Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects
Liliana Legedz, Giampiero Bricca, Pierre Lantelme, Marie-Odile Rial, Pierre Champomier, Madeleine Vincent, Hugues Milon
Vascular Health and Risk Management 2006, 2:485-490
Published Date: 15 December 2006
Outcomes of coronary artery bypass graft surgery
Anna Louise Hawkes, Madeleine Nowak, Benjamin Bidstrup, Richard Speare
Vascular Health and Risk Management 2006, 2:477-484
Published Date: 15 December 2006
Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment
Leila Fernandes Araujo, Alexandre de Matos Soeiro, Juliano Lara Fernandes, Antônio Eduardo Pesaro, Carlos V Serrano Jr
Vascular Health and Risk Management 2006, 2:465-475
Published Date: 15 December 2006
The impact of health literacy on cardiovascular disease
Richard S Safeer, Catherine E Cooke, Jann Keenan
Vascular Health and Risk Management 2006, 2:457-464
Published Date: 15 December 2006
Sexual function in hypertensive patients receiving treatment
Thorsten Reffelmann, Robert A Kloner
Vascular Health and Risk Management 2006, 2:447-455
Published Date: 15 December 2006
Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
JV (Ian) Nixon
Vascular Health and Risk Management 2006, 2:441-446
Published Date: 15 December 2006
Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
Heng Joo Ng, Lai Heng Lee
Vascular Health and Risk Management 2006, 2:433-440
Published Date: 15 December 2006
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
Melvin R Echols, Clyde W Yancy
Vascular Health and Risk Management 2006, 2:423-431
Published Date: 15 December 2006
Sildenafil in the treatment of pulmonary hypertension
Christopher F Barnett, Roberto F Machado
Vascular Health and Risk Management 2006, 2:411-422
Published Date: 15 December 2006
Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
Mark Greathouse
Vascular Health and Risk Management 2006, 2:401-409
Published Date: 15 December 2006
A review of levosimendan in the treatment of heart failure
Hulya Akhan Kasikcioglu, Nese Cam
Vascular Health and Risk Management 2006, 2:389-400
Published Date: 15 December 2006
Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)
Huyen Tran, Shamir R Mehta, John W Eikelboom
Vascular Health and Risk Management 2006, 2:379-387
Published Date: 15 December 2006
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
Alexander GG Turpie
Vascular Health and Risk Management 2006, 2:371-378
Published Date: 15 December 2006
Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery
David Bergqvist
Vascular Health and Risk Management 2006, 2:365-370
Published Date: 15 December 2006
Bivalirudin in percutaneous coronary intervention
Sam J Lehman, Derek P Chew
Vascular Health and Risk Management 2006, 2:357-363
Published Date: 15 December 2006
Management of cancer-associated venous thrombosis
Ozlem Er, Leo Zacharski
Vascular Health and Risk Management 2006, 2:351-356
Published Date: 15 December 2006
Olmesartan medoxomil: current status of its use in monotherapy
Hans R Brunner
Vascular Health and Risk Management 2006, 2:327-340
Published Date: 15 December 2006
Society News: ISVH – A multi-disciplinary society ||FREE PAPER||
Roland Asmar
Vascular Health and Risk Management 2006, 2:325-326
Published Date: 15 December 2006
A large scale study of angiotensin II inhibition therapy in an elderly population: the CHANCE study
Roland Asmar, Sophie Nisse-Durgeat
Vascular Health and Risk Management 2006, 2:317-323
Published Date: 15 September 2006
Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models
Demosthenes B Panagiotakos, Vassilis Stavrinos
Vascular Health and Risk Management 2006, 2:309-315
Published Date: 15 September 2006
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
Robert Weiss
Vascular Health and Risk Management 2006, 2:303-308
Published Date: 15 September 2006
Metabolic syndrome: the danger signal in atherosclerosis
Patrick Mathieu, Philippe Pibarot, Jean-Pierre Després
Vascular Health and Risk Management 2006, 2:285-302
Published Date: 15 September 2006
Insulin detemir in the treatment of type 1 and type 2 diabetes
Jean-Christophe Philips, André Scheen
Vascular Health and Risk Management 2006, 2:277-283
Published Date: 15 September 2006
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms
Sudesh Vasdev, Vicki Gill, Pawan K Singal
Vascular Health and Risk Management 2006, 2:263-276
Published Date: 15 September 2006
A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels
Clemens von Schacky
Vascular Health and Risk Management 2006, 2:251-262
Published Date: 15 September 2006
Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?
Jonathan R Emberson, Derrick A Bennett
Vascular Health and Risk Management 2006, 2:239-249
Published Date: 15 September 2006
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
Raed Osman, Philippe L L’Allier, Nader Elgharib, Jean-Claude Tardif
Vascular Health and Risk Management 2006, 2:221-237
Published Date: 15 September 2006
Angiogenesis in cancer
Naoyo Nishida, Hirohisa Yano, Takashi Nishida, Toshiharu Kamura, Masamichi Kojiro
Vascular Health and Risk Management 2006, 2:213-219
Published Date: 15 September 2006
Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
John Pullman, Tamara Darsow, Juan P Frias
Vascular Health and Risk Management 2006, 2:203-212
Published Date: 15 September 2006
A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours
Philippe Gosse
Vascular Health and Risk Management 2006, 2:195-201
Published Date: 15 September 2006
Editorial: Metabolic syndrome: sign of things to come ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2006, 2:193-194
Published Date: 15 September 2006
Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program
Martin Claridge, Simon Hobbs, Clive Quick, Donald Adam, Andrew Bradbury, Teun Wilmink
Vascular Health and Risk Management 2006, 2:189-191
Published Date: 15 June 2006
Vascular risks and management of obesity in children and adolescents
Courtney J Jolliffe, Ian Janssen
Vascular Health and Risk Management 2006, 2:171-187
Published Date: 15 June 2006
Leptin and hypertension in obesity
Paco E Bravo, Stephen Morse, David M Borne, Erwin A Aguilar, Efrain Reisin
Vascular Health and Risk Management 2006, 2:163-169
Published Date: 15 June 2006
Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence
Craig S Patch, Linda C Tapsell, Peter G Williams, Michelle Gordon
Vascular Health and Risk Management 2006, 2:157-162
Published Date: 15 June 2006
Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction
Krishnankutty Sudhir
Vascular Health and Risk Management 2006, 2:153-156
Published Date: 15 June 2006
Metabolic syndrome, inflammation and atherosclerosis
Rodolfo Paoletti, Chiara Bolego, Andrea Poli, Andrea Cignarella
Vascular Health and Risk Management 2006, 2:145-152
Published Date: 15 June 2006
The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J Materson
Vascular Health and Risk Management 2006, 2:139-144
Published Date: 15 June 2006
Valsartan in the treatment of heart attack survivors
Bodh I Jugdutt
Vascular Health and Risk Management 2006, 2:125-138
Published Date: 15 June 2006
A review of Perindopril in the reduction of cardiovascular events
Duncan J Campbell
Vascular Health and Risk Management 2006, 2:117-124
Published Date: 15 June 2006
Endovascular stent-graft placement for vascular failure of the thoracic aorta
Yoshihiko Kurimoto, Kiyofumi Morishita, Yasufumi Asai
Vascular Health and Risk Management 2006, 2:109-116
Published Date: 15 June 2006
Clinical implications of angiogenesis in cancers
Roberta WC Pang, Ronnie TP Poon
Vascular Health and Risk Management 2006, 2:97-108
Published Date: 15 June 2006
Editorial: Risk of cardiovascular events and cyclooxygenase-2 inhibitors ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2006, 2:95-96
Published Date: 15 June 2006
Evaluation of efficacy and safety of fixed dose lovastatin and niacinER combination in Asian Indian dyslipidemic patients: a multicentric study
Manoj Sharma, Deepika R Sharma, Vikram Singh, RB Panwar, HS Hira, Bishav Mohan, Naveen Kumar, SK Sharma, Rajeev Gupta
Vascular Health and Risk Management 2006, 2:87-93
Published Date: 15 March 2006
Effects of eprosartan on target organ protection
Alejandro de la Sierra
Vascular Health and Risk Management 2006, 2:79-85
Published Date: 15 March 2006
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
Catherine A Schnabel, Matthew Wintle, Orville Kolterman
Vascular Health and Risk Management 2006, 2:69-77
Published Date: 15 March 2006
Insulin glargine in the treatment of type 1 and type 2 diabetes 59
Anthony H Barnett
Vascular Health and Risk Management 2006, 2:59-67
Published Date: 15 March 2006
Ximelagatran: direct thrombin inhibitor
Shir-Jing Ho, Tim A Brighton
Vascular Health and Risk Management 2006, 2:49-58
Published Date: 15 March 2006
Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?
Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, Gregory A Volturo
Vascular Health and Risk Management 2006, 2:39-48
Published Date: 15 March 2006
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
Ryan C Neal, Peter H Jones
Vascular Health and Risk Management 2006, 2:31-38
Published Date: 15 March 2006
Noninvasive assessment of preclinical atherosclerosis
Helen A Lane, Jamie C Smith, J Stephen Davies
Vascular Health and Risk Management 2006, 2:19-30
Published Date: 15 March 2006
Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa
Todd W Rice
Vascular Health and Risk Management 2006, 2:3-18
Published Date: 15 March 2006
Editorial: Incidence of stroke after myocardial infarction ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2006, 2:1-2
Published Date: 15 March 2006
Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification
Elizabeth Turner, Victor Dishy, Cecilia P Chung, Paul Harris, Rosanna Pierce, Yu Asanuma, Annette Oeser, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, C Michael Stein
Vascular Health and Risk Management 2005, 1:357-360
Published Date: 15 December 2005
Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study
Jeetesh V Patel, Sandeep Gupta, Frank Lie, Elizabeth A Hughes
Vascular Health and Risk Management 2005, 1:351-356
Published Date: 15 December 2005
Prognostic factors for amputation or death in patients submitted to vascular surgery for acute limb ischemia
Clebes Fagundes, Flávio Danni Fuchs, Almondi Fagundes, Ronaldo A Poerschke, Maurício Z Vacaro
Vascular Health and Risk Management 2005, 1:345-349
Published Date: 15 December 2005
The genetic basis for altered blood vessel function in disease: large artery stiffening
Alex Agrotis
Vascular Health and Risk Management 2005, 1:333-344
Published Date: 15 December 2005
Optimal lipid modification: the rationale for combination therapy
James M Backes, Cheryl A Gibson, Patricia A Howard
Vascular Health and Risk Management 2005, 1:317-331
Published Date: 15 December 2005
A critical dialogue: communicating with type 2 diabetes patients about cardiovascular risk
Paris Roach, David Marrero
Vascular Health and Risk Management 2005, 1:301-307
Published Date: 15 December 2005
Pathophysiology of tumor neovascularization
Mitsuko Furuya, Mariko Nishiyama, Yoshitoshi Kasuya, Sadao Kimura, Hiroshi Ishikura
Vascular Health and Risk Management 2005, 1:277-290
Published Date: 15 December 2005
Drug-eluting stent: a review and update
Thein Htay, Ming W Liu
Vascular Health and Risk Management 2005, 1:263-276
Published Date: 15 December 2005
Editorial: Corticosteroids and endothelial dysfunction ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2005, 1:261-262
Published Date: 15 December 2005
Blood pressure and control of cardiovascular risk
Judith A Whitworth
Vascular Health and Risk Management 2005, 1:257-260
Published Date: 15 October 2005
Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral a1-adrenoceptor activation
Adriaan M Kamper, Anton JM de Craen, Rudi GJ Westendorp, Gerard J Blauw
Vascular Health and Risk Management 2005, 1:251-256
Published Date: 15 October 2005
Serial changes in plasma levels of cytokines in patients with coronary artery disease
Roberto H Heinisch, Carlos R Zanetti, Fabiano Comin, Juliano L Fernandes, José A Ramires, Carlos V Serrano Jr
Vascular Health and Risk Management 2005, 1:245-250
Published Date: 15 October 2005
Optimal blood pressure level and best measurement procedure in hemodialysis patients
Annie Saint-Remy, Jean-Marie Krzesinski
Vascular Health and Risk Management 2005, 1:235-244
Published Date: 15 October 2005
Ultrasound assessment of endothelial function in children
Mikko J Järvisalo, Olli T Raitakari
Vascular Health and Risk Management 2005, 1:227-233
Published Date: 15 October 2005
Premature coronary artery disease in Indians
Meenakshi Sharma, Nirmal Kumar Ganguly
Vascular Health and Risk Management 2005, 1:217-225
Published Date: 15 October 2005
Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus
Michio Otsuki, Kayoko Goya, Soji Kasayama
Vascular Health and Risk Management 2005, 1:209-215
Published Date: 15 October 2005
Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis
Soniya Survase, Melanie E Ivey, Julie Nigro, Narin Osman, Peter J Little
Vascular Health and Risk Management 2005, 1:199-208
Published Date: 15 October 2005
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome
Hadi AR Hadi, Cornelia S Carr, Jassim Al Suwaidi
Vascular Health and Risk Management 2005, 1:183-198
Published Date: 15 October 2005
Lercanidipine in hypertension
Claudio Borghi
Vascular Health and Risk Management 2005, 1:173-182
Published Date: 15 October 2005
Editorial: Guidelines for choosing drugs in chronic heart failure ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2005, 1:171-172
Published Date: 15 October 2005
Treatment of high blood pressure and gain in event-free life expectancy
Behrouz Kassaï, Jean-Pierre Boissel, Michel Cucherat, Florent Boutitie, François Gueyffier
Vascular Health and Risk Management 2005, 1:163-169
Published Date: 15 July 2005
Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia
Genovefa D Kolovou, Katherine Anagnostopoulou, Nektarios D Pilatis, Klelia D Salpea, Ioannis S Hoursalas, Ilias Petropoulos, Helen I Bilianou, Dennis V Cokkinos
Vascular Health and Risk Management 2005, 1:155-161
Published Date: 15 July 2005
Nonsteroidal antiinflammatory drugs are associated with increased aortic stiffness
Martin Claridge, Simon Hobbs, Clive Quick, Nick Day, Andrew Bradbury, Teun Wilmink
Vascular Health and Risk Management 2005, 1:149-153
Published Date: 15 July 2005
Knowledge of risk factors and warning signs of stroke
Marcus B Nicol, Amanda G Thrift
Vascular Health and Risk Management 2005, 1:137-147
Published Date: 15 July 2005
Carotid ultrasound assessment of patients with coronary artery disease: a useful index for risk
Roman Komorovsky, Alessandro Desideri
Vascular Health and Risk Management 2005, 1:131-136
Published Date: 15 July 2005
Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL
Giuseppe D Norata, Alberico L Catapano
Vascular Health and Risk Management 2005, 1:119-129
Published Date: 15 July 2005
Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?
Ramesh Mazhari, Judith Hsia
Vascular Health and Risk Management 2005, 1:111-117
Published Date: 15 July 2005
A new paradigm of cardiovascular risk factor modification
Muhammad Firdaus, Jeffery M Asbury, Dwight W Reynolds
Vascular Health and Risk Management 2005, 1:101-109
Published Date: 15 July 2005
Opinion - Thyroid (dys)function in heart failure: is it a potential target for medical treatment?
Alessandro Pingitore, Giorgio Iervasi
Vascular Health and Risk Management 2005, 1:97-100
Published Date: 15 July 2005
Opinion - Are we over oxidized? Oxidative stress, cardiovascular disease, and the future of intervention studies with antioxidants
Greg J Dusting, Chris Triggle
Vascular Health and Risk Management 2005, 1:93-96
Published Date: 15 July 2005
Editorial: Ecosinoids and blood vessel structure ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2005, 1:91-92
Published Date: 15 July 2005
Relationship between arterial stiffness and heart rate recovery in apparently healthy adults
Ding-Yu Fei, Ross Arena, James A Arrowood, Kenneth A Kraft
Vascular Health and Risk Management 2005, 1:85-89
Published Date: 15 April 2005
Folic acid: a marker of endothelial function in type 2 diabetes?
Arduino A Mangoni, Roy A Sherwood, Belinda Asonganyi, Emma L Ouldred, Stephen Thomas, Stephen HD Jackson
Vascular Health and Risk Management 2005, 1:79-83
Published Date: 15 April 2005
Restenosis after percutaneous angioplasty: the role of vascular inflammation
Martin Schillinger, Erich Minar
Vascular Health and Risk Management 2005, 1:73-78
Published Date: 15 April 2005
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium
Hong Ding, Chris R Triggle
Vascular Health and Risk Management 2005, 1:55-71
Published Date: 15 April 2005
New anticoagulants for the prevention and treatment of venous thromboembolism
Simon J McRae, Jeffrey S Ginsberg
Vascular Health and Risk Management 2005, 1:41-53
Published Date: 15 April 2005
Ongoing clinical trials of the pleiotropic effects of statins
Jean Davignon, Lawrence A Leiter
Vascular Health and Risk Management 2005, 1:29-40
Published Date: 15 April 2005
In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease
Rabea Asleh, Andrew P Levy
Vascular Health and Risk Management 2005, 1:19-28
Published Date: 15 April 2005
Cardiovascular risk assessment and management in developing countries
Shanthi Mendis
Vascular Health and Risk Management 2005, 1:15-18
Published Date: 15 April 2005
Barriers to and strategies for effective blood pressure control
David Siegel
Vascular Health and Risk Management 2005, 1:9-14
Published Date: 15 April 2005
Opinion - Coxibs: can this class of drugs survive?
Reza Tabrizchi
Vascular Health and Risk Management 2005, 1:5-8
Published Date: 15 April 2005
Opinion - Reducing cardiovascular risk: too little, too late, too short-term
David Gray
Vascular Health and Risk Management 2005, 1:3-5
Published Date: 15 April 2005
Editorial ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2005, 1:1-1
Published Date: 15 April 2005